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Summary  
Necrotizing enterocolitis (NEC), primarily seen in preterm infants, is associated with high 
morbidity and mortality. The pathogenesis is not fully understood but risk factors include 
prematurity, enteral feeding (especially with milk formula), and the intestinal microbiota. 
Mother’s milk, rich in bioactive factors, has a protective effect against NEC, but not all pre-
term infants are able to receive mother’s milk. The overall aim of this thesis was to investi-
gate if bovine colostrum (BC), also rich in bioactive factors, could serve as an alternative to 
mother’s milk. A preterm pig model of NEC was used to investigate the effect of BC products 
on intestinal structure, digestive and absorptive functions, microbiota, plasma and tissue pro-
teins and tissue gene expression levels of inflammatory markers. 
In Study I, the aim was to investigate if BC could correct intestinal dysfunction and reduce 
inflammation induced by total parenteral nutrition (TPN) combined with an abrupt transition 
to milk formula, which has shown to initiate detrimental intestinal responses. A group of pre-
term pigs fed milk formula followed by BC was compared with groups of preterm pigs fed 
either milk formula or BC alone after the TPN period. This study showed that BC feeding 
restores intestinal dysfunction and reduces a proinflammatory response induced by short term 
(6 hours) formula feeding to preterm TPN-fed pigs.  
A prerequisite for the use of BC in clinical settings is that a standardized product is readily 
available, and in Study II it was investigated if pasteurized and/or spray dried BC had similar 
beneficial effects on intestinal dysfunction and inflammation as fresh BC. Preterm pigs were 
given TPN for two days followed by 6 hours of formula feeding before given either formula, 
BC, spray dried BC, or pasteurized and spray dried BC. The study showed that even though 
spray drying and pasteurization affected BC proteins, pasteurized and/or spray dried BC de-
creased the severity of NEC in pigs compared with milk formula, while a tendency towards 
lower NEC severity was observed in pig fed raw BC compared with milk formula. All three 
BC products maintained trophic and anti-inflammatory effects on the immature pig intestine. 
A simple and standardized system was required to investigate the effects of milk formula 
versus BC on intestinal epithelial cells. In Study III, the IPEC-J2 cell line was evaluated as 
an in vitro model for the premature pig intestine. It was investigated if diet-induced effects 
could be observed on the expression of 48 epithelial- and immune response-related genes in 
IPEC-J2 cells stimulated with milk formula, BC or growth medium. Distal small intestinal 
samples from preterm pigs fed milk formula or colostrum were included for comparison. This 
study showed that careful considerations must be made prior to gene expression analysis of 
diet-induced responses in IPEC-J2 cells as a system for the premature intestine, since no diet-
induced effects in the IPEC-J2 cells were detected. 
C. perfringens is a pathogen associated with NEC in preterm infants and pigs, and in 
Study IV, the association between NEC and the abundance of C. perfringens and total bacte-
ria in intestinal samples from preterm pigs was investigated using quantitative polymerase 
chain reaction. Furthermore, host-pathogen interactions were investigated in IPEC-J2 cells by 
analyzing the expression of 48 epithelial- and immune response-related genes after stimula-
4 
 
tion with C. perfringens. An association between the abundance of total bacteria and C. per-
fringens and NEC was observed, and an in vitro study in IPEC-J2 cells showed that increased 
numbers of C. perfringens were associated with changes in gene expression response.  
To increase the effect of BC against C. perfringens, Study V aimed to investigate if BC 
with increased activity toward C. perfringens could be produced. Western blot confirmed that 
anti-C. perfringens hyperimmune BC could be produced by immunization of pregnant cows 
with a clostridial specific vaccine.  
In conclusion, BC products have a beneficial effect on the intestinal environment in pre-
term pigs based on improvements in intestinal structure, digestive and absorptive functions, 
the microbiota, and by reduced level of inflammatory markers. BC products, modified to meet 
the nutritional requirements of preterm infants, may serve as valuable alternatives to mother’s 
milk during the first critical days after birth. However, well-designed studies in preterm in-
fants are required to investigate if BC is a safe and effective alternative for these vulnerable 
infants when mother’s milk is not available. 
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Sammendrag  
Nekrotiserende enterocolitis (NEC), som primært ses hos præmature spædbørn, er forbundet 
med høj morbiditet og mortalitet. Patogenesen er ikke kendt fuldt ud, men risikofaktorer in-
kluderer præmaturitet, enteral ernæring (især modermælkserstatning) og tarmmicrobiotaen. 
Modermælk, rig på bioaktive faktorer, har en beskyttende effekt imod NEC, men ikke alle for 
tidligt fødte spædbørn har mulighed for at få modermælk. Formålet med denne afhandling var 
at undersøge om kocolostrum (BC), som også er rig på bioaktive faktorer, kunne tjene som et 
alternativ til modermælk. En præmatur grisemodel for NEC blev anvendt i studierne til at 
undersøge effekten af BC produkter på tarmens struktur, fordøjelses- og absorptionskapacitet, 
mikrobiota, og inflammatoriske markører målt på både vævs- og plasma- proteinniveauer og 
på vævs-genekspression niveau.  
Formålet med Studie I var at undersøge, om BC kunne korrigere tarm dysfunktion og in-
flammation induceret af total parenteral ernæring (TPN) kombineret med en brat overgang til 
modermælkserstatning, hvilket har vist at igangsætte skadelige reaktioner i tarmen. En gruppe 
præmature grise fik modermælkserstatning efterfulgt af BC og blev sammenlignet med grup-
per af præmature grise, som fik enten modermælkserstatning eller BC efter TPN. Dette studie 
viste, at BC ernæring kunne reversere tarmdysfunktion og reducere inflammation forårsaget 
af kortvarig (6 timer) ernæring med moderate mængder af modermælkserstatning til præmatu-
re TPN-ernærede grise.  
En forudsætning for brug af BC i klinikken er, at et standardiseret produkt er let tilgænge-
ligt, og Studie II undersøgte om pasteuriseret og/eller spraytørret BC var lige så gavnligt som 
frisk BC. Præmature grise fik TPN i to dage efterfulgt af 6 timers modermælkserstatning før 
de fik enten modermælkserstatning, BC, spraytørret BC, eller pasteuriseret og spraytørret BC. 
Studiet viste, at selvom spraytørring og pasteurisering påvirker BC proteiner, så blev en lave-
re grad af NEC observeret i grise, som fik spraytørret BC, eller pasteuriseret og spraytørret 
BC, mens grise, som fik BC, havde en tendens til lavere grad af NEC en modermælksernære-
de grise. All BC produkterne bevarede trofiske og antiinflammatoriske virkninger på den 
umodne tarm.  
Et simpelt og standardiseret system var nødvendigt til at undersøge effekterne af moder-
mælkserstatning versus BC på tarmepitelceller. I Studie III blev IPEC-J2 cellelinien vurderet 
som en mulig in vitro model for den præmature grisetarm. Diæt-inducerede forskelle på eks-
pressionen af 48	  epitel- og immunrespons-relaterede gener blev undersøgt i IPEC-J2 celler 
stimuleret med modermælkserstatning, BC eller vækstmedium. Vævsprøver fra den distale 
tyndtarm fra præmature grise ernæret med modermælkserstatning eller BC blev inkluderet til 
sammenligning. Studiet viste, at grundige overvejelser skal foretages inden genekspressionsa-
nalyse af diæt-inducerede reaktioner i IPEC-J2 celler som et system for den præmature tarm, 
da diæt-inducerede effekter i IPEC-J2 cellerne ikke kunne observeres.  
C. perfringens er en patogen bakterie associeret med NEC hos præmature spædbørn og gri-
se, og i Studie IV blev mængden af C. perfringens samt total bakterier i tarmprøver fra præ-
mature grise kvantificeret med qPCR. Endvidere blev vært-patogen interaktioner undersøgt i 
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IPEC-J2 celler ved at analysere ekspressionen af 48 epitel- og immunrespons-relaterede gener 
i IPEC-J2 celler stimuleret med C. perfringens. En association mellem C. perfringens eller 
total bakterier og NEC blev observeret, og in vitro studiet viste, at et øget antal C. perfringens 
er forbundet et ændret immunrespons. For at øge BCs aktivitet imod C. perfringens, blev det i 
Studie V undersøgt om hyperimmunt colostrum med øget aktivitet mod C. perfringens kunne 
produceres. Western blot blev anvendt til at bekræfte, at anti-C. perfringens hyperimmunt BC 
blev produceret ved immunisering af drægtige køer med en clostridia specifik vaccine. 
Sammenfattende kan det konkluderes, at BC produkter har en gavnlig effekt på tarmmiljø-
et hos præmature grise baseret på en forbedring i tarmens struktur, fordøjelses- og absorptions 
funktioner, mikrobiotaen og et reduceret niveau af inflammatoriske markører. BC produkter, 
modificeret så de opfylder de ernæringsmæssige krav fra det præmature spædbarn, kan være 
værdifulde alternativer til modermælk i de første kritiske dage efter fødslen. Imidlertid er vel-
designede studier i præmature spædbørn nødvendige for at undersøge om BC er sikkert og 
effektivt at bruge som ernæring for disse sårbare spædbørn, når modermælk ikke er tilgænge-
lig. 
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Abbreviations 
 
ApA Aminopeptidase A  NEC Necrotizing enterocolitis   
ApN Aminopeptidase N  NTC No-template control 
BC Bovine colostrum  OA Organic acids 
BHI Brain hearth infusion  PAF Platelet-activating factor   
BW Body weight  PBS Phosphate buffered saline 
CD Cluster of differentiation  PCA Principal component analysis 
cDNA  Complementary deoxyribonucleic 
acid 
 PCR Polymerase chain reaction 
CFU Colony forming units  POW Gamma-irradiated spray dried bovine colos-
trum 
COLOS  Gamma-irradiated  bovine colostrum   POWPAS Pasteurized, gamma-irradiated spray dried 
pasteurized bovine colostrum 
Cq Quantification cycle  PUFA Polyunsaturated fatty acids 
DNA Deoxyribonucleic acid  qPCR Quantitative PCR 
DPPIV Dipeptidyl peptidase IV  RIN RNA integrity number 
ELISA Enzyme-linked immunosorbent assay  RNA Ribonucleic acid 
FISH   Fluorescence in situ hybridisation    rRNA Ribosomal RNA 
IECs Intestinal epithelial cells  RT-qPCR Quantitative real-time reverse transcription 
PCR 
Ig Immunoglobulin   SDS-page Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis 
IGF Insulin-like growth factor  SEM Standard error of the mean 
IL Interleukin    sIgA Secretory IgA 
Lf Lactoferrin  SAA Serum amyloid A 
M Molecular weight marker  TGF Transforming growth factor 
MEN Minimal enteral nutrition  TLR Toll-like receptor   
MOI Multiplicity of infection  TNF Tumor necrosis factor 
mRNA Messenger RNA  TPN Total parenteral nutrition   
MSR deMan, Rogosa and Sharpe    
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Chapter 1 Introduction 
When an infant is born prematurely, major concerns rise for the parents regarding the short- 
and long-term perspectives for their child due to the high risk of complications. One of the 
most common critical and potentially lethal diseases in the preterm gastrointestinal tract is 
necrotizing enterocolitis (NEC), which contributes significantly to infant morbidity and mor-
tality in neonatal intensive care units. The primary predisposing factor for NEC is prematur-
ity, but enteral feeding (especially with milk formula) and abnormal bacterial colonization are 
considered prerequisites for NEC (1-3).   
Mother’s milk is rich in bioactive factors that support, protect, and mature intestinal func-
tion and structure, immune system, and microbiota (4). Bovine colostrum (BC) also rich in 
bioactive factors could be an alternative for the preterm infant when mother’s milk is not 
available. 
 The focus of this PhD project was to investigate the efficacy of BC and BC products on 
intestinal dysfunction and inflammation in a preterm pig model of NEC. The specific objec-
tives that were addressed are 
 
 
1. To investigate the ability of BC to restore intestinal dysfunction and reduce inflamma-
tion induced by total parenteral nutrition (TPN) combined with an abrupt transition to 
enteral feeding with milk formula. 
 
 
2. To compare the efficacy of pasteurized and/or spray dried BC to raw BC in the treat-
ment of intestinal dysfunction and inflammation. 
 
 
3. To characterize the IPEC-J2 cell line as an in vitro model for the premature pig intes-
tine based on the expression of multiple intestinal genes. 
 
 
4. To determine the association between C. perfringens and total bacterial abundance in 
the distal small intestine with NEC. 
 
 
5. To determine if hyperimmune BC against C. perfringens could be produced by immu-
nization of cows with clostridial antigens. 
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Following this Introduction (Chapter 1), three chapters (Chapter 2, The preterm gut; Chapter 
3, Colostrum; and Chapter 4, Models and Methods) will provide background knowledge for a 
discussion (Chapter 5) and conclusion (Chapter 6) of the objectives. The objectives were in-
vestigated through two papers submitted to peer-reviewed journals, one paper ready for sub-
mission, and two works still in progress. 
 
Paper I (Støy et al. (I)): Ann Cathrine F. Støy, Peter M. H. Heegaard, Thomas Thymann, 
Mette Bjerre, Kerstin Skovgaard, Mette Boye, Barbara Stoll, Mette Schmidt, Bent B. Jensen, 
Per T. Sangild. Bovine colostrum improves intestinal function following formula-induced gut 
inflammation in preterm pigs. Submitted to Clinical Nutrition. 
 
Paper II (Støy et al. (II)): Ann Cathrine F. Støy, Per T. Sangild, Kerstin Skovgaard, Thomas 
Thymann, Mette Bjerre, Dereck E. W. Chatterton, Stig Purup, Mette Boye, Peter M. H. 
Heegaard. Mild heat treatment does not reduce the colitis-protective effects of bovine colos-
trum in preterm pigs. Ready for submission. 
 
Paper III (Støy et al. (III)): Ann Cathrine F. Støy, Peter M. H. Heegaard, Per T. Sangild, 
Mette V. Østergaard, Kerstin Skovgaard. Gene expression analysis of the IPEC-J2 cell line as 
a simple system for the inflammation-sensitive preterm intestine. Submitted to Comparative 
and Functional Genomics. 
 
Paper IV (Støy et al. (IV)): Ann Cathrine F. Støy, Camilla L. Delègue, Thomas Thymann, 
Per T. Sangild, Peter M. H. Heegaard, Kerstin Skovgaard, Sarmauli Manurung, Lars Mølbak. 
Total bacterial and C. perfringens abundance is associated with necrotizing enterocolitis in 
preterm pigs, and C. perfringens induces gene expression changes in IPEC-J2 cells. Work in 
progress. 
 
Conference presentation (Støy et al. (V)): Ann Cathrine F. Støy, Per T. Sangild, Peter M. H. 
Heegaard. Bovine colostrum with hyperimmunity against Clostridia. Poster presentation at the 
“Alternatives to Antibiotics” Symposium in Paris, 25–28 September 2012. Work in progress. 
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Chapter 2 The preterm gut  
A preterm infant is born before the 37th week’s gestation with varying degree of immaturity of 
the organs including the gastrointestinal tract, which is a key risk factor for the development 
of NEC. In this section, a short description of NEC will be given, followed by a discussion of 
how immaturity of the intestine and the gut immune system, and an abnormal microbiota con-
tributes to the pathogenesis of NEC. Throughout this chapter reference will be made to hu-
mans unless otherwise stated.  
 
Necrotizing enterocolitis  
NEC is the most common gastrointestinal disease in premature infants, affecting up to 12% of 
infants in neonatal intensive care units. Preterm infants account for 90% of the cases, and 
NEC is inversely related to gestational age at birth and birth weight, thereby making prema-
turity a key risk factor (1;5;6). Other contributing factors are bacterial colonization and enteral 
feeding, especially with milk formula. Altered blood flow leading to ischemia and mucosal 
injury may also contribute to the pathogenesis of NEC (1-3;7).  
The most frequently affected part of the gastrointestinal tract is the ileo-colic region where 
a mucosal or transmural necrotic segment develops, but gangrene may extend from the stom-
ach to the rectum (3;8-10). The affected part of the intestine becomes dull, dilated, and grey, 
and extensive hemorrhage and pneumatosis intestinalis may be observed (9-12). The staging 
system proposed by Bell et al. (13) can be employed to diagnose and classify the severity of 
NEC (Table 1). The onset can be insidious or fulminant and is characterized by inflammation 
and necrosis. The disease ranges from mild cases with diarrhea and occult blood in the stool 
to severe cases with pneumatosis intestinalis and transmural necrosis that rapidly can progress 
into peritonitis, sepsis, shock, or multisystem organ failure. NEC is fatal in up to 40% of the 
cases (1;5;6;9;14).  
Due to the incomplete understanding of the mechanisms leading to NEC, the management 
strategies are only partly effective in many patients (15). Most cases of NEC are medically 
managed, and supportive care and medical stabilization including termination of enteral nutri-
tion and provision of antibiotics is initiated when NEC is suspected (9;11;16). However, in 
approximately half of the cases, intestinal resection is necessary, which contributes to a con-
siderable subsequent morbidity and a mortality rate of up to 60% (1;5;9).  
The most serious long-term postoperative complication is short bowel syndrome that may 
result in growth failure and malnutrition, and moreover patients surviving NEC are at risk of 
impairments including increased risk of functional and developmental delay that affect family 
life (5;9;14;17). As presented here, NEC is a severe gastrointestinal disease with short- and 
long-term consequences for both the child and its parents, and being a major societal cost 
(18), and a disease with no exact prevention- or treatment strategy, this justifies the significant 
research done within this field. 
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Table 1. Modified Bell’s criteria for staging of NEC (adapted from (13;19)). 
Stage Abdominal  Systemic Radiographic 
Stage 1a  
suspected NEC 
elevated pregavage residuals 
mild abdominal distension 
occult blood in stool 
temperature instability, apnea, 
bradycardia 
normal or intestinal 
dilatation, mild ileus 
Stage 1b 
suspected NEC 
grossly bloody stool same as above same as above 
Stage 2a  
definite NEC 
mildly ill 
same as stage 1 plus  
lack of bowel sounds,  
possible abdominal tenderness 
same as above ileus, pneumatosis 
intestinalis 
Stage 2b  
definite NEC 
moderately ill 
same as above plus peritonitis, 
definite abdominal tenderness, 
possible abdominal cellulitis, 
right lower quadrant mass 
same as stage 1 plus mild 
metabolic 
acidosis, mild thrombocy-
topenia 
same as above plus 
possible portal 
venous gas 
Stage 3a  
advanced NEC 
severely ill; intact 
bowel 
same as above, with marked 
tenderness and abdominal 
distention 
same as stage 2b plus hy-
potension, 
bradycardia, severe apnea,  
combined respiratory and 
metabolic acidosis, dissemi-
nated intravascular coagula-
tion, and neutropenia 
same as above plus 
ascites 
 
 
Stage 3b  
advanced NEC 
severely ill, perfo-
rated bowel 
same as stage 3a same as stage 3a pneumoperitoneum 
 
 
The preterm intestine  
Intestinal maturation starts during the first trimester, and from mid-gestation the fetus begins 
to swallow amniotic fluid stimulating intestinal maturation due to its content of several of the 
same bioactive factor as found in human milk including transforming growth factors (TGF)-β, 
lysozyme, lactoferrin (Lf) and hormones (2;20-22). At birth, the initiation of enteral feeding 
and stimuli from bacteria colonizing the intestinal tract will further stimulate development and 
maturation of the gastrointestinal tract and the gut associated immune system (23;24). Thus, 
dependent on the gestational age at birth, the preterm infant may be born with a compromised 
intestinal function compared with mature newborns.  
The gastrointestinal tract is a site for nutrient digestion and absorption, but it is also a ma-
jor immunological defense barrier, and its ability to optimal conduct these tasks in parallel is 
due to the interplay and synergistic effects of a number of different cell types. Along the small 
intestine the overall structure is similar (Figure 1); furthest away from the intestinal lumen is 
the serosa, followed by the muscularis externa, and submocusa. The muscularis mucosae lies 
between the submucosa and the lamina propia, and is responsible for peristalsis, which is only 
mature at 8 months of gestation (25-28). The mucosa comprises the lamina propia with 
Peyer’s patches, found only in the ileum, and the apical layer facing the intestinal lumen con-
sist of intestinal epithelial cells (IECs) (27). IECs constitute the major cell population of the 
mucosal epithelium and consist of four cell types: enteroendocrine-, goblet-, Paneth-, and ab-
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sorptive cells (29). The mucosal epithelium has a very large surface area (~200 m2) due to 
villi, and microvilli on the IECs, and begins to develop between 10 and 12 weeks of gestation 
(27;29). The small intestinal mucosa of newborn infants has mature crypt-villus architecture 
with continuous stem cell proliferation, differentiation and migration of cells to the top the 
villi where they are extruded (30). The IECs are joined by tight junctions responsible for the 
integrity and selective impermeability of the epithelial barrier (25;29). Tight junctions deter-
mine the guts permeability and regulate the fluctuation of fluids, selective permeability to 
small ions, absorption of nutrients, and functions as one of the first lines of defense towards 
luminal antigens. However, in preterm infants born before 34–35 weeks of gestation an in-
creased permeability of the intestine is seen, increasing the risk of bacterial and toxin translo-
cation (31). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Simplified illustration of the general structure of the small intestinal wall (modified after (27) 
and reproduced with permission from Polyteknisk Forlag). IEC (Intestinal epithelial cell). 
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Brush-border enzymes  
Mucosal injury as seen in NEC disrupts the crypt-villus architecture leading to reduced en-
terocyte renewal and villus heights. This has consequences for the intestinal digestive and 
absorptive functions and for the ability of the preterm infant to thrive. Brush-border enzymes 
are involved in digestion of carbohydrates and proteins and embedded in the microvilli (Fig-
ure 1). Lactase is located at the top of the villi, while sucrase and maltase are located at mid-
villus level (32-34). The brush-border enzymes may therefore be lost during mucosal damage. 
Prematurity disturbs the normal developmental pattern of these enzymes. Although brush-
border enzymes appear at 10–11 weeks of gestation (8), they first start to become active at 24 
weeks of gestation and as the fetus approaches term a significant rise in activities takes place 
(29;35). As an example, the last of the disaccharidases to develop is lactase, and	  at 34 weeks 
of gestation the activity of lactase is only 30% of that seen in term infants (33;34). After ini-
tiation of enteral nutrition, especially mother’s milk, the activity of lactase increases (36). 
This makes the investigation of diet-induced effects on brush-border enzyme function impor-
tant, so the infant’s ability to digest nutrients can be optimized.  
 
The mucosal layer  
The mucosal layer is formed by trefoil peptides and mucin glycoproteins secreted from gob-
lets cells, and surfactant lipids secreted by epithelial cells and covers the apical surface of the 
mucosal epithelium (37;38). Besides being a complex physicochemical barrier between the 
underlying tissues and the luminal environment, it is also a site for host-bacterial interactions 
(2;37-39). The expression and structure of glycoconjugates in the microvillus membrane is 
controlled by the host’s genome, and thus genetic susceptibility is a key factor in determining 
which bacteria have the best affinity to interact with the glycoconjugates (39-41). When in-
digenous bacteria colonize the intestine, they affect biochemical, physiological, and immu-
nological functions of the host (42;43), and ferment nutrients and produce metabolites like 
organic acids (OA) and bacteriocins (39-41;44-47). This may affect the interaction of patho-
genic bacteria with the mucosal layer and thus may prevent bacteria-induced diseases and 
intestinal damage. In the preterm gut, the composition of the glycoconjugates differ from that 
of the mature epithelium, and this immaturity combined with a reduced number of glycocon-
jugates in the immature epithelium may contribute to the development of an abnormal intesti-
nal microbiota (2). Furthermore, a lack of trefoil factor peptides in infants with NEC is seen 
compared with healthy infants and adults, and this may impair the function and restoration of 
the mucosal layer (48). 
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The preterm gut immune system  
The gut immune system is a very important part of the immune system due to the extensive 
contact and interaction with the external environment (29;39), and it has to respond in a 
proper way against environmental factors like microbes and nutrients. In addition to special-
ized immune cells, IECs are also involved in immune responses. Besides their function as a 
physical barrier, IECs initiate and coordinate the immune response though secretion of cyto-
kines, chemokines and antibacterial peptides (39;49;50). Due to this central role in the im-
mune response, it is relevant to study the IECs response towards diet and C. perfringens as 
performed with the IPEC-J2 cell line in Støy et al. (III;IV). Dendritic cell extensions sampling 
antigens in the intestinal lumen and intraepithelial lymphocytes are distributed between the 
IECs (29). If an antigen crosses the first line of defense, the innate immune system will be 
activated followed by the adaptive immune system. The innate immune system provides non-
specific responses toward antigens, and is important in the immediate period after birth until 
activation of the adaptive immune system, which results in the establishment of a long lasting 
specific memory (28;29;51).  
In addition to the impaired intestinal epithelial barrier, the immune system is immature, as 
seen by deficiencies in complement system proteins (52), and a lower number and functional 
deficiencies, including decreased cytokine release, of total lymphocytes, B- and T cells 
(12;53). Furthermore, altered cytokine production in fetal monocytes with impaired interleu-
kin (IL-6) and tumor necrosis factor (TNF)-α synthesis, and reduced phagocytic capacity and 
expression of several adhesion molecules, but increased level of respiratory burst products in 
phagocytes (54) are seen in preterm infants compared with term infants and adults. This im-
maturity increases the risk of infections in the postnatal period, but the encounter with anti-
gens and microbes and processing of these under controlled conditions within the lymphatic 
system is essential for the maturation of the immune system (12). The interaction between 
dendritic cells and external antigens like commensal bacteria is of importance for the 
achievement of a balanced immune system responding properly towards antigens, and im-
mune responses are induced, resulting in either tolerance or activation of an immune re-
sponse. Upon microbial priming, dendritic cells drive the differentiation of naive T cells into 
T helper 1 (proinflammatory), T helper 2 (anti-inflammatory/antibody stimulating) or T regu-
latory cells (maintaining immune cell homeostasis) through cytokine production (28;55-57). 
This stimulation will also lead to B cell differentiation and the production of antibodies (28). 
  
The immature immune system and necrotizing enterocolitis  
Several proinflammatory mediators and markers of inflammation including IL-8, IL-6, plate-
let-activating factor (PAF), C-reactive protein, serum amyloid A (SAA), and TNF have been 
found to be implicated in the pathogenesis of NEC due to increased levels in plasma during 
NEC (58-63). The chemokine IL-8 may play a key role in providing an increased cellular ac-
tivity at the inflammation site, due to its stimulation of neutrophil migration. The concentra-
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tion of IL-8 in plasma has been found to correlate positively with the degree of, severity and 
onset of symptoms of NEC (58;59). After removal of the necrotic intestinal segment, a de-
crease in circulating IL-8 was observed (58). In contrast, the level of anti-inflammatory fac-
tors varies. The level of plasma acetylhydrolase, which degrades PAF, has been found to be 
lower in preterm infant (60). The expression of fecal HBD2 encoding the antimicrobial pep-
tide β-defensin2 has been found to be lower in severe NEC cases compared with cases with a 
moderate NEC disease course (64). In contrast, the plasma concentration of IL-1 receptor an-
tagonist and IL-10 is elevated in NEC infants compared with preterm infants without NEC 
(59;61).  
A high expression of toll-like receptor (TLR)-4 in intestinal mucosa that recognizes 
lipopolysaccharides from Gram-negative bacteria has been associated with NEC in both hu-
man, and experimental models of NEC, inducing NEC with hypoxia (65;66). This may lead to 
an increased level of TLR-4, and upon activation with lipopolysaccharides, an increased ac-
tivity of NF-κB and consequently an increased proinflammatory response (8;28;67). In con-
trast, absence of TLR-4 has shown to be protective against NEC in mice and rat models of 
NEC (65;66).  
Immunoglobulin (Ig) A is one of the main effectors of the mucosal immune system. It is 
released as secretory IgA (sIgA) into the intestinal lumen where it is responsible for immune 
exclusion by agglutination of microbes, and neutralization of pathogens and bacterial entero-
toxins, that otherwise may contribute to bacterial invasion of the intestinal mucosa and trans-
location that would lead to a systemic immune response (68-70). In relation to C. perfringens 
type A associated NEC (see later section), the prevention of a close contact between this op-
portunistic pathogenic bacterium and the epithelial barrier is of importance, since this bacte-
rium, as with C. perfringens type C, may up regulate toxin production when in close contact 
with the epithelium (71). The role of the commensal bacteria is of importance for the sIgA 
production. Bifidobacterial diversity may enhance mucosal sIgA maturation, while lack of 
bacterial exposure in germ-free animals may result in an underdevelopment of Peyer’s 
patches, which are lymphoid follicles containing a large number of B- and T cells, and an 
deficiency of sIgA (28;29;72).  It may take several weeks before a proper antibody response is 
provided (51), and not until two weeks after birth, sIgA producing plasma cells begin to ap-
pear in the lamina propia. The delay of sIgA may therefore be explained by the decreased 
number of sIgA producing plasma cells in the intestinal mucosa of newborn infants compared 
with older infant (73;74).  
 
The microbiota  
Colonization of the sterile neonatal gut is a complex process with great variations, and the 
colonization pattern in preterm infants is different from that of term infants, and these differ-
ences in colonization may be important for the development NEC.  
In full-term vaginally delivered infants, the initial colonizing bacteria resembles those of 
the maternal gut- and/or vaginal microbiota and include facultative anaerobic or aerobic bac-
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teria like enterobacteria, enterococci, streptococci, staphylococci, clostridia, and lactobacilli 
(75;76). In contrast, Caesarean section results in colonization of a larger number of bacteria 
from the environment (76-78), and delays the colonization process in both pigs and humans, 
but these differences are not permanent (76;79). Hereafter, the type of diet is a major determi-
nant for the composition of the microbiota, but data on the nutritional impact, breast milk ver-
sus milk formula, on the microbiota is inconsistent. During the first month of life, which is of 
importance in relation to NEC, the predominant bacteria are Bifidobacterium and E. coli fol-
lowed by Lactobacillus, Bacteroides, with Bifidobacterium being predominating in breast-fed 
infants while formula fed infants have a more complex microbiota (76;80-85).  
The colonization pattern in preterm infants differs from that of full-term vaginally deliv-
ered infants. Preterm infants seem to have a lower bacterial density and a delayed coloniza-
tion. Colonization with the natural inhabitants of the intestine, Lactobacillus and Bifidobacte-
rium, may be deficient and delayed, which increases the risk of colonization with potentially 
pathogenic bacteria. This may in part be caused by the relatively aseptic environment in the 
neonatal intensive care units with isolation in incubators, hygiene procedures, and treatment 
with antibiotics (85-89).  
 
The microbiota and necrotizing enterocolitis 
An association between NEC and several enteric bacteria has been observed including E. coli 
(90;91), Klebsiella (90;91), Enterobacter (90), Enterococcus species and Candida albicans 
(92), S. fecalis, S. aureus, B. fragilis (91), and more strongly Clostridium species (90;91;93-
95). In contrast, other studies have not observed an association between NEC and a specific 
bacterial species (89;96-99). The mucosal layer normally prevents close contact between host 
cells and bacteria however, during intestinal frailty due to immaturity of the gastrointestinal 
tract as previously discussed, bacteria may invade the intestinal epithelium or translocate if a 
total breach of the epithelial lining occurs and thereby contribute to further intestinal injury. 
Since NEC has not been seen in stillborn infants or before the intestine is colonized (3;7;100), 
the microbiota seems to play an important role in NEC development. Still, it may first be in 
the late pathogenesis; since the immaturity of the gastrointestinal tract affects the microbiota 
both in relation to its composition, but it may also affect the behavior of the bacteria, as will 
be described next for C. perfringens.  
Gram-positive C. perfringens species are opportunistic pathogens associated with NEC in 
preterm infants, including C. perfringens type A (93), which also has been found in preterm 
pigs suffering from NEC (22;101). In Støy et al. (IV) the role of C. perfringens in NEC de-
velopment was investigated, and therefore is its pathogenic properties elucidated in the fol-
lowing.  
In preterm pigs with NEC, C. perfringens invaded the intestinal tissue, while it was located 
at the surface of the tissue in healthy pigs (102). This close contact between host cells and 
bacteria may lead to up regulation of toxins as showed by Vidal et al. (71), in which C. per-
fringens type C up regulated toxin production when in close contact with Caco-2 cell. This 
 18 
 
may also be seen with other C. perfringens subspecies, for example type A, and thus contrib-
ute to NEC, since the immature and frail intestine may allow a closer contact between bacteria 
and host cells. The production of toxins by clostridia may lead to tissue necrosis, and thus 
may account for a faster development of and more extensive gangrene as seen in clostridia-
associated NEC compared with NEC associated with Klebsiella, E. coli, or Bacteroides fragi-
lis (91). However, the concentration of α-toxin from C. perfringens type A does not seem to 
correlate with disease severity or mortality in preterm infants (93). Furthermore, metabolites 
from carbohydrate fermentation including butyrate, acetate and lactate may be toxic to the 
intestine (100;103). The inoculation with C. paraputrificum, C. butyricum, and α-toxin pro-
ducing C. perfringens type A in gnotobiotic quails are strongly implicated in the formation of 
cecal NEC lesions, possible through a short chain fatty acid profile with a high level of bu-
tyrate (100). This may result in more extensive pneumatosis intestinalis and increased inci-
dence of portal venous gas as seen in infants with clostridia-associated NEC compared with 
NEC associated with Klebsiella, E. coli, or Bacteroides fragilis (91). In a study by Smith et 
al. (99) the presence of C. butyricum and C. parputrificum correlated with histological pneu-
matosis intestinalis. Thus, when the opportunity is given, C. perfringens may be strongly im-
plicated in the late events of disease progression and contribute to a rapid and more severe 
NEC progression than other bacteria.  
 
Summary - necrotizing enterocolitis and the preterm gut 
Deficiencies in peristalsis, barrier function and digestive capacities, concomitant with an in-
appropriate intestinal immune response increase the susceptibility to inflammatory diseases, 
such as NEC, in preterm infants. Immaturity of the intestine leads to accumulation of undi-
gested nutrients in the intestinal lumen serving as bacterial substrate that can lead to bacterial 
overgrowth. Together with undigested nutrients, bacteria and toxins may not be flushed from 
the intestinal lumen due to increased transit time thereby stressing the mucosal barrier. This 
increases the risk of adherence of potential pathogenic bacteria, and combined with concomi-
tant intestinal frailty due to hyper-permeability and impaired intestinal restitution of an al-
ready weakened intestinal barrier the risk of a breach of the intestinal epithelium is signifi-
cant. A breach of the intestinal barrier increases bacterial and toxin translocation, which may 
result in pneumatosis intestinalis, and further activation of a systemic immune response. The 
immature immune response leads to an inflammatory cascade with increased tissue and serum 
levels of inflammatory mediators. This vicious cycle of events and ongoing inflammatory 
response may lead to NEC. These events might happen rapidly leading to shock, multisystem 
organ failure or be fatal. Dietary intervention with colostrum containing a high level of bioac-
tive factors may support the intestine during this immature period by improvement of the in-
testinal structure and function, dampen an increased inflammatory response and contribute to 
the establishment of a beneficial microbiota.  
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Chapter 3 Colostrum  
The type of nutrition and the feeding route play a significant role in the pathogenesis of NEC 
and several different nutritional strategies can be employed for preterm infants. Currently, 
research is performed in human infants and in several in vivo and in vitro models of NEC to 
determine the optimal nutritional strategy in relation to the type of diet, nutritional supple-
ments, and feeding route and volume. Mother´s milk is the natural and optimal diet for infants 
to support their nutritional demands. Nevertheless, alternatives need to be considered, because 
in several cases, mother’s milk cannot be provided.  
In the following sections, the focus will be on BC as one alternative to mother’s milk. Af-
ter an introducing section on colostrum and its nutritional composition, the focus will be on 
bioactive factors in colostrum and milk. Finally, the optimal nutritional strategy for the pre-
term infant and the effect of processing procedures on bioactive factors in colostrum will be 
discussed. The primary focus will be on the comparison of bovine and human colostrum, but 
comparison of bioactive factors in milk will be made if no reference is available on colostrum.  
 
Definition and composition of colostrum 
Colostrum not only serves as a basis for the growth of the newborn, it also has a high content 
of bioactive factors defined by Schrezenmeir et al. (104) as “food components that can affect 
biological processes or substrates and hence have an impact on body function or condition 
and ultimately health”. The bioactive factors assist the newborn in the maturational process 
and provide passive immunity against infections seen in the newborns immediate environ-
ment (70;105). Colostrum contains a large number of interacting factors, including proteins, 
carbohydrates, lipids, vitamins, minerals, electrolytes, and trace minerals, in addition to bacte-
ria and cells (Table 2 (106;107)).  
 
Table 2. Classes of human milk constituents (adapted from (106)). 
Proteins Carbohydrates Lipids Vitamins Minerals Cells 
Caseins Lactose Triglycerides Fat-soluble Calcium Leukocytes 
α-Lactalbumin Oligosaccharides Fatty acids A and carotene Phosphorus Epithelial cells 
Lactoferrin Bifidus factors Phospholipids D Magnesium  
Immunoglobulins Glycopeptides Sterols E Potassium Bacteriaa 
β-Lactoglobulin  Hydrocarbons K Sodium  
Lysozyme   Water-soluble  Chlorine  
Enzymes   Thiamin Sulfur  
Hormones   Riboflavin Trace elements 
Growth factors   Niacin Iodine  
Non-protein nitrogen compounds  Pantothenic acid Iron  
Urea   Biotin Copper  
Creatine   Folate Zinc  
Creatinine   Vitamin B6 Manganese  
Uric acid   Vitamin B12 Selenium  
Glucosamine   Vitamin C Chromium  
α-Amino nitrogen   Inositol Cobalt  
Nucleic acids   Choline   
Nucleotides      
Polyamines      
a References (107;113) 
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In humans, colostrum is produced during the first five days after birth, and gradually changes 
to mature milk during the first two weeks after birth (108;109). In this thesis, the following 
definitions are used regarding human milk. Preterm human colostrum and milk were collected 
from mothers giving birth preterm (~29 week of gestation), while full term colostrum and 
milk were collected from mothers giving birth at full term (> 37 week of gestation). Preterm 
and full term colostrum were collected at day 3–5 after birth, while preterm and full term milk 
were collected between day 8–29 after birth (110;111).  
BC is referred to as milk produced during the first 48 hours after parturition, and the high-
est amount of bioactive factors is found in colostrum from the first milking after birth (4;112). 
Therefore, colostrum from the first milking was used in the studies included in this thesis.  
In addition to a fluctuation of the amount of nutrients over time, the composition of colos-
trum is species dependent, it varies between individuals within a species, within each nursing, 
and is influenced by the health status of the mother (106;109). Fluctuations of macronutrients: 
proteins, carbohydrates and lipids over time and within species are evident (Table 3) and un-
derline that the neonate has specific needs at a certain time point and between species. This 
should be considered when formulating nutritional products to human infants based on BC 
and bovine milk. This is also an issue in the translational studies included in this thesis, in 
which bovine products are tested in preterm pigs, for which sow’s colostrum and milk are the 
optimal nutrient (Table 3). However, BC may be equal to sow’s colostrum in decreasing the 
risk of NEC development in preterm pigs (102). Besides, sow’s colostrum will probably not 
be considered as an alternative nutritional source in the clinics due to cultural considerations 
and production difficulties. This justifies the investigation of the possible use of BC products 
as possible nutritional alternatives for the human infant, and the use of a preterm pig model of 
NEC to study its effects. 
 
Proteins  
Milk proteins are broadly classified as caseins and whey proteins, and dependent on the spe-
cies, caseins constitute up to 80% of the total protein fraction (116). In human milk the whey-
to-casein ratio is 70:30 while it is 20:80 in bovine milk (117;118). Caseins: α-casein, β-casein 
and κ-casein, are phosphoproteins present in colostrum and milk only, and form micelles with 
calcium, phosphate, and magnesium ions (106). In the stomach, caseins are precipitated by 
gastric acids and enzymes including chymosin, and form a curd that retains the caseins in the 
stomach for a longer period of time than whey proteins, which remain soluble in the milk se-
rum (109;116;119). In the polypeptide chain of caseins, bioactive factors with possible im-
mune-modulating and antimicrobial capacities are hidden and can be released during enzy-
matic digestion of caseins (116;120). Whey proteins such as Ig, Lf, lactalbumin, lactoglobu-
lin, and serum albumin passes through the stomach to the small intestine after clotting of ca-
sein (45;116;118).  
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The protein content is higher in preterm human milk than full term human milk (110). Fur-
thermore, the content of several free amino acids, especially the essential amino acids, is sig-
nificantly higher in preterm human milk than full term human milk (121). 
 
Table 3. Macronutrient composition in human, bovine and porcine colostrum and milka. Addi-
tionally, the composition of the products used in the studies in this thesis is shown. 
 Total energy (Kcal/L) Protein (g/L) Lactose (g/L) Lipids (g/L) 
Human 
Preterm colostrum 580 ± 20b ~23b, c 50.4 ± 1.2b 30.0 ± 2.3b 
Preterm milk 710 ± 20b ~15b, c 59.7 ± 1.0b 43.3 ± 2.4b 
Full term colostrum 480 ± 30b ~20b, c 51.4 ± 2.2b 18.5 ± 3.5b 
Full term milk 590 ± 20b ~15b, c, d ~70b, d ~35b, d 
     
Bovine     
Colostrume 1430f ~150f, g ~26g ~60f, g 
Milk 660f 32 f, g ~50g ~45f, g 
     
Porcine h     
Colostrum ~1500 ~138 ~32 ~60 
Milk ~1070 ~53 ~55 ~66 
     
Products used in the studies included in this thesisi   
Colostrum    
COLOS 1000 110 35 50 
POW 900 100 35 40 
POWPAS 900 95 45 35 
     
Milk formula 1100 60 60 70 
a Data are presented as mean ± standard error of mean, or as an approximate value (~) when estimated 
from several studies or if SEM was not given. 
b (110). 
c (111). 
d (106). 
e First milking. 
f (112). 
g (114). 
h All data on sow’s colostrum and milk are obtained from (115). 
i Gamma-irradiated BC (COLOS), gamma-irradiated, spray dried BC (POW), pasteurized, gamma-
irradiated spray dried BC (POWPAS). 
 
 
Carbohydrates 
Lactose is the principal carbohydrate in human milk and consists of D-galactose and D-
glucose bonded through a β(1-4) glycosidic linkage, and is hydrolyzed by lactase (β-
galactosidase) to galactose and glucose, which are absorbed in the small intestine 
(33;106;122). In contrast to protein and fat, the concentration of lactose is lower in preterm 
human milk than in full term human milk (110).  
Human milk contains a range of moderate-chain-length carbohydrates, oligosaccharides 
and glycoconjugates with bioactive abilities (106). In contrast, the level of oligosaccharides in 
bovine milk is very low (123;124). Oligosaccharides function as prebiotics, which are non-
digestible food compounds acting as selective substrates for commensal bacteria in the colon 
by stimulating their growth and activity. This induces beneficial effects on the host’s health 
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(125). They thereby exert an indirect defense function by stimulating the succession of a 
beneficial microbiota, and inhibition of pathogen attachment to intestinal glycoconjugates by 
acting as analogs for these (105;126).  
 
Lipids 
Milk triglycerides account for 98% of the lipid content with the remaining content consisting 
of phospholipids, cholesterol, and free fatty acids (106;127;128). Lipids are the major source 
of energy in milk and are contained within membrane-enclosed milk fat globules that are dis-
persed in the milk serum. The globule membrane consists of phospholipids, cholesterol, and 
proteins while triglycerides constitute the core (106). Preterm human milk has a higher con-
tent of lipids than full term human milk (110). Long-chain polyunsaturated fatty acids 
(PUFA) have shown to reduce the incidence of NEC and intestinal inflammation in a neonatal 
rat model, and TLR4 and PAFR expression in IEC-6 cells has been blocked by PUFA supple-
mentation (129;130). 
 
Bioactive factors in colostrum 
Colostrum contains a huge number of bioactive factors (Table 4) that may aid in gastrointesti-
nal maturation, priming of the immune system, and the succession of a beneficial microbiota 
(4;12;22;105;131). These factors are relatively easy to isolate from colostrum or milk, but to 
provide evidence for their relevance is more difficult. The mere presence of a factor with a 
known effect in colostrum is not adequate to assume an effect in the gastrointestinal tract (12). 
To have physiological relevance, the bioactive factor has to pass through the gastrointestinal 
tract to the site of action without being degraded. To facilitate this, colostrum contains glyco-
proteins and protease inhibitors (inhibiting trypsin, chymotrypsin, and elastase) and further-
more, some factors are hard to digest by being acid resistant (132;133). On the contrary, some 
factors are activated by the acidic environment in the stomach, and furthermore, bioactive 
peptides may be released from proteins during enzymatic digestion in the gastrointestinal tract 
(116;120;134). Thus, bioactive factors have to be present in sufficient quantity, in an active 
state, and not being inhibited by other factors (12;131). 
The antimicrobial effect of bioactive factors can be due to a direct effect on the microbiota 
by agglutination of microbes and neutralization of pathogens by for example Igs, and degra-
dation of the bacterial cell walls by for example lysozyme and defensins (68-70;126). The 
antimicrobial effect may also be through modulation of the immune system. As an example, 
cluster of differentiation (CD) 14 is involved in the binding of lipopolysaccharides to TLR-4. 
Soluble CD14 is found in human colostrum and BC, but not milk formula, and may mediate 
this binding, and thereby play a role in the defense against Gram-negative pathogens (135). 
Both pro- (including IL-1β, IL-6, IL-8, and TNF-α) and anti-inflammatory (including IL-
10, TGF-β) cytokines are present in colostrum and milk (reviewed in (4;131)) and they have 
the potential to affect the immune response in the intestine. The concentration of cytokines 
(IL-1β, IL-6, TNF-α, INF-g and IL-1 recepter antagonist) has been found to be higher in bo-
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vine colostral whey than milk whey (136). At concentrations found in human milk, TGF-β 
and the hormone erythropoietin have shown to mediate a suppressive effect on TNF-α and IL-
1β induced IL-8 secretion in a fetal human enterocyte cell line	  (137). The presence of PAF-
acetylhydrolase in preterm human milk and full term human milk may compensate for the low 
plasma level of PAF-acetylhydrolase in preterm infant with NEC compared with age-matched 
control infants (60;138).  
 
Table 4. Overview of some immunological and antimicrobial factors found in colostrum and milk 
(adapted from (131)). 
Antimicrobial  Immune development  Anti-inflammatory Tolerance/priming 
Immunoglobulins: sIgA, 
SIgG, SIgM 
Macrophages Cytokines: IL-10, TGF-β Cytokines: IL-10 ; TGF-β 
Lactoferrin, lactoferricin B 
and H  
Neutrophils IL-1 receptor antagonist Anti-idiotypic antibodies  
Lysozyme  Lymphocytes TNF-α and IL-6 recep-
tors 
 
Lactoperoxidase Cytokines sCD14  
Nucleotide-hydrolyzing 
antibodies 
Growth factors Adhesion molecules  
κ-Casein and α-
lactalbumin 
Hormones Long-chain PUFA  
Haptocorrin  Milk peptides Osteoprotegerin  
Mucins  Long-chain PUFA Lactoferrin  
Lactadherin  Nucleotides  
Free secretatory compo-
nent  
Oligosaccharides and 
prebiotics 
Fatty acids  
Maternal leukocytes and 
cytokines  
Adhesion molecules  
sCD14   
Complement and comple-
ment receptors  
  
β-Defensin-1    
Toll-like receptors   
Bifidus factor   
Hormones and growth 
factors 
cortisol, estrogen, preg-
nadiol, progesterone, 
thyroid hormones, 
erythropoietin, go-
nadotropin, insulin, 
leptin, prolactin, procal-
citonin 
  
 
 
 
The achievement of tolerance may be affected by colostral factors. For example, TGF-β, IL-6, 
and IL-10 coupled with commensal bacteria and dietary antigens found in colostrum may aid 
in development of tolerance toward the commensal microbiota and dietary antigens. This is 
done through modulation of lymphocyte, macrophage and dendritic cell differentiation, pro-
liferation and activation (12;56;131 ;139;140). Finally, it is speculated that breast milk lym-
phocytes with immunological memory may have some modulating effects on the infant’s im-
mune response (56). The content of hormones and growth factors in colostrum may enhance 
intestinal barrier function and recovery after injury and modulate the intestinal response as 
described for erythropoietin (12;126).   
This short review of some of the effects of the bioactive factors presented in Table 4 
clearly shows that a huge number of factors may be of importance in achieving a beneficial 
gut environment in the preterm infant. All are probably of importance to some extent, but the 
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exact function of many of the factors is difficult to determine. It would be a very comprehen-
sive task to discuss them all in detail therefore, only the bioactive factor analyzed in Støy et 
al. (II): Ig, Lf, lactoperoxidase, insulin-like growth factor (IGF)-I and TGF-β will be further 
discussed.  
 
Immunoglobulins 
In mammals, five major classes of Igs have been classified: IgG, IgA, IgE, IgM, and IgD, 
which share the same basic chemical structure, but exert different biological functions in rela-
tion to the host defense against microbes (28). sIgA is the major Ig in human colostrum and 
decreases in mature milk. IgM and IgG are present in small amounts in human colostrum and 
milk (106). Igs remain stable on digestion with pepsin, trypsin, and chymotrypsin, thereby 
staying active in vivo to exert effects in the intestine (134). In humans, Igs are transferred 
from mother to fetus and provide passive immunity in the infants during the first period of 
life. However, this transfer occurs after 32 weeks of gestation thereby leaving preterm infants 
born earlier without this passive protection (12). In human colostrum and milk, the concentra-
tion of IgA and sIgA ranges between 2–9 g/L (106;141;142). The supply of antibodies is es-
sential for the newborn infant due to the decreased number of B cells and sIgA in the intesti-
nal mucosa during the first period after birth, as described previously (73;74). One study 
found that sIgA in preterm human milk seemed to be constant for a longer period of time, 
while it decreased in full term human milk during the first month (142). This gives a higher 
and much needed protection from sIgA in preterm infants during a longer period of time. 
However, mothers of preterm infants may not be able to provide colostrum and in these cases 
an alternative source of Igs could be BC.  
A high level of Igs in BC is important for the newborn calf, due to a lack of transfer of Igs 
over the placenta (143). In BC and bovine milk the primary Ig is IgG, and in BC the concen-
tration is approximately 80 g/L (total Ig: range 20–150 g/L) and drops to less than 2 g/L in 
mature milk (112;118;144). Hence, preterm infants not so fortunate to receive mother’s colos-
trum could get a passive protection from the IgG fraction in BC. To increase its effect on spe-
cific pathogens, hyper-immune colostrum with increased amount of Igs targeting a specific 
pathogen could be produced. Hyper-immune colostrum is produced when cows are immu-
nized during gestation with specific antigens, for example attenuated pathogens and their tox-
ins. After calving, a higher concentration of antibodies against these antigens will be secreted 
into colostrum. Hyperimmune colostrum products have been beneficial in the prevention and 
treatment of infections caused by E. coli (145) and rotavirus (146). One of the opportunistic 
pathogens associated with NEC is C. perfringens as previously described, and hyper-immune 
colostrum towards this bacterium could be used in cases with Clostridium associated NEC. 
Støy et al. (V) confirmed that hyper-immune BC against C. perfringens could be produced by 
immunizing cows with a clostridial vaccine. The increased level of anti-C. perfringens anti-
bodies could possibly neutralize C. perfringens in the intestinal lumen. 
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Lactoferrin and lactoperoxidase  
Lf is the dominating whey protein in human colostrum, and the levels in preterm- and full 
term human colostrum and milk vary (approximately 5 g/L (111;147)). However, in preterm 
human milk the concentration of Lf seems to remain rather constant for a longer period of 
time than full term human milk (111) and thus maintain an increased protection of the preterm 
infants for a longer period of time. In bovine milk the concentration is approximately 2 g/L in 
the first milking after parturition (112).  
Lf possesses many biological activities including antimicrobial- and immune modulatory 
effects, and thus plays an important role in the innate immune defense against infections 
(148). Lf has an antimicrobial effect due to iron-sequestration thereby competing for iron with 
iron-demanding bacteria for example E. coli (149). By reducing the availability of iron, Lf 
may reduce the numbers of possible pathogens, and thereby be indirectly involved in down 
regulation of immune cell recruitment and activation. Furthermore, Lf has a direct immune 
modulating effects, both anti- and proinflammatory (150;151). Lf remains stable on digestion 
with pepsin, trypsin, and chymotrypsin (134), but antimicrobial peptides, lactoferrincin B and 
lactoferrampin with effects toward Gram-positive- and negative bacteria may be released if Lf 
is digested (126;152;153).  
Lactoperoxidase is involved in the antimicrobial defense, and has a synergistic effect with 
Lf (154). Lactoperoxidase is found in BC and milk (approximately 0.03 g/L) (118), and in 
human colostrum (0.004% of the total protein content) (155).  
 
IGF-I and TGF-β 
The content of growth factors in colostrum is species dependent; in human milk, epidermal 
growth factor is dominating, while IGF-I and IGF-II dominates in BC (4). The concentration 
of IGF-I is much higher in bovine than human colostrum (300 versus 18 g/L) (112;156), and 
hereafter the level of IGF-I decreases rapidly (112). TGF-β and TGF-β-like molecules are 
present in high concentrations in BC (20–40 mg/L) and bovine milk (1–2 mg/L) (4), while in 
human colostrum the concentration of TGF-β1 is 650 pg/mL (range 0–8000 pg/L) and in 
milk, 250 pg/mL (range 0–8000 pg/L) (157).	  IGF-I and TGF-β survives the acidic conditions 
in the stomach thereby retaining their biological activity.	   IGFs are involved in the trans-
membrane transport and metabolism of various nutrients, and in the regulation of cell prolif-
eration and differentiation. TGF-β is involved in immune regulation for example by its anti-
inflammatory properties and in intestinal recovery after injury (reviewed in (4;131)). In pre-
term infants, the level of epidermal growth factor is reduced making the nutritional supply of 
growth factors important to stimulate intestinal barrier maturation (158). 
 
Nutritional strategy for the preterm infant 
One of the central risk factors for NEC development is the feeding regimen and the majority 
of infants developing NEC have received enteral nutrition (159;160). Human colostrum and 
milk is the natural diet for infants and is looked upon as the golden standard for infant nutri-
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tion. The World Health Organization recommends exclusive breastfeeding for all healthy 
women and infants from within an hour after birth and throughout the first 6 month of life 
(161). Mothers of preterm infants are often unable to provide milk, or enough milk, to their 
preterm infants (162). However, provision of the most optimal diet is of utmost importance 
for these vulnerable infants at high risk of complications including NEC. Recently the Ameri-
can Society for Parenteral and Enteral Nutrition put forward the clinical guidelines regarding 
nutritional support of neonatal patients at risk of NEC (18). These guidelines are based on a 
systematic review to provide evidence for different types of nutritional support to neonates at 
risk of NEC (Table 5). Question 1 (when and how should feeds be started in infants at high 
risk for NEC?) and question 2 (does the provision of mother’s milk reduce the risk of devel-
oping NEC relative to bovine-based products or formula?) are of special interest in relation to 
the objectives put forward in this thesis, and will be discussed next. 
 
Table 5. Nutrition support guideline recommendations for neonatal patients at risk for NEC put forward 
by the American Society for Parenteral and Enteral Nutrition (18). 
Question Recommendation Evidence 
1 When and how should feeds be 
started in infants at high risk for 
NEC? 
We suggest that minimal enteral nutrition should 
be initiated within the first 2 days of life and ad-
vanced by 30 mL/kg/d in infants ≥1000 g. 
 
Weak 
2 Does the provision of mother’s milk 
reduce the risk of developing NEC 
relative to bovine-based products 
or formula? 
We suggest the exclusive use of mother’s milk 
rather than bovine based products or formula in 
infants at risk for NEC. 
 
Weak 
    
3 Do probiotics reduce the risk of 
developing NEC? 
 
There are insufficient data to recommend the use 
of probiotics in infants at risk for NEC. 
 
Further research 
needed 
 
4 Do certain nutrients either prevent 
or predispose to the development 
of NEC? 
We do not recommend glutamine supplementa-
tion for infants at risk for NEC. 
 
There is insufficient evidence at this time to rec-
ommend arginine and/or long-chain polyunsatu-
rated fatty acid supplementation for infants at risk 
for NEC. 
 
Strong 
 
 
Further research 
needed 
 
5 When should feeds be reintroduced 
to infants with NEC? 
There are insufficient data to make a recommen-
dation regarding time to reintroduce feedings to 
infants after NEC. 
Further research 
needed 
 
 
TPN may be necessary to ensure adequate energy intake in cases with feeding intolerance. 
Unfortunately, negative consequences are observed with TPN, which have shown to result in 
mucosal atrophy and dysfunction and an increased incidence and degree of NEC in preterm 
pigs after the initiation of enteral feeding. Additionally, TPN may suppress intestinal function, 
and lactose digestion when enteral feeding is initiated (102;163). The optimal nutritional 
strategy may be minimal enteral nutrition (MEN) which is the combination of small doses of 
enteral nutrition and parenteral nutrition. This will provide the infant with adequate intake of 
nutrients and still provide the beneficial effects of enteral nutrition on intestinal and immune 
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system maturation, especially in preterm infants for who it is possible to give mother’s own 
milk or donor breast milk. As stated in Table 5, the effect of MEN remains uncertain in pre-
term infants (18;164). In contrast, the protection against NEC in preterm pigs is completely 
when colostrum is provided in slowly increasing volumes from the time of birth (165). There-
fore, further research is of importance to elucidate the optimal dose, volume initiation and 
advancement of MEN.  
There is no doubt that human breast milk should be the preferred choice of feeding for 
neonates, but for mothers unable to breast feed or express milk, donor milk is the preferred 
alternative option, while the second alternative is bovine milk-based infant formula. However, 
modified BC-based products could be a third alternative. Fluctuations of nutrients in colos-
trum and milk within time and species indicate that the milk is designed to different develop-
mental stages and species. The question is therefore, how important are these differences, and 
is it possible that colostrum or milk from different lactation periods and species can be good 
and safe alternatives to mother’s milk. A prospective observational study comparing preterm 
infants exclusively on mother’s own milk or mother’s own milk supplemented with donor 
milk showed that the amount of maternal milk was inversely correlated to NEC. Furthermore, 
the weight gain was improved in preterm infants fed exclusively mother’s own milk com-
pared with preterm infants fed mother’s own milk supplemented with donor milk (166). When 
comparing the two alternatives to human breast milk: donor milk and milk formula, a Coch-
rane review concluded that infant formula increased the risk of NEC in preterm infant com-
pared with donor breast milk (167). Nutrient-fortified donor milk is often used for preterm 
infants, but the majority of studies are conducted with non-fortified donor milk. Therefore, 
additional studies are required to investigate the effect of nutrient-fortified donor milk on the 
preterm infant in relation to for example NEC (167). Until now, results from studies compar-
ing fortified diets, either human-based or bovine/human-based, are inconsistent (162;168). In 
contrast, results from the preterm pig model of NEC are more clear, showing that preterm 
pigs fed bovine or porcine colostrum, or human banked milk have lower NEC incidence com-
pared with formula fed pigs (79;102;169;170). This also shows that colostrum or milk from 
one mammalian species may be effective in another species. In contrast, formula feeding re-
duces brush-border enzyme activity and nutrient absorption, and induces mucosal atrophy 
compared with colostrum feeding in preterm pigs, and this could potentially lead to inflamma-
tory responses and NEC (79;102).  
As shown in Table 5, several other potential nutrition therapies have been considered, but 
none has yet proven a success (18). Based on Cochrane reviews, no evidence support admini-
stration of oral Ig for the prevention of NEC (171), and there is no evidence of the efficacy of 
oral Lf prophylaxis to prevent NEC when given together with antibiotic therapy (172;173). 
Thus, it is of relevance to investigate which nutritional strategy is the safest and most benefi-
cial for the preterm infant when mother’s milk is not available.   
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Processing procedures 
The bacterial contamination standards are set at a very low level for infant formula or donor 
breast milk given to preterm infant (174). A prerequisite for the use of BC in a clinical setting 
is that a product with low bacterial contamination and which is easy to handle and store can 
be produced. Several processing methods can be employed to increase storage time, reduce 
bacterial load and facilitate handling of BC products. However, the bioactivity of BC also 
needs to be preserved, leaving the number of feasible methods limited. Pasteurized, gamma-
irradiated, and/or spray dried BC products were used in the studies in this thesis, and these 
processing methods will be presented and discussed next.  
Pasteurization does not lead to a sterile product; instead the number of viable organisms is 
reduced, thereby reducing the number of pathogens able to cause disease. Two common 
methods of pasteurization are used for milk and colostrum: high temperature, short time pas-
teurization (72 ºC for 15 sec) as used in Støy et al. (II), and Holder (batch) pasteurization at 
approximately 63 ºC for 30 min (143). Spray drying, performed by filter mat spray drying in 
Støy et al. (II) (confidence procedure, Biofiber-Damino), besides being a dry preservation 
method, increases handling and storage capacity of the colostrum. Spray drying is faster and 
less costly than other dehydration methods like freeze-drying and microwave vacuum evapo-
ration (175). 
Besides destruction of microorganisms, heat treatment may cause Maillard reactions (176), 
protein aggregation (177), inactivation of bioactive peptides and enzymes, and loss of certain 
vitamins, but the extent is temperature dependent (178;179). A review of the effects of pas-
teurization on several compounds in human milk can be found in (174), but the effects of pas-
teurization on the bioactive factors in focus in this thesis will be presented next.  
Holder pasteurization is often used to pasteurize donor milk (180), and has been found to 
both have little effect on the levels of IgA and Lf, but also to reduce the levels of IgA, IgG 
and Lf in human milk (181-183). The level of TGF-α and TGF-β2 (184), oligosaccharides 
(185) and PUFA (180) is preserved after Holder pasteurization. Pasteurization of colostrum at 
75 °C for 5 min reduces IgG by ~20% while a 59% reduction is seen at 95 °C for 15 s. In con-
trast, isolated IgG in phosphate buffered saline is reduced by a 100% at 95 °C for 15 s. This 
difference in reduction may be explained by the content of sugars or glycerol in colostrum, 
which protect and stabilize IgG during heat treatment (186). Furthermore, heat treatment 
causes conformational changes in the IgG molecule (187) and reduces the antigen-binding 
activity of bovine IgG (177). Pasteurization does not seem to alter the levels of IGF-I in milk, 
but heat treatment at 121 ºC for 5 min destroys IGF-I (188). Hence, the lower the temperature, 
the smaller is the negative effect on the concentration and bioactivity of several bioactive fac-
tors. Compared with other dehydration methods (freeze-drying and microwave vacuum 
evaporation), spray drying may preserve the quantity and function of Ig (175). Spray dried 
milk powder may have a poor solubility (176), which also was observed in Støy et al. (II). 
This may be caused by the formation of free milk lipids coating the powder particles thereby 
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reducing their solubility in water, but the solubility can be increased by coating the particles 
with surfactants like lecithin (176). 
The BC products used in the studies in this thesis were also sterilized by gamma-irradiation 
to eliminate possible contaminating organisms causing disease. Studies have shown that both 
structural changes and the amount of milk proteins (casein, β-lactoglobulin, IgA, and Lf) can 
be affected in varying degree by gamma-irradiation (181;189). The conditions (liquid or pow-
der) can also affect the proteins. No significant changes of gamma-irradiation were observed 
for β-lactoglobulin in a solid phase, while the protein aggregated when in a solution (190). A 
joint “Food and Agriculture Organization of the United Nations/International Atomic Energy 
Agency/World Health Organization” study group on high-dose irradiation has concluded that 
it is safe to consume gamma-irradiated food and that is does not cause toxicological hazard 
based on thorough scientific evidence (191).  
Briefly, it should be mentioned that colostrum may maintain its immunological properties 
during storage at -20°C for more than 6 months (192). This is relevant for the studies in this 
thesis, since the products have been stored at -20°C between production and use.  
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Chapter 4 Models and methods	 
In vivo and in vitro models are important to investigate human diseases, and can be used to 
investigate physiological mechanism, invasive intervention, or experimental designs not ethi-
cal to perform or practical to conduct in humans. These are significant considerations in rela-
tion to NEC, due to the vulnerability of preterm infants and the period in which action can be 
taken, since they may rapidly become seriously ill or are dying. For both in vivo and in vitro 
models, one should be cautious to apply results directly into the clinic due to interspecies 
variations. Additionally, ethical approval and considerations should be considered when em-
ploying in vivo models.  
In the following sections, the preterm pig model of NEC, the IPEC-J2 cell line, and the 
methods used to investigate the intestinal environment will be discussed, thereby justifying 
their usefulness to investigate the objectives put forward in this thesis. 
 
The preterm pig model of necrotizing enterocolitis 
Several animal models including flies, worms, mice, rats, rabbits, sheeps, quails, chickens and 
pigs can be used in NEC research (15;22;25;100;193-195). In this thesis, the preterm pig 
model of NEC has been chosen as in vivo model for NEC. Other models induce NEC with 
physical- (hypoxia) (3), chemical- (casein, endotoxin, PAF) (3;196), or microbiological (Clos-
tridium) stress factors (100;193;195;197). In preterm pigs, NEC develops due to prematurity, 
bacterial colonization and feeding strategies (22), much like in preterm infants. Additionally, 
the clinical setting with incubators, oxygen supply, heat-regulation, and the nutritional strat-
egy, including a TPN period is also used in the preterm model of NEC.  
 Enteral nutrition is a risk factor for NEC in both preterm infants (198) and preterm pigs 
(102). In preterm pigs, NEC only develops after the initiation of enteral nutrition (102) as in 
preterm infants, but the degree of NEC is dependent on the feeding regimen. If a TPN period 
precedes enteral nutrition, a higher incidence of NEC is seen in formula- (62% versus 39%) 
and sow’s colostrum (26% versus 5%) fed preterm pigs (102). The best protection against 
NEC in preterm pigs is seen when colostrum is given as MEN (165), while the effect of MEN 
in preterm infants remains uncertain (18;164). This indicates that the transition from TPN to 
enteral nutrition is challenging for the preterm neonate. Consequently, it is relevant to investi-
gate if it is possible to revert and restore any damage that happens during this challenging 
period as performed in Støy et al. (I).  
The pathogenesis and clinical signs of NEC in preterm pigs also closely resembles those 
observed in preterm infants (22;24;194). As shown in Table 1, the staging system proposed by 
Bell et al. (13) can be used to diagnose and classify the severity of NEC in preterm infants. In 
preterm infants and pigs, abdominal distension, feeding intolerance, regurgitation, and leth-
argy are some of the first signs of NEC (1;11;13;22). In preterm infants and pigs, NEC is 
most often seen in the ileo-colonic region, but in severe cases, the entire gastrointestinal tract 
can be affected (3;8-10;22;102), which also was observed in a few pigs in Støy et al. (I;II). 
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Furthermore, in some preterm pigs, NEC-like lesions were observed only in the stomach. This 
may be caused by the continued bolus feeding in preterm pigs despite appearance of clear 
signs of distress, which in preterm infants would lead to termination of enteral nutrition and 
bowel rest (9;11;16). Thus, several conditions and similarities favor the use of the preterm pig 
model of NEC in NEC research, but differences between humans and pigs exist, which may 
complicate interpretations of the results. In humans, Igs are transferred in utero from the 
mother to the fetus and will protect the newborn during the first period of life. This transfer 
lacks in pigs and makes them more vulnerable toward infections after birth (199). Hence, the 
preterm pigs are given maternal plasma during the first 24 hours after birth. As reviewed in 
(49), some part of the immune system in pigs differs from that of humans: pigs have some 
unusual immune cells including CD4/CD8 double-positive αβT cells; their lymph nodes have 
an inverted structure that could affect T cell trafficking; they have up to eight IgG subclasses; 
IgA is found primarily as dimers and larger polymers while monomeric IgA dominates in 
human serum; and antibody diversification happens early in life in Peyer’s patches and not in 
bone marrow throughout life as in humans. Furthermore, acute phase proteins may behave 
very differently during an acute phase reaction (200). However, the immune system appears 
to function in a similar fashion, and with the same result as in other species (49). Several of 
these differences are related to the adaptive immune response, and thus are of less relevance 
in relation to the preterm pig model of NEC, because the pigs are euthanized after 5 days, 
preventing a full initiation of the adaptive immune response.  
 The gestational length of the pig is shorter than of the human (114–116 days versus ap-
proximately 270 days) and the functional maturation of the gastrointestinal tract starts earlier 
in humans than pigs. This delayed maturation in pigs results in poor viability until 90% gesta-
tion is completed, whereas preterm infants can survive when 70% of the gestation is com-
pleted. However, the clusters of maturational changes of the GIT take place during rather 
similar periods (201). Therefore, it is of importance to choose a gestational time for delivery 
of the pigs by Caesarean section, where the maturational state of the preterm pigs, especially 
the gastrointestinal tract, most closely resembles that of preterm infants and where the pigs 
are able to survive. The optimal time for preterm delivery of pigs is therefore at 92% gestation 
(105–106 days) comparable to approximately 80% gestation (30 weeks) in humans (201). 
Figure 2 illustrates the overall experimental design, and more detailed protocols can be found 
in Støy et al. (I;II). 
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Figure 2. Experimental setup in the preterm pig model of NEC. Preterm pigs were delivered by Cae-
sarean section at 92% gestation and placed in incubators. They were given maternal serum during the 
first 24 hours after birth, and fed TPN for 2 days through a vascular catheter. Hereafter, the pigs re-
ceived enteral nutrition through an orogastric feeding tube and after ~2 days of enteral feeding pigs 
were euthanized, the tissue collected, and the intestine evaluated for NEC lesions. Caesarean section 
(a), preterm pig with an oral feeding tube (b), preterm pig in an incubator (c), incubators with preterm 
pigs (d), intestine with severe NEC (NEC severity score = 6, e), and a healthy intestine (NEC severity 
score = 1, f) (Støy 2007; Støy 2008). 
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0 h 48 h 72-102 h 
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IPEC-J2 cell line 
Cell lines give the opportunity to simplify the biological system of interest, in this case the 
small intestine, and investigate a limited number of interacting factors and components, which 
is impossible in the complex and heterogeneous intestinal tissue. The IPEC-J2 cell line is a 
non-transformed, nontumorigenic small intestinal cell line that originates from jejunal epithe-
lia isolated from an unsuckled neonatal pig less than 12 hours old (202;203) (Figure 3). The 
IPEC-J2 cell line has been a valuable tool in investigating host-pathogen interactions (202-
209), and thus could be a possible cell line for studying the effects of pathogens and diet on 
the IECs in relation to NEC research.  
 
 
Figure 3. IPEC-J2 cells (a) and IPEC-J2 cells infected with C. perfringens (Multiplicity of infection 
(MOI) = 20, b). Pictures are obtained from an infection study in chamber slides with essentially the 
same experimental set up as used in Støy et al. (III), (Støy 2011). 
 
 
The IPEC-J2 cell line shows great similarity with IECs with the presence of microvilli and 
tight junction, and in addition, they express porcine b-defensins, cytokines and TLRs, secrete 
mucin, and produce cytokines (202;203;209;210). Thus, the IPEC-J2 cell line is a convenient 
system to simulate innate immune functions of the intestinal epithelium and study the re-
sponse against diet and pathogens (C. perfringens) as performed in Støy et al. (III;IV). De-
spite, that the IPEC-J2 cell line is capable of producing the same cytokines as IECs, cell lines 
will never be identical to the original tissue, and can have a highly variable gene expression 
pattern. As with the preterm pig model of NEC, the cellular response is species-specific and 
this can lead to misinterpretation of results when transferring the results to humans. Further-
more, due to the simplicity of the cell line and thus lack of the interacting response from other 
cell types and tissues in the body, one should be careful not to over-interpret the results.  
To achieve the most optimal growth conditions for the IPEC-J2 cell line, Transwell-COL 
collagen-coated membranes were used in Støy et al. (III), which have shown to optimize the 
growth of IPEC-J2 cells so they differentiate into a single monolayer of polarized enterocyte-
like cells with apical microvilli, tight junctions, expression of occludin, and intercellular 
spaces (211). Furthermore, trans-epithelial electric resistance, a measure of functional integ-
a 
 
b 
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rity of the monolayer (confluence and viability), can be use as an indication of when to initi-
ate experiments (211).  
 
Laboratory analyses 
The methods used to analyze the intestinal response are divided into 3 areas of investigation: 
intestinal digestive function and morphology, immune response, and microbiota, and will be 
presented in the following sections. 
 
Intestinal digestive function and morphology  
To measure intestinal loss of structure and integrity, the following morphological measure-
ments can be used. Villi heights and crypt depths decrease during intestinal disease or injury, 
while intestinal circumference increases due to loss of muscular tone, and finally can mucosal 
mass decrease due to reduced activity of the mucosal surface (22). When the intestine loses its 
structure and integrity, the brush-border enzymes are lost, and thus the measure of brush-
border enzyme activity is both a measure of the activity of the enzymes, but a decreased activ-
ity may also give indication of intestinal injury. Plasma galactose absorption can be used as an 
estimate of the function of the sodium-glucose linked transporter 1, and thus the active car-
rier-mediated transport, while mucosal permeability can be estimated by the urinary lactulose-
to-mannitol ratio and thus give an idea of mucosal integrity and tight junction function 
(22;102;212). The used of sugars of different sizes has been used previously to determine in-
testinal permeability (213;214). Collectively, these methods to evaluate intestinal digestive 
function and morphology give a very good indication of the health status of the intestine, and 
how NEC progression and diet interventions affect the developing intestine. 
 
Intestinal immune response 
Gene expression was analyzed using quantitative reverse transcription polymerase chain reac-
tion (RT-qPCR), while the protein levels of inflammatory factors were investigated using a 
Luminex multiplex assay and an enzyme-linked immunosorbent assay (ELISA).  
 
Gene expression analysis 
RT-­‐qPCR	   allows	   quantification of complementary deoxyribonucleic acid (cDNA), reverse 
transcribed from messenger ribonucleic acid (mRNA), by measuring product formation upon 
amplification of cDNA at each polymerase chain reaction (PCR) cycle during the PCR reac-
tion. During the first PCR cycles, no product is detected because the fluorescent	  signal	  of	  the	  
amplicons	  is	  below	  the	  detection	  threshold.	  At	  one	  point,	  the	  fluorescence	  from	  the	  ac-­‐
cumulating	   amplicons	  will	   be	   detected	   dependent	   on	   the	   amount	   of	   starting	  material.	  
Hereafter,	   in	   theory,	   an	   exponential	   accumulation	   of	   amplicons	   occurs,	   resulting	   in	   a	  
doubling	  of	  the	  PCR	  product	  at	  each	  cycle.	  At	  some	  point,	  a	  shortage	  of	  PCR	  reagents	  will	  
lead	  to	  a	  level	  where	  the	  net	  synthesis	  approximates	  zero	  and	  the	  curve	  becomes	  hori-­‐
zontal.	  Quantification	  is	  done	  by	  placing	  a	  threshold	  line	  somewhere	  at	  the	  exponential	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phase	  thereby	  assigning	  a	  quantification cycle (Cq) value to each sample, which is inversely 
proportional	  to	  the	  start	  amount	  of	  transcript	  for	  the	  gene	  of	  interest	  in	  question	  (215).	  
Thus,	  a	  high	  Cq	  value	  is	  proportional	  to	  a	  low	  amount	  of	  template	  in	  the	  sample.	  
Two quantitative PCR (qPCR) platforms were used in the studies to investigate the effect 
of diet on the gene expression in distal small intestinal tissue from preterm pigs, and of diet 
and C. perfringens in IPEC-J2 cells. A Rotor gene Q platform (Qiagen, Ballerup, Denmark) 
was used to investigate a few genes related to inflammation in distal small intestinal tissue 
(Støy et al. (I;II)), while a high throughput platform (BioMark, Fluidigm Corporation, San 
Francisco, CA, USA) was used for analysis of multiple epithelial- and immune response-
related genes in the distal small intestinal tissue from preterm pigs and in IPEC-J2 cells (Støy 
et al. (III;IV)).  
To ensure an optimal experimental setup, the “Minimum information for publication of 
quantitative real-time PCR experiments” guidelines (216), which describe the minimum in-
formation necessary for evaluating qPCR experiments, were taken into account. Throughout 
the working procedures, from sample collection to data interpretation, the most optimal pro-
cedures possible were used to preserve the quality and integrity of the ribonucleic acid 
(RNA), which is the single most important factor to obtain a valid quantification (217). The 
scope of this section is not to give a thorough explanation of the methods or all considerations 
done; this can be found in Støy et al. (I;III). The focus will be on how to evaluate the quality 
and quantity of the RNA thereby assuring that the obtained results can be trusted. 
The quality of the purified RNA is variable and depends on initial sample (healthy or ne-
crotic tissue), storage, and extraction procedure. The RNA should be free of protein, genomic 
deoxyribonucleic acid (DNA), inhibitors (biological components from the sample or extrac-
tion reagents), and nucleases (217;218).	  Therefore, optical density measurement to quantify 
and qualify the RNA and DNase treatment to eliminate genomic DNA were included. Fur-
thermore, to examine the integrity of the RNA, a RNA integrity number (RIN) was calculated 
based on an algorithm that involves the 18S:28S ratio, 5S and other regions of ribosomal 
RNA (rRNA) (217;219). RIN ranges from 1 (degraded RNA) to 10 (high quality non-
degraded RNA). In the studies in this thesis, the mean RIN number was 6.5 (range 4.4–9.9) 
indicating that the RNA in general was of average quality and suitable for further analysis 
(217). The PCR efficiency, measured by the steepness of the standard curve, can assess the 
presence of inhibitors that can cause inaccurate or false-negative results (218;220). The opti-
mal qPCR reaction is a doubling of the amount of cDNA in each cycle indicated by a PCR 
efficiency of 100% but this is seldom achievable. The fluorescence dyes, SYBR Green and 
EVA Green, are non-specific dyes binding to double stranded DNA, and could lead to forma-
tion of primer-dimers resulting in additional fluorescence. Therefore, melting curves were 
evaluated to make sure that the right amplicon was obtained. Finally, no-template controls 
were included and evaluated to exclude contamination and nonspecific amplification. 
Normalization of the values to a number of reference genes is important to eliminate sam-
ple-to-sample differences in amount of mRNA and in the upstream procedures of qPCR. The 
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reference genes are stable genes adequately expressed in the tissue of interest, but with little 
expression variation between samples and thereby not affected by disease or experimental 
conditions. It is important to choose more than one reference gene as the expression of the 
gene can vary between tissues, cell lines and individuals (221-223). Several programs can be 
used to rank putative reference genes including GeNorm, which were used in the studies in 
this thesis. In GeNorm a stepwise exclusion of putative reference genes based on a gene-
stability measure followed by geometric averaging of the reference genes selected to be most 
stable gives the normalization factor (224). After normalization, the relative values between 
experimental groups can be compared.  
The gene expression does not always correlate with the protein level (225) however; gene 
expression analysis may provide knowledge of the immediate host response to a particular 
stimulus since mRNA is a measure of the immediate steady-state because it is short lived, 
while an accumulation of proteins is seen (225). 
 
Protein analysis 
For protein analysis of intestinal tissue and plasma, the Luminex multiplex assay (IL-1β, IL-6, 
IL-8, and IL-10) and ELISA (SAA) were used in Støy et al. (I;II). The two assays built on 
essentially the same sandwich principle, but in a multiplex assay, the primary antibody is 
coupled to a bead, while it is coupled to the well in an ELISA. 
The multiplex assay is based on color-coded beads (regions), where each region is coupled 
with monoclonal antibodies specific for one of the proteins of interest. Thus, several different 
regions each coupled with a specific monoclonal antibody can be added to the same well in a 
microtiter plate, and give the opportunity of simultaneous detection of multiple proteins of 
interest, for example inflammatory factors, within the same sample. The protein is then cap-
tured and detected by a biotinylated antibody specific for another region of the antigen than 
the primary antibody. When reading the sample in the Luminex reader, the beads pass by a 
dual laser, where the color code of the bead determines the protein type, while fluorescence of 
phycoerythrin-labeled streptavidin bound to the secondary antibody determines the amount of 
the protein (226-229). Several commercially multiplex kits are available for the simultaneous 
detection of proteins in humans and rodents, but only a limited number of assays are available 
for pigs (229;230). 
For both types of assays, multiplex or ELISA, several considerations have to be taken in 
relation to sensitivity, specificity, simplicity, reliability, costs and hand-on time (228), but it is 
not the scope of this thesis to thoroughly examine these. 
 
Intestinal microbiota 
Up to 500 bacterial species may colonize the intestine and the number of bacteria reaches 1012 
colony forming units/g contents in the colon (23;231). To analyze this complex microbiota 
several methods can be used, and in this thesis, the density of the microbiota was analyzed 
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using conventional culture-dependent microbiology, fluorescence in situ hybridization (FISH) 
and qPCR. 
Conventional culturing gives an estimate of the total amount of bacteria in a sample. In 
Støy et al. (I), the nutrition rich C-calves blood agar was used, which promotes the growth of 
a wide variety of microorganisms (232). However, approximately 50% of the intestinal mi-
crobiota consist of non-cultivable species, and moreover, bacteria are sensitive towards incu-
bation conditions, and may require certain nutrients thereby affecting the growth of certain 
bacteria, which can distort the results (47;233;234). Furthermore, culture-dependent methods 
are time- and labor consuming (47;235), but they give a visual presentation of the bacterial 
colonies, and pure isolates can be identified through sequencing of the 16S rRNA gene 
(233;236). 
FISH is a molecular method using bacterial oligonucleotide probes, either general or spe-
cific, that target the 16S- or 23S rRNA gene. FISH provides the opportunity to visualize bac-
terial cells in situ, gives information of the ecosystem under study, and is quantitative, thereby 
allowing enumeration in a culture-independent manner (47;237). However, cell impermeabil-
ity can lead to insufficient access of probes to the target site and may result in low fluorescent 
signal and erroneous interpretations. Furthermore, only probes to bacterial groups with a 
known 16S- or 23S rRNA gene can be designed. FISH is unsuitable for analysis of the diver-
sity of the total microbial community, since only a few species can be visualized at the same 
time (237;238). 
qPCR on the Rotor gene Q platform (Qiagen) was used to determine the absolute abun-
dance of total bacteria and C. perfringens in Støy et al. (IV). This analysis was based on es-
sentially the same principle as the qPCR described for gene expression analysis, but using 
TaqMan probe-based chemistry instead of DNA binding fluorescent dyes. 
Finally, organic acid (OA) measurements can provide information of abnormal bacterial 
fermentation of carbohydrates. Excess bacterial fermentation of carbohydrates leading to in-
creased concentration of OA or a non-favorable OA profile may injure the intestine and con-
tribute to NEC development (100;102;239). 
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Chapter 5 Summarizing discussion 
Dietary intervention with colostrum may support the function of the gastrointestinal tract and 
gut associated immune system, and the establishment of a beneficial microbiota, due to the 
high level of bioactive factors in colostrum as reviewed in Chapter 3. Studies have shown that 
raw BC protects against NEC in preterm pigs (102;240). Støy et al. (I) now documented that 
BC also has a beneficial and restoring effect on intestinal function and reduce pro-
inflammatory responses after milk formula-induced inflammation, which have shown to be 
present after a short period (8 hours) of milk formula feeding to preterm TPN-fed pigs (241). 
Furthermore, we showed that pasteurized and spray dried BC products reduced the severity of 
NEC lesions induced by formula feeding to TPN-fed preterm pigs (Støy et al. (II)), while 
feeding raw BC showed a tendency towards lower NEC severity than milk formula feeding to 
TPN-fed preterm pigs. Further studies are required to investigate what is responsible for this 
tendency towards an improved effect on NEC severity of pasteurized and/or spray dried BC 
products compared with raw BC and milk formula. 
A lower intestinal circumference (indicating better muscular tone) and colonic lactic acid 
production, in addition to increased villus height, enzyme activities and hexose absorption 
were observed in preterm pigs fed BC products (raw colostrum, pasteurized and/or spray 
dried colostrum) compared with preterm pigs fed milk formula. This supports previous stud-
ies showing a reduction of brush-border enzyme activity and nutrient absorption, and an in-
duction of mucosal atrophy in milk formula- compared with colostrum fed preterm pigs 
(79;102). Furthermore, BC products may affect the immune response as observed by de-
creased IL-1β and IL-8 tissue concentrations in pigs fed BC products compared with milk 
formula (Støy et al. (I;II)). A reduced concentration of intestinal IL-1β has also been observed 
in preterm pigs fed sow's colostrum compared with milk formula (169). Minekawa et al. (242) 
found that human breast milk suppresses IL-8 secretion induced by IL-1β and LPS in Caco-2 
cells, while BC may increase the production of IL-8 compared with skim milk or growth me-
dium in HT-29 cells (243). Therefore, caution should be applied when considering BC prod-
ucts to preterm infants. 
A positive correlation between IL-1β tissue concentration, the expression of IL1B, IL6, 
IL8, and SAA, and mean NEC severity was observed, while no correlation was observed for 
IL-8 tissue concentration or serum concentration of IL-10 and SAA (Støy et al. (I;II)). In-
creased concentrations of plasma IL-6, IL-8 and SAA have been observed in preterm infants 
with NEC (58;59;61-63), while no association between plasma IL-1β concentration and NEC 
has been observed (59). No correlation between the expression of TLR4 in intestinal tissue 
and NEC progression was observed in Støy et al. ((I;II)), as seen in other experimental mod-
els of NEC and in preterm infants (65;66). These differences, observed in inflammatory re-
sponses between preterm infants and pigs may be due to a different behavior of these inflam-
matory markers in different species, as observed for acute phase proteins (200). The expres-
sion of the anti-inflammatory cytokine IL10 in distal intestinal tissue was positively correlated 
with NEC in Støy et al. (I). In preterm infants, a higher plasma concentration of anti-
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inflammatory factors, IL-10 and IL-1 receptor antagonist, has been observed compared with 
infants not suffering from NEC (59;61). Furthermore, the expression of IL1RN, IkBA and 
TNPAIP3 was increased in IPEC-J2 cells concomitant with proinflammatory factors (Støy et 
al. (III;IV)). Up regulation of anti-inflammatory factors concomitantly with a proinflamma-
tory response is thus a part of a general immune response during infection or mucosal injury 
(59;61;225). 
No association between the type of diet and bacterial density was observed in Støy et al. 
(I;II). Thus, the bacterial density at the mucosal surface may be more correlated with disease 
progression than with the type and amount of the enteral diet (165). This is supported by a 
positive correlation between the severity of NEC and the total number of bacteria determined 
by FISH (Støy et al. (I;II)) and qPCR (Støy et al. (IV)). Also intestinal tissue from preterm 
infants suffering from NEC has been observed to be more heavily colonized by bacteria than 
tissue from infants not suffering from NEC, although no positive correlation was observed 
between bacterial density and NEC (99). Therefore, bacterial density more than specific bac-
teria may be important for the development of NEC as previously suggested (101). Intestinal 
immaturity may be responsible for bacterial overgrowth due to accumulation of undigested 
nutrients serving as substrate for bacterial fermentation and increased intestinal transit time 
(reviewed in Chapter 1). Furthermore, intestinal frailty during NEC may lead to increased 
access for bacteria to the intestinal epithelial, as observed by increased penetration into villi 
and translocation to muscularis mucosae (102;Støy et al. (I)). Collectively, this indicates that 
the involvement of bacteria in NEC development may not be part of the primary pathogene-
sis, but first contributes in the later events. One could speculate, that the association between a 
specific bacteria and NEC (90;91;93-95;Støy et al. (IV)) may be a cause of the general in-
crease in total bacteria. However, the role of the specific pathogens like C. perfringens in in-
testinal injury may still be significant due to production of toxin and metabolites as reviewed 
in Chapter 1. Furthermore, pathogenic bacteria may contribute to changes in gene expression 
in host cells as observed for C. perfringens in Støy et al. (IV) that may lead to adverse effects 
in the intestine.  
A preterm pig model of NEC and an IPEC-J2 cell line were used to investigate the effect 
of nutritional intervention on intestinal mucosal immunity and microbiota. As shown in Støy 
et al. (III), diet effects were seen on the intestinal gene expression in the preterm pig model of 
NEC, while no diet effects were seen in the IPEC-J2 cell line. In contrast, several genes were 
affected by increasing numbers of C. perfringens (Støy et al. (IV)), supporting other studies 
showing that the IPEC-J2 cell line is a valuable system for investigation of host-pathogen 
interactions (202-209). Cell lines provide important systems to investigate the interaction be-
tween a limited numbers of factors in a standardized setting, while animal models gives the 
opportunity to study dietary interventions on the organism as a whole. The cellular response is 
species-specific and this can lead to misinterpretation of results when transferring the results 
to humans. However, human research is dependent on studies in animal model and cell lines, 
since they provide the possibility to investigate physiological mechanism, invasive interven-
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tion, or experimental designs that are not ethically possible or practical to conduct in humans. 
In relation to the diet-dependent research of NEC, further studies in vitro, in vivo, but also in 
human preterm infants are required to investigate which nutritional strategy is most beneficial 
and safe for preterm infants.  
Clearly, mother’s colostrum and milk is arguably the first choice of nutrient, but milk for-
mula is a lifesaving alternative when mother’s milk or human donor milk is not available. The 
BC products investigated in this thesis, showed great potential against NEC in a preterm pig 
model of NEC. The beneficial effects of colostrum on the intestinal environment are undoubt-
edly due to multiple factors acting in concert to exert immune modulation, promote intestinal 
growth and the succession of a beneficial microbiota (reviewed in Chapter 3), and it is very 
unlikely that only a single factor is responsible. However, caution	  should	  be	  applied	  when	  
considering	   BC	   for	   preterm	   infants,	   especially	   unmodified,	   due	   to	   the	  marked	   species	  
differences	  in	  nutritional	  content	  (Chapter 3, Table 3). Results from studies in preterm in-
fants are inconsistent regarding the evidence for an association between increased risk of 
NEC when giving a human-based diet including bovine based products compared with an 
exclusively human-based diet (162;168). In contrast, results from the preterm pig model of 
NEC show that preterm pigs fed either bovine or porcine colostrum, or human banked milk 
have lower NEC incidence compared with pigs fed milk formula (79;102;169;170).  
When considering alternatives to mother’s own milk, processing procedures are required to 
achieve a low bacterial safety level. A temperature-dependent protein denaturation has been 
observed previously, showing that a higher temperature during heat treatment leads to in-
creased protein denaturation of some milk proteins, including IgG (182;186). However, the 
pasteurized and/or spray dried BC products maintained the beneficial biological effects on the 
preterm pig intestine to the same degree as BC, thereby suggesting that some extend of pro-
tein denaturation may not necessarily reduce the biological effect of colostrum bioactive fac-
tors (174). Furthermore, heat treatment of colostrum at temperatures similar to those used 
during pasteurization and spray drying of colostrum in Støy et al. (II) has shown not to radi-
cally affect the important passive transfer of immunity from colostrum to newborn calves (re-
viewed in (69;143)). As reviewed in Chapter 3 (Table 4), several other non-protein bioactive 
factors for example PUFA (106) are present in colostrum, and could account for some of the 
beneficial effects observed by the pasteurized and/or spray dried BC products. PUFA are not 
affected by Holder pasteurization (180;185), and one could speculate that PUFA also are pre-
served during high temperature, short time pasteurization. Furthermore, IGF-I was not af-
fected by heat treatment in Støy et al. (II), which also was observed in (188). Further studies 
in the preterm pig model of NEC could include groups of preterm pigs receiving BC products 
exposed to pasteurization and/or spray drying at lower or higher temperatures, to explore the 
effects of heat treatment on the beneficial effects of BC products seen in the preterm pig 
model of NEC. Gamma-irradiation did not appear to lead to significant denaturation of pro-
teins compared with non-irradiated colostrum from the same pool of colostrum (unpublished 
data, Støy et al. (II)), while other studies have shown that gamma-irradiation may lead to 
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structural changes in milk proteins (181;189). While powdered colostrum may be easier to 
handle and store, a poorer solubility of such products can be observed (176;Støy et al. (II)). 
However, solubility increases by coating of milk particles with surfactants like lecithin (176) 
or by gentle heating (< 50 ºC) (unpublished observations). To avoid processing, one alterna-
tive could be to feed raw donor breast milk as is currently practiced in some countries. How-
ever, the clinical outcome of this should be monitored, due to the presence of possible con-
taminating organisms in the raw milk that could cause diseases (174).  
The research done in this thesis showing a beneficial effect of BC products on the imma-
ture gastrointestinal tract may also benefit other patient groups by providing knowledge about 
the effects of a bioactive product in a sensitive model for intestinal inflammatory disorders, as 
the preterm pig model of NEC. Even though one should keep in mind that species and matu-
rational (term born infants and adult) specific responses are often present, these studies pro-
vide some general knowledge with regards to the nutritional impact on gut disease in general. 
Thus, BC products may prove to be beneficial for patients with other gastrointestinal diseases 
like short-bowel syndrome, inflammatory bowel disease, and mucosal injury caused by non-
steroidal anti-inflammatory drugs or chemotherapy (4;139;214;244). Despite a questionable 
use of hyperimmune colostrum for preterm infants (Støy et al. (V)) due to the involvement of 
several bacteria in the pathogenesis of NEC, it still may prove to be useful in the prevention 
and treatment of diseases caused by specific known pathogens (145;146;245). In relation to 
investigation of hyperimmune colostrum towards C. difficile, the preterm pig model of NEC 
could be a sensitive model to investigate the efficacy of anti-C. difficile hyperimmune colos-
trum, while the IPEC-J2 cell line could be used to test the anti-C. difficile activity.  
In relation to preterm infants, it	  is	  still	  relevant to investigate the efficacy and safety of BC 
products. However, some modifications of the BC products may be necessary to achieve a 
product that is safe and meets the nutritional requirements of preterm infants. 
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Chapter 6 Conclusion  
Based on the work presented in this thesis, it can be concluded that 
 
1. BC has a restoring effect on intestinal function and reduces intestinal inflammation af-
ter formula-induced intestinal inflammation in TPN-fed preterm pigs. 
 
2. Pasteurized and/or spray dried BC decrease the severity of NEC, while a tendency to-
wards lower NEC severity is observed when feeding raw BC compared with milk 
formula. All three BC products improve intestinal structure, function, and reduce the 
level of inflammatory markers relative to milk formula. Thus, pasteurized and/or spray 
dried BC are as effective as raw BC in the treatment of intestinal dysfunction and in-
flammation. 
 
3. Differences in gene expression to nutritional factors are seen between intestinal tissue 
from preterm pigs and IPEC-J2 cells, and no diet effects are observed in the IPEC-J2 
cells. Therefore careful considerations must be made prior to analysis and interpreta-
tion of diet-induced effects on gene expression in the IPEC-J2 cell line. In contrast, in-
creasing numbers of C. perfringens lead to changes in gene expression proving that 
the IPEC-J2 cell line is valuable in investigation of host-pathogen interactions. 
 
4. Increased abundance of total bacteria and C. perfringens is associated with NEC in a 
preterm pig model of NEC.  
 
5. Anti-C. perfringens hyper-immune BC is produced after immunization of late-
gestational cows with an Clostridia specific vaccine. 
 
The results from this thesis underline the importance of an optimal diet composition during 
the first enteral feeding period in preterm neonates. BC products, modified to meet the nutri-
tional requirements of preterm infants, may benefit preterm infants during the first critical and 
challenging period after birth. Further experimental studies in vivo and in vitro, in addition to 
well-designed studies in preterm infants are required to investigate if BC products could serve 
as safe and effective alternatives when mother’s milk is not available. 
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Abstract 
Background & Aims: In preterm infants, rapid transition from total parenteral nutrition to 
enteral nutrition, especially using infant formula, predisposes to necrotizing enterocolitis 
(NEC). A few hours of formula feeding induce proinflammatory effects in the preterm pig 
model of NEC. We hypothesized that bovine colostrum, rich in bioactive factors, may im-
prove intestinal function following exposure to formula.  
Methods: After receiving total parenteral nutrition for 2 days, preterm pigs were fed for-
mula (FORM, n = 14), bovine colostrum (COLOS, n = 6), or formula (6 h) followed by bo-
vine colostrum (FCOLOS, n = 14). Intestinal lesions, function, and structure, number and 
location of bacteria, and inflammation markers were investigated.  
Results: NEC severity and ileal IL-1β and IL-8 protein concentrations were lower in CO-
LOS and FCOLOS pigs, relative to FORM pigs. Villus height, galactose absorption, and 
brush-border enzyme activities were increased in COLOS and FCOLOS pigs. Expression of 
IL1B, IL6, IL8, IL10 and SAA and bacterial number and location score correlated positively 
with NEC severity.  
Conclusions: Bovine colostrum restores intestinal function after initial formula-induced in-
flammation in preterm pigs. Further studies are required to test if bovine colostrum may also 
benefit preterm infants during the challenging transition from total parenteral nutrition to en-
teral nutrition, when human milk is unavailable. 
 
 
Keywords: Bovine colostrum; necrotizing enterocolitis; inflammation; animal model. 
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Introduction 
Necrotizing enterocolitis (NEC) is a serious gastrointestinal disease that mainly affects pre-
term infants. Short gestational age, aggressive formula feeding, and abnormal bacterial colo-
nization are factors that predispose to NEC1-3. Before the initiation of enteral nutrition, pre-
term neonates may require a period of total parenteral nutrition (TPN), and NEC occurs very 
seldom in the absence of enteral food in infants4 and pigs5. Although TPN may be a life-
saving therapy for many infants, TPN may also reduce the digestive- and absorptive func-
tion6, increase intestinal permeability7, and cause a degree of mucosal atrophy in the develop-
ing intestine8. When milk formula feeding is initiated after a few days of TPN, this may be 
associated with a more difficult and less tolerant transition to enteral nutrition, as indicated 
from studies in preterm pigs5. An abrupt transition to milk formula reduces villus height, mu-
cosa percentage, digestive enzyme activities and nutrient absorption, and increases bacterial 
adherence, mucosal atrophy and inflammatory cytokine levels within just 8 hours of feed-
ing5,9,10. In contrast, preterm pigs fed porcine or bovine colostrum are almost protected from 
NEC5,10,11, most completely when colostrum is provided in slowly increasing volumes already 
from the time of birth12.  
Colostrum is rich in bioactive compounds such as growth factors, antioxidants, antimicro-
bial and immune-modulatory factors, which may support intestinal maturation, balance and 
priming of the immune system and establishment of a beneficial gut microbiota13,14. Although 
it is known that colostrum may prevent the inflammatory cascade leading to NEC lesions12, 
the ability of colostrum to regenerate an already compromised gut exposed to a short period 
of formula is unknown. This is important because lack of mother´s milk following preterm 
birth may require formula feeding for some time after birth. Formula feeding may last for 
much longer if breast-feeding remains impossible and if banked human milk is not available. 
There is a need to know how mother´s own milk, or a possible substitute bioactive product 
like bovine colostrum, may help to suppress the pro-inflammatory state of the immature intes-
tine resulting from a few days of TPN followed by a period of formula feeding. 
We hypothesized that the gut dysfunction induced by the combination of TPN with an 
abrupt transition to milk formula, is corrected if bovine colostrum is fed shortly after the for-
mula feeding period. We used a preterm pig model of NEC5,10 to investigate the effects of 
bovine colostrum on intestinal structure, digestive and absorptive functions, microbiota, and 
plasma and tissue proteins and tissue mRNA levels of inflammatory markers. A group fed 
formula followed by colostrum was compared with groups of pigs fed either formula (nega-
tive control) or colostrum alone (positive control) after the TPN period. 
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Materials and methods 
Animals and their treatment 
The procedures for caesarean section and nursing of the preterm pigs followed a standard pro-
tocol5,15. Thirty-four preterm pigs were delivered from four sows by caesarean section (Large 
White × Danish Landrace × Duroc, Askelygaard Farm, Roskilde, Denmark) at 105–107 d 
gestation (90–92% gestation). The pigs were fitted with an oro-gastric feeding tube (6F, Por-
tex, Kent, UK) and a vascular catheter (4F, Portex) in an umbilical artery, and placed in tem-
perature-regulated incubators with oxygen supply. To provide passive immunity, pigs were 
given maternal plasma three times (4, 5, and 7 ml/kg body weight) through the vascular cathe-
ter during the first 24 h after birth. The following 48 h, pigs were given TPN through the vas-
cular catheter (4 ml/kg/h advancing to 6 ml/kg/h). The TPN solution was based on Nutriflex 
Lipid Plus (Braun, Melsungen, Germany) and adjusted in nutrient composition to meet the 
requirements of pigs5. After the TPN period, pigs were abruptly shifted to total enteral nutri-
tion for an additional two days before euthanasia and tissue collection. At transition to enteral 
nutrition the pigs were randomly assigned according to birth weight into three enteral nutri-
tion groups fed either a milk formula (FORM, n = 14), bovine colostrum (COLOS, n = 6), or 
6 h of milk formula followed by bovine colostrum until euthanasia (FCOLOS, n = 14). The 
feeding dose for all groups was 15 ml/kg body weight/3 h. The milk formula contained 80 g 
Pepdite, 70 g Maxipro, and 75 g Liquigen/L of water5, all products kindly donated by Nutri-
cia, Allerød, Denmark. Bovine colostrum was obtained from the first milking after parturition 
(kindly donated by Biofiber-Damino, Gesten, Denmark). Before use, the colostrum was steril-
ized by gamma-irradiation (1 x 10 kGy; Sterigenics, Espergærde, Denmark) and stored at -20 
°C. The products were warmed to body temperature in a water bath and colostrum was dis-
solved in tap water to obtain the same dry matter content as in the milk formula before use. 
All animal protocols and procedures were approved by the Danish National Committee on 
Animal Experimentation (Licence: 2004/561-910). 
 
Clinical evaluation and tissue collection 
Pigs were monitored closely and euthanized if clinical symptoms of NEC, such as abdominal 
distension, lethargy, cyanosis or bloody diarrhea were observed. Pigs not showing clinical 
signs of NEC were euthanized after 45–50 h of enteral feeding. Euthanasia and tissue collec-
tion were performed according to earlier protocols11. Proximal, middle and distal small intes-
tine, stomach and colon were given a NEC severity score: 1 = No or minimal focal hyperae-
mic gastroenterocolitis; 2 = Mild focal gastroenterocoli-tis; 3 = Moderate locally extensive 
gastroenterocolitis; 4 = Severe focal gastroentero-colitis; 5 = Severe locally extensive hemor-
rhagic and necrotic gastroenterocolitis; or 6 = Severe extensive hemorrhagic and necrotic gas-
troenterocolitis. Pigs with a severity score of 3 or more in any gastrointestinal region were 
considered suffering from NEC. To determine small intestinal enzyme activities, gene expres-
sion, and cytokine concentrations, full thickness tissue samples from the small intestinal re-
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gions were immediately snap-frozen in liquid nitrogen and stored at -80 °C. A 10 cm segment 
of each small intestinal region was used to measure intestinal circumference and to determine 
the proportion represented by mucosa according to5. Samples from the distal small intestine 
were collected and fixed in 4% neutral buffered paraformaldehyde for 24 h and transferred to 
70% ethanol before preparation for fluorescence in situ hybridization (FISH) and evaluation 
of gut morphology. 
Blood collected at euthanasia was used for later determination of inflammatory factors (see 
below). All blood samples were collected in EDTA- or heparin coated tubes, placed on ice, 
centrifuged for 10 min at 4 °C and 2,500g and the plasma was stored at -20 °C until further 
analyses. 
 
Gut morphology and intestinal function 
Distal intestinal villus height and crypt depths were evaluated on scanning pictures obtained 
from FISH analysis using the morphometric software SoftWoRx Explorer version 1.2.0 (Ap-
plied Precision, Issaquah, WA, USA). One representative cross-section was selected from 
each pig and 10 representative villi and crypts were measured. Intestinal function was evalu-
ated by measuring enzyme activities of dipeptidyl peptidase IV, aminopeptidase N, amin-
opeptidase A, lactase and maltase according to16. Finally, trehalase activity was measured as 
described for lactase and maltase in Sangild et al.16 using 0.6 M D-(+)-trehalose dihydrate 
(EC 202-739-6, Sigma-Aldrich, Brøndby, Denmark) as a substrate. The enzyme activities 
were expressed as U/g of wet intestine, where one unit of activity correspond to 1 µmol sub-
strate released per min at 37 °C. In vivo galactose absorption was used as an index of the 
hexose uptake capacity via the sodium-glucose linked transporter 1. Plasma galactose was 
measured before enteral nutrition (0 h) and at 6 h and 30 h after enteral food introduction by 
collection of a blood sample 20 min after an oral bolus (15 ml/kg, 5% galactose) via the oro-
gastric feeding tube. Plasma concentrations of galactose were measured according to Thy-
mann et al.17 and the results from each treatment group at 6 h and 30 h were compared with 
the baseline level at 0 h. To get an estimate of gut permeability, an oral bolus of 5% lactulose 
and 2% mannitol (15ml/kg) was given 4 to 6 h prior to kill and urine was sampled from the 
bladder by cystocentese. The urinary ratio of lactulose to mannitol was determined as previ-
ously described5.  
 
Gene expression analyses of inflammatory factors 
The expression of IL1B, IL6, IL8, IL10, PBD-2, TLR4, TNF and SAA and reference genes 
B2M, ACTB and HPRT1 in distal intestinal tissue was determined using quantitative real-time 
PCR. Total RNA was extracted using RNeasy Lipid Tissue Midi kit (Qiagen, Ballerup, Den-
mark) and on-column DNAse treated using RNase-free DNase set (Qiagen) according to 
manufacturer’s protocol. The quantity of extracted total RNA was measured on a Nanodrop 
ND-1000 UV-spectrophotometer (Saveen Biotech, Aarhus, Denmark) and the quality of ex-
tracted total RNA was determined using on-chip electrophoresis on an Agilent 2100 Bioana-
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lyzer (Agilent Technologies, Nærum, Denmark) yielding an RNA integrity number (RIN) 
assigned to each sample using the 2100 Expert software (Agilent Technologies, Hørsholm, 
Denmark). One µg of total extracted RNA was converted into first-strand cDNA using Quan-
tiTect Reverse Transcription Kit (Qiagen) according to manufacturer’s instructions and stored 
at -20 °C. Quantitative PCR was performed using diluted cDNA (1:5 or more) in a total reac-
tion volume of 25 µl containing gene-specific primers (300 nM; Table 1), SYBR Green PCR 
Master Mix (Sigma-Aldrich) and MgCl2 (Table 1). PCR cycling was performed on a Ro-
torGene 3000 Detection System (Corbett Research, Sydney, Australia) using the following 
conditions: 2 min at 50 °C, 10 min at 95 °C, followed by 40 cycles with 15 s at 95 °C and 1 
min at 59–62 °C (Table 1). Sequences for primers were obtained from Genbank and NCBI, 
and to confirm total gene specificity of the primer sequences and absence of polymorphisms 
at the primer site, an in silico screen was performed in BLAST. Primers were designed using 
Primer3 (5http://frodo.wi.mit.edu/4) and synthesized at TAG Copenhagen, Copenhagen, 
Denmark. To confirm a single PCR product having the predicted melting temperature, melt-
ing curves were generated after each run and selected amplicons were initially validated by 
sequencing. All reactions were performed in triplicate and outliers excluded using Grubbs 
test18. To exclude contamination and nonspecific amplification problems, no-template con-
trols were included in each run. Standard curves of samples expressing the gene of interest at 
a high level were included to calibrate the assay in order to calculate relative expression lev-
els, and to assign primer efficiency and dynamic range. The primer efficiency for the standard 
curves ranged between 0.85 and 1.10 with a correlation coefficient > 0.99. Interrun calibration 
was performed based on several samples. Rotor-Gene series Software 6000 1.7 (Corbett Re-
search) was used to analyze the data and the quantification cycle was defined as the cycle 
number at which the reporter fluorescence reached a predetermined threshold. To normalize 
relative expression levels of samples, a normalization factor was calculated in geNorm19 
based on the three most stable reference genes B2M, ACTB and HPRT1 (Table 1) out of five 
potential reference genes, thereby excluding RPL13A (NM_001244068) and GAPDH 
(AF017079) as reference genes. To assess differential gene expression among the three treat-
ment groups, the normalized mean for the COLOS group was set to one, and the normalized 
mean of the gene in question from the two other groups was displayed as fold change com-
pared to this. 
 
Levels of circulating and tissue inflammatory factors 
A multiplex assay was used to determine the concentrations of interleukin (IL)-6, IL-8 and 
IL-10 in distal small intestinal samples homogenized in 1% Triton X-100 and in plasma sam-
ples, as previously described 20, with analysis of IL-1β added to the assay. Briefly, magnetic 
beads coupled with the specific antibodies were incubated with plasma samples or intestinal 
homogenates. For plasma analysis, standards, controls and samples were diluted in assay 
buffer, to which was added 10% filtered and heat inactivated (56 °C for 30 min) normal por-
cine plasma. Biotinylated antibodies were added followed by wash and incubation with phy-
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coerythrin-labeled streptavidin and reading by the Luminex100 and the data was analyzed 
using BioPlex software Manager 4.1.1 (Bio-Rad Laboratories, Copenhagen, Denmark). The 
results were expressed relative to total protein concentration in each sample determined by 
spectrophotometry (E280). 
Plasma concentrations of serum amyloid A (SAA) were determined using a sandwich- En-
zyme-linked immunosorbent assay kit according to the manufacturer's instructions (Tridelta 
Developments Ltd., Maynooth, County Kildare, Ireland). 
 
Microbiology and organic acids 
The luminal contents of the distal small intestine were immediately stored on ice and plated 
on C-calves blood agar (SSI Diagnostica, Hillerød, Denmark), and incubated under anaerobic 
and aerobic conditions at 37 °C for 24 h to determine the number of colony forming units 
(CFU)/g luminal content. The abundance and location of bacteria in the distal small intestine 
were evaluated using FISH. Cross-sections of 3 µm formalin-fixed and paraffin-embedded 
distal small intestinal tissue samples were mounted on SuperFrost/plus slides (Menzel-Gläser, 
Braunschweig, Germany), deparaffinized in xylene, and dehydrated in 99% ethanol. Hybridi-
zation was performed using an AlexFluor555-oligonucleotide probe targeting 16S rRNA in 
most bacteria (5'-GCT GCC TCC CGT AGG AGT-3´ ((21), Eurofins MWG Operon AG, Ebers-
berg, Germany) according to (22) with minor modifications. The slides were scanned on an 
ArrayWoRxe microarray scanner (Applied Precision, Issaquah, WA, USA) and evaluated us-
ing Adobe Photoshop version C4 (Adobe Systems, San Jose, CA, USA). All slides were 
evaluated using the two following semi-quantitative scores: Bacterial abundance: 1 = No or 
very few microcolonies; 2 = Few microcolonies; 3 = Intermediate number of microcolonies; 4 
= Abundant number of microcolonies; 5 = Extensive colonization. Bacterial location was 
scored as follows: 1 = Present only in the lumen; 2 = Present in the lumen and in association 
with the tip of the villus; 3 = Present in the lumen and between villi; 4 = Present in the lumen 
and between villi and translocation to muscularis mucosae. As a marker of bacterial metabolic 
activity, the concentrations of 15 organic acids (OA) were measured in stomach and colon 
contents as described by Canibe et al.23, however only one gram gastrointestinal sample were 
used in the extraction procedure. 
 
Statistical analysis  
Group differences in NEC incidences were evaluated using Fisher’s exact test. All other sta-
tistical analyses were based on parametric ANOVA using the MIXED model of SAS with 
treatment and region as fixed variables and litter as random variable, a non-parametric 
Kruskal-Wallis or Mann-Whitney test in SAS or GraphPad Prism 5 (Version 5.02, La Jolla, 
CA, USA). Correlation analyses were performed in GraphPad Prism 5 using Spearman corre-
lation according to Zar24. Results are presented as means with standard error of mean (SEM) 
and p < 0.05 was used as the critical level of significance. 
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Results 
Clinical outcome, organ dimensions and intestinal function 
The NEC severity score was lower in COLOS pigs and tended to be lower in FCOLOS pigs 
(p = 0.07, Figure 1a), relative to FORM pigs. The incidence of NEC did not differ signifi-
cantly among groups (FORM: 71%, 10/14; FCOLOS: 64%, 9/14; COLOS: 50%, 3/6). Mean 
daily weight gain was higher in FCOLOS pigs (21 ± 6 g/d, p < 0.01) than in FORM pigs (6 ± 
3 g/d), with COLOS pigs being intermediate (17 ± 2 g/d).   
Intestinal villus height was lower in FORM relative to FCOLOS pigs, with intermediate 
values in COLOS pigs (Figure 1b), and small intestinal circumference was higher in FORM 
(10.3 ± 0.2 mm) relative to FCOLOS pigs (9.6 ± 0.13 mm, p < 0.01), with values in COLOS 
pigs being in-between (9.7 ± 0.2 mm). The two groups fed colostrum had a higher proportion 
of dry mucosa in the small intestine (0.70 ± 0.01, pooled values), relative to the FORM group 
(0.65 ± 0.02, p < 0.05). The galactose absorption capacity (Figure 2) decreased in the FCO-
LOS groups after the initiation of enteral feeding. With subsequent colostrum feeding in the 
FCOLOS group, the values increased to reach values at 0 h and the COLOS group at 30 h of 
enteral feeding, while the value in FORM decreased further. The digestive capacity, indicated 
by small intestinal enzyme activities across the three small intestinal regions, were increased 
for both colostrum groups (COLOS, FCOLOS) relative to the FORM for four of the six en-
zymes measured (Figure 1c-f), and FCOLOS had a higher maltase activity than COLOS and 
FORM (Figure 1g). Only trehalase activity did not show any difference among the groups 
(0.30 ± 0.02 U/g of wet tissue, pooled values). Intestinal permeability measured as the ratio of 
lactulose to mannitol did not differ among the three groups (0.12 ± 0.04). No differences were 
observed between the groups in the following parameters (pooled values): body weight at 
birth (919 ± 28 g) and at euthanasia (973 ± 28 g), total life span (89 ± 2 h), relative length of 
the small intestine (308 ± 9 cm/kg body weight), ileum crypt depth (93 ± 4 µm), total small 
intestinal area (303 ± 11 cm2), or relative weights (to body weight, g/kg) of stomach (7.0 ± 
0.4), small intestine (29.6 ± 1.1), large intestine (9.6 ± 0.5), heart (7.9 ± 0.2), lungs (20.3 ± 
0.7), liver (26.0 ± 0.5), kidneys (10.1 ± 0.3), and spleen (2.1 ± 0.1). 
 
Tissue and circulating cytokine mRNA and protein levels 
The intestinal tissue expression of IL6, IL8, IL10, PBD-2, TLR4, TNF and SAA did not differ 
between the three groups, while IL1B was lower in FORM compared with FCOLOS (Table 
2). Positive correlations were observed between the mean NEC severity and the expression of 
IL1B (r = 0.594, p < 0.001), IL6 (r = 0.576, p < 0.001), IL8 (r = 0.669, p < 0.001), IL10 (r = 
0.415, p < 0.05) and SAA (r = 0.376, p < 0.05), whereas no correlation was observed with 
PBD-2, TLR4 and TNF and mean NEC severity (not shown).  
The protein concentrations of IL-1β in the distal small intestine were higher in FORM pigs 
than in COLOS and FCOLOS pigs (Figure 1h). Furthermore, the IL-1β tissue concentration 
correlated positively with mean NEC severity (r = 0.350, p < 0.05) and with the expression of 
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IL1B in tissue (r = 0.656, p < 0.001). The protein concentration of IL-8 was higher in FORM 
than FCOLOS, while the difference between FORM and COLOS was p = 0.062 (Figure 1i). 
No significant correlations were found for the protein concentration of IL-8 and the total 
mean NEC severity or the expression of IL8 (not shown). The distal small intestinal concen-
trations of IL-6 and IL-10 were generally below detection limit and hence no results are 
shown for these cytokines. Plasma levels of IL-10 (58.1 ± 6.2 pg/mL, pooled values) and 
SAA (81 ± 12 g/mL, pooled values) showed similar values across the three groups, and no 
correlation was observed between either IL-10 or SAA, and the mean NEC severity (not 
shown). The plasma levels of IL-1β, IL-6, and IL-8 were generally below the detection limit 
(not shown). 
 
Microbiology and organic acid concentrations 
The luminal concentration of bacteria in the distal small intestine was in the range of 108 CFU 
per g contents and did not differ among the three groups neither for anaerobic bacteria (6.3 x 
108 ± 2.0 x 108 CFU/g luminal content, pooled values) nor aerobic bacteria (4.4 x 108 ± 1.5 x 
109 CFU/g luminal content, pooled values). Likewise, FISH analyses of the distal small intes-
tinal mucosa-associated microbiota revealed no differences in the score for bacterial abun-
dance (1.9 ± 0.2, pooled values) or location (2.2 ± 0.2, pooled values) among the three groups 
(Figure 3a, b). However, a positive correlation between mean NEC severity and the bacterial 
abundance score (r = 0.630, p < 0.001) and bacterial location score (r = 0.381, p < 0.05) was 
observed.  
The total concentration of OA in stomach contents (Figure 4a) did not differ between 
groups. Of the individual organic acids, octanoic acid was lower in the COLOS group than in 
the FORM group, with FCOLOS group being intermediate. Furthermore, the concentration of 
butyric acid in the stomach was lower in FORM compared with FCOLOS and COLOS, which 
weas similar. 
The concentration of OA in the colon contents (Figure 4b) was higher in the FORM group 
compared with values of the two colostrum groups combined (pooled values, p < 0.01). Fur-
thermore, a significantly higher concentration of lactic acid was observed in the FORM pigs 
compared with COLOS and FCOLOS pigs.  
 
Discussion 
We have previously shown that an abrupt transition from parenteral to moderate amounts of 
an enteral diet induces an intestinal dysfunction that may predispose to development of NEC, 
at least in preterm pigs5-8,10,11. Changes to intestinal structure and function occur within just 8 
hours of enteral feeding and are much more pronounced with formula, relative to sow´s colos-
trum9, and we now document that bovine colostrum feeding reverses the immediate pro-
inflammatory effects of a short term (6 hours) feeding with moderate amounts of formula to 
preterm TPN-fed pigs. This was seen by the observed lower NEC severity and intestinal cir-
cumference (indicating better muscular tone), increased villus height, enzyme activities and 
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hexose absorption and lower tissue IL-1β and IL-8 levels and colonic lactic acid production in 
the FCOLOS group, relative to the FORM group. The intact colostrum diet had this effect 
even when it was obtained from another species (bovine) and after sterilization by gamma-
irradiation. Further studies will show whether intact bovine colostrum could be considered as 
a supplemental diet also for preterm infants during the challenging parenteral-enteral nutri-
tional transition.  
As in previous studies, formula-fed pigs had an increased severity of NEC, compared with 
pigs fed bovine colostrum5,25. Colostrum feeding did not fully protect against NEC, as a mild 
degree of NEC was observed in both colostrum groups. This was not surprising, as it has pre-
viously been documented that bovine colostrum only protects 100% against NEC when pro-
vided already from the time of birth, and in slowly increasing volumes12. An abrupt transition 
to enteral colostrum feeding after TPN may also be associated with a higher incidence of 
NEC-like lesions in the stomach region 5,26 and indeed, two of the three NEC-diagnosed CO-
LOS pigs had high NEC scores only in the stomach region. The overall higher NEC severity 
in the FORM group was accompanied by a reduced activity relative to the colostrum groups 
of five brush border enzymes. While the direct diet effects have been demonstrated previ-
ously11,15,25, the present study proves for the first time that colostrum feeding can reverse the 
diet-induced effects on enzyme activities known to take place already within the first hours of 
formula feeding9.  
Results that clearly illustrate the restorative effect of colostrum feeding were the galactose 
absorption tests. As expected, the absorption capacity fell in the FCOLOS and FORM groups 
during the first 6 hours after initiation of enteral feeding, whereas the absorption capacity of 
galactose in COLOS pigs remained at the 0-hour level during this period. Thus, as demon-
strated previously, the initial formula feeding appears to induce a very rapid decrease in the 
function of the sodium-glucose linked transporter 112,25. The decrease was reversed by colos-
trum feeding since the galactose level in FCOLOS pigs at 30 hours after start of feeding were 
similar to that in COLOS pigs, while the level very decreased further in FORM pigs at 30 
hours. The improved digestive and absorptive capacity not only removes more nutrients from 
the intestinal lumen but also reduces the amount of substrate available for bacterial fermenta-
tion. This can explain that the concentration of colonic lactic acid was reduced in both colos-
trum groups, relative to formula.  
Colostrum feeding resulted in a decrease of the formula-induced increases in both IL-1β 
and IL-8 production in the distal small intestine. A previous study showed that feeding sow's 
colostrum to preterm pigs down-regulates IL-1β and the initial feeding-induced intestinal le-
sions relative to formula10, and this study shows that bovine colostrum has a similar effect. 
The group differences seen at the protein level for IL-1β and IL-8 were not observed at the 
mRNA level and for IL-1β a higher tissue level in the FCOLOS group was observed com-
pared with the FORM group. The lack of correlation between protein- and mRNA levels may 
be due to differences in onset of the expression of the mRNA and the following secretion of 
the protein27. The positive correlation between the expression of IL1B, IL6, IL8, IL10 and SAA 
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and the mean NEC severity suggests that the expression of these inflammatory factors is more 
correlated to disease progression than to the type and amount of nutrition. No correlation was 
observed between the IL-10 and SAA levels in plasma and the mean NEC severity. Plasma 
SAA levels have been found to correlate with NEC disease progression in infants28,29. How-
ever, acute phase proteins like SAA may behave very differently in different species30. Fur-
thermore, protein levels of IL-1β, IL-6 and IL-8 in plasma were below detection preventing 
their use as biomarkers for NEC in preterm pigs.  
The density of the gut microbiota in the distal small intestine, as well as the bacterial at-
tachment to the mucosa, was not significantly affected by diet in our study, however, mean 
NEC severity correlated positively with both the bacterial abundance and location scores. 
Bacterial density at the tissue surface is therefore correlated more with the progression of 
NEC than with the nature and amount of the enteral diet12. The trend towards higher total 
amount of colonic OA in the FORM group suggests that FORM resulted in a higher microbial 
activity in the colon. Thus, colostrum does not suppress bacterial density and mucosal at-
tachment, but rather support tissue responses towards feeding and bacteria. This study under-
lines the importance of diet composition in the first enteral feedings to preterm neonates to 
promote intestinal maturation and resistance against NEC. It remains to be investigated 
whether bovine colostrum could be used as a safe and effective substitute product to preterm 
infants when human mother´s milk or colostrum is not available during the challenging par-
enteral to enteral nutrition transition. We do underline that preterm pigs may not accurately 
reflect the physiology of preterm infants born at different gestational ages and with different 
clinical complications, and studies in infants are clearly needed. Nevertheless, further studies 
in preterm pigs may help to better define the optimal diet, timing and amount of the first en-
teral food for the immature infant intestine.  
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FIGURE LEGENDS 
 
FIGURE 1: Mean NEC severity scores across the five gut regions based on macroscopic tis-
sue evaluation (a), distal small intestinal villus height (b), activity of brush-border enzymes: 
dipeptidylpeptidase IV (c), aminopeptidase A (d), aminopeptidase N (e), lactase (f), and mal-
tase (g) across the three small intestinal regions and values for IL-1β (h) and IL-8 (i) protein 
levels in distal small intestinal tissue in FORM pigs (white), COLOS pigs (gray), and FCO-
LOS pigs (black). All data are presented as means ± SEM, and means not sharing the same 
superscript symbols are significantly different (p < 0.05). 
 
FIGURE 2: Arterial plasma concentrations of galactose after an oral bolus of galactose given 
before (0 h, pooled values, horizontal lines) as well as 6 h and 30 h after initiation of the en-
teral feeding period (means ± SEM) in FORM pigs (white), COLOS pigs (gray), and FCO-
LOS pigs (black). Means at 6 h and 30 h are compared with the mean for 0 h, and significant 
differences are shown by different superscript symbols (p < 0.05). 
 
FIGURE 3: Examples of FISH analyses applied to cross-sections of the distal small intestine. 
Scanning photos showing bacteria (red signal) of representative pigs: bacterial abundance 
score = 1, no or very few microcolonies and distal NEC score = 1, no or minimal focal hyper-
aemic gastroenterocolitis (a), and bacterial abundance score = 5, extensive colonization and 
distal NEC score = 5 (b). 
 
FIGURE 4: Total concentration (means ± SEM) and the concentration of the dominating 
OAs in stomach contents (a) and colon contents (b) in FORM pigs (white), COLOS pigs 
(gray), and FCOLOS pigs (black). Different superscript symbols indicate significant differ-
ences (p < 0.05). 
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TABLES 
 
Table 1. Primer sequences and reaction conditions for quantitative real-time PCR analysis. 
Gene Accession number Sequence (5´- 3´) Amplicon length Ta (ºC)
a MgCl2 (mM)b 
B2M DQ845172.1 F: TGAAGCACGTGACTCTCGAT 
R: CTCTGTGATGCCGGTTAGTG 
70 62 1.5 
ACTB DQ845171.1 F: CTACGTCGCCCTGGACTTC 
R: GCAGCTCGTAGCTCTTCTCC 
76 62 1.5 
HPRT1 AF143818.1 F: ACACTGGCAAAACAATGCAA  
R: TGCAACCTTGACCATCTTTG 
71 60 1.5 
IL1B NM_214055.1 F: CCAAAGAGGGACATGGAGAA 
R: GGGCTTTTGTTCTGCTTGAG 
123 59 3.0 
IL6 AF518322.1 F: GCAGTCACAGAACGAGTGGA  
R: CAGGCTGAACTGCAGGAAAT 
82 59 3.0 
IL8  NM_213867.1 F: GAAGAGAACTGAGAAGCAACAACA 
R: TTGTGTTGGCATCTTTACTGAGA 
99 60 3.0 
IL10 NM_214041.1 F: CTGCCTCCCACTTTCTCTTG 
R: TCAAAGGGGCTCCCTAGTTT 
95 60 1.5 
PBD-2 NM_214442.1 F: CAGGATTGAAGGGACCTGTT 
R: CTTCACTTGGCCTGTGTGTC 
99 60 1.5 
TLR4 GQ304754.1 F: TTTCCACAAAAGTCGGAAGG 
R: CAACTTCTGCAGGACGATGA 
145 60 3.0 
TNF JF831365.1 F: CCCCCAGAAGGAAGAGTTTC 
R: CGGGCTTATCTGAGGTTTGA 
92 62 1.5 
SAA EF362780.1 F: TAAAGTGATCAGCAATGCCAAA 
R: TCAACCCTTGAGTCCTCCAC 
96 60 3.0 
a Annealing temperature. 
b MgCl2 is the total concentration of MgCl2 in the reaction mix. 
 
 
Table 2. Relative expression of inflammatory markers in the distal small intestine. 
Genea FORM COLOS FCOLOS 
IL1B 8.6 ± 2.8* 1.0 ± 0.1 25 ± 17§ 
IL6 1.8 ± 0.7 1.0 ± 0.2 7.6 ± 5.2 
IL8 3.0 ± 1.0 1.0 ± 0.4 2.7 ± 1.5 
IL10 1.8 ± 0.5 1.0 ± 0.3 1.4 ± 0.5 
PBD-2 1.5 ± 0.5 1.0 ± 0.3 0.9 ± 0.2 
TLR4 1.5 ± 0.3 1.0 ± 0.1 1.0 ± 0.2 
TNF 1.0 ± 0.2 1.0 ± 0.1 1.2 ± 0.2 
SAA 1.9 ± 0.5 1.0 ± 0.6 1.3 ± 0.6 
a Values are presented as mean ± SEM, and means not sharing the same superscript symbol within each gene are 
significantly different (P < 0.05). 
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Abstract  
Fresh bovine colostrum (BC) prevents development of necrotizing enterocolitis (NEC) in pre-
term pigs. Spray drying and pasteurization are required to use BC in clinical settings but this 
may also reduce its bioactivity.  
In studies on preterm pigs, we compared raw BC with spray dried and pasteurized BC. Pre-
term pigs were fed a few hours of formula followed by two days of formula (FORM, n = 14), 
fresh BC (COLOS, n = 14), spray-dried BC (POW, n = 8), or spray dried, pasteurized BC 
(POWPAS, n = 9).  
POW and POWPAS pigs showed lowered gut NEC severity, IL-1β and -8 levels and lactic 
acid levels, and higher intestinal villus heights, hexose absorption, hydrolase activities (lac-
tase, maltase, peptidases) than FORM pigs (all P < 0.05). These values in POW and POW-
PAS groups were similar to those in the COLOS group. Intestinal expression of IL1B, IL6 and 
IL8 and bacterial abundance score were positively correlated with NEC severity (P < 0.05). 
All three colostrum diets stimulated wound-healing capacity of intestinal IEC-6 cells in vitro, 
but spray drying, and especially pasteurization, increased the breakdown of growth factors 
(TGF-β1 and -β2) and the aggregation of milk proteins.  
Spray drying and pasteurization affect BC proteins but such treatments do not necessarily 
decrease its trophic and anti-inflammatory effects on the immature intestine. It remains to be 
studied if such colostrum products also improve gut maturation in preterm infants.  
 
 
Keywords: Pasteurized bovine colostrum, spray dried bovine colostrum, animal model, ne-
crotizing enterocolitis. 
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Introduction 
Colostrum, the first milk after birth, is particularly rich in bioactive compounds including 
antioxidants, growth factors, and antimicrobial- and immune-modulatory factors. These bio-
actives are essential in stimulating gastrointestinal- and immunological maturation, and estab-
lishment of a beneficial gut microbiota (1-3). Compared with mature milk, the concentration 
of many bioactive factors is several times higher in colostrum, and some are found to be ele-
vated also in preterm milk (2, 4-9). Provision of colostrum is particularly important for pre-
term neonates, because the intestinal immaturity makes these individuals very sensitive to 
maldigestion, abnormal bacterial colonization and dys-regulated immune responses, which 
potentially can lead to necrotizing enterocolitis (NEC). Feeding infant formula, both alone 
and in combination with mother’s milk, predispose to infant NEC (10-13). In a preterm pig 
model of NEC, formula-fed preterm pigs had decreased villus heights and mass of the intesti-
nal mucosa, decreased digestive enzyme capacity and nutrient absorption and more NEC le-
sions compared with preterm pigs fed bovine colostrum (BC) or porcine colostrum (14, 15). 
These studies also indicate that the beneficial actions of colostrum or milk from one mammal-
ian species may be effective in another species and that both BC and donor human milk de-
creased NEC in preterm pigs compared with infant formula (16). Thus, when human colos-
trum and milk are not available for preterm infants during the first critical days after birth, an 
alternative to infant formula could be BC, adjusted in macro- and micronutrients composition 
to meet the nutritional requirement of the preterm infant.  
A prerequisite for use of BC in clinical settings is a readily available standardized and with 
a low bacterial contamination. It is well known that heat treatment is associated with loss of 
bioactivity to a varying degree dependent on the processing conditions (17-19). We hypothe-
sized that gentle spray drying, combined with high-temperature, short-time pasteurization 
would not markedly affect the beneficial effects of BC in the preterm pig intestine. Using a 
preterm pig model of NEC (14), we investigated if spray dried and sterilized BC would be 
superior to infant formula, and similar to raw BC, with respect to effects on NEC lesions, in-
testinal structure, digestive and absorptive functions, microbiota, and tissue protein and 
mRNA levels of immune factors. Preterm pigs were given TPN for two days followed by 6 
hours of formula feeding, which have been shown to initiate detrimental intestinal changes 
(20), before being given either formula or either one of the three different colostrum products. 
In vitro cell migration assay was used to determine wound healing in the presence of increas-
ing doses of the three colostrum products. Finally, we determined the concentrations of some 
bioactive proteins in the colostrum products and studied the possible treatment-related aggre-
gation of proteins. 
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Materials and methods 
Animals and their treatment 
The procedures for caesarean section and nursing of the preterm pigs followed a standard pro-
tocol (14, 21). Forty-five preterm pigs were delivered from four sows by caesarean section 
(Large White × Danish Landrace × Duroc, Askelygaard Farm, Roskilde, Denmark) at 105–
107 d gestation (90–92% gestation). The pigs were fitted with an oro-gastric feeding tube (6F, 
Portex, Kent, UK) and a vascular catheter (4F, Portex) fitted into an umbilical artery and 
placed in temperature-regulated incubators with extra oxygen supply if necessary. To provide 
passive immunity, the pigs received isolated maternal plasma three times (4, 5, and 7 
mL•kgbody weight (BW)-1 at 3, 8 and 12 h after birth, respectively) through the vascular 
catheter. Pigs were given TPN for 48 h via the vascular catheter based on Nutriflex Lipid Plus 
(Braun, Melsungen, Germany; 4 mL•kgBW-1 advancing to 6 mL•kg BW-1 per h) and adjusted 
in nutrient composition to meet their nutritional requirements (14). Following the TPN period, 
pigs were shifted to total enteral nutrition for an additional 2 d before euthanasia and tissue 
collection. Over the first 6 h of enteral feeding, all the pigs received milk formula (containing 
80 g Pepdite, 70 g Maxipro, and 75 g Liquigen per L of water, all products kindly donated by 
Nutricia, Allerød, Denmark (14)). Hereafter, the pigs were randomly assigned according to 
birth weight into four enteral nutrition groups fed either raw BC (COLOS, n = 14), spray 
dried BC (POW, n = 8), pasteurized spray dried BC (POWPAS, n = 9), or milk formula 
(FORM, n = 14). The feeding dose was 15 mL/kg BW/3 h for all groups. The colostrum 
products were obtained from the same batch of first milking after parturition and kindly do-
nated by Biofiber-Damino, Gesten, Denmark. Pasteurization of liquid BC was performed us-
ing high temperature, short time pasteurization at 72 ºC for 15 seconds, while the powdered 
BC was produced by filter mat spray drying (Biofiber-Damino). COLOS, POW and POW-
PAS were sterilized by gamma-irradiation (1 x 10 kGy, Sterigenics, Espergærde, Denmark). 
The products were tested free of bacterial contamination, and were stored at -20 ºC. The for-
mula and three BC products were all dissolved in tap water to obtain the same dry matter con-
tent (approximately 15 g•L-1) and warmed to body temperature in a water bath before use. All 
animal protocols and procedures were approved by the Danish National Committee on Ani-
mal Experimentation. 
 
Clinical evaluation and tissue collection 
Pigs were monitored closely and euthanized if clinical symptoms of NEC such as abdominal 
distension, lethargy, cyanosis or bloody diarrhea were observed. Pigs not showing clinical 
signs of NEC were euthanized after 45–50 h of enteral feeding. Euthanasia and tissue collec-
tion were performed according to earlier described protocols (15). In all pigs the proximal, 
middle and distal small intestine, stomach and colon were given a NEC severity score: 1, no 
or minimal focal hyperaemic gastroenterocolitis; 2, mild focal gastroenterocolitis; 3, moderate 
locally extensive gastroenterocolitis; 4, severe focal gastroenterocolitis; 5, severe locally ex-
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tensive hemorrhagic and necrotic gastroenterocolitis; or 6, severe extensive hemorrhagic and 
necrotic gastroenterocolitis. Pigs with a severity score of minimum 3 in any gastrointestinal 
region was regarded as a case of NEC. Mean NEC severity was expressed as the mean of the 
NEC severity score from the five regions. Full thickness tissue samples from the small intes-
tinal regions were immediately snap-frozen in liquid nitrogen and stored at -80 ºC until analy-
sis of small intestinal enzyme activities, gene expression, and cytokine concentrations. A 10 
cm segment of each small intestinal region was used to measure intestinal circumference and 
to determine the proportion of dry mucosa as described in (22). Samples from the distal small 
intestine were collected and fixed in 4% neutral buffered paraformaldehyde for 24 h before 
being transferred to 70% ethanol and prepared for fluorescence in situ hybridization (FISH) 
and gut morphology investigations.  
 
Gut morphology and intestinal digestive function 
Villus heights and crypt depths in the distal small intestine were evaluated on scanning pic-
tures obtained from FISH analysis using the morphometric software SoftWoRx Explorer ver-
sion 1.2.0 (Applied Precision, Issaquah, WA, USA). For each pig, one representative cross 
section was selected and 10 random selected villi and crypts were measured. To determine the 
in vivo galactose absorption capacity, each pig was given an oral bolus (15 mL•kg BW-1, 5% 
galactose) via the oro-gastric feeding tube before enteral nutrition, 6 h and 30 h after enteral 
food introduction. Arterial blood was obtained exactly 20 min after administration of each 
bolus for measurements of plasma galactose concentrations (23). All blood samples were col-
lected in EDTA- or heparin coated tubes, placed on ice, centrifuged for 10 min at 4°C and 
2,500 × g and the plasma stored at -20°C until further analyses. Blood collected at euthanasia 
was used for later determination of plasma cytokine levels. The ratio of lactulose to mannitol 
in urine was used as a surrogate marker of intestinal permeability. Pigs received an oral bolus 
containing 5% lactulose and 2% mannitol (15 mL•kg BW-1) four to six hours prior to eutha-
nasia, at which time urine was sampled from the bladder by cystocentesis and the urinary ratio 
of lactulose to mannitol in urine was determined as previously described (14). Finally, intesti-
nal digestive capacity was measured on frozen intestinal sections as hydrolytic activities ex-
pressed as U•g-1 of wet intestine of lactase, maltase, aminopeptidase N, aminopeptidase A and 
dipeptidyl-peptidase IV, as described previously (24). Trehalase activity was measured as 
described for lactase and maltase in (24) using 0.6 M D-(+)-trehalose dihydrate (EC 202-739-
6, Sigma-Aldrich, Brøndby, Denmark) as a substrate. 
 
Immune gene expression in intestinal tissue 
Gene expression of IL1B, IL6, IL8, IL10, defensin β4A (DEFB4A), toll-like receptor 4 
(TLR4), TNF-α (TNF) and serum amyloid A (SAA) and reference genes β-2-microglobulin 
(B2M), β-actin (ACTB), and hypoxanthine phosphoribosyltransferase 1 (HPRT1) in distal in-
testinal tissue was determined using quantitative real-time PCR. Total RNA was extracted 
using RNeasy Lipid Tissue Midi kit (Qiagen, Ballerup, Denmark) and on-column DNAse 
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treated using RNase-free DNase set (Qiagen) according to manufacturer’s protocol. Quantity 
and quality of extracted total RNA was measured as described previously (25). One µg of 
total extracted RNA was converted into cDNA using QuantiTect Reverse Transcription Kit 
(Qiagen) according to manufacturer’s instructions. Quantitative PCR was performed using 
diluted cDNA (1:5 or more) in a total reaction volume of 25 µl containing gene-specific prim-
ers (300 nM), SYBR Green PCR Master Mix (Sigma-Aldrich) and MgCl2 (Table 1). PCR 
cycling was performed on a RotorGene 3000 Detection System (Corbett Research, Sydney, 
Australia) using the following conditions: 2 min at 50 ºC, 10 min at 95 ºC, followed by 40 
cycles with 15 s at 95 ºC and 1 min at 59–62 ºC (Table 1). Primer design and validation were 
performed as described in (25), and synthesized at TAG Copenhagen, Copenhagen, Denmark. 
All PCR reactions were performed in triplicate and outliers excluded using Grubbs test (26). 
To exclude contamination and nonspecific amplification problems, no-template controls were 
included in each run. Standard curves of samples expressing the gene of interest at a high 
level were included to assign primer efficiency and dynamic range. The primer efficiency for 
the standard curves ranged between 0.85 and 1.10 with a correlation coefficient > 0.99. Inter-
run calibration was performed based on several samples. Expression levels of all samples 
where normalized to the normalization factor calculated in geNorm (27) based on the geomet-
ric mean of three out of five most stable reference genes: B2M, ACTB, and HPRT1 (Table 1). 
To assess differential gene expression between the four treatment groups the mean for the 
COLOS group was set to one, and the mean of the gene in question from the three other 
groups was displayed as fold change compared to the COLOS group. 
 
Intestinal and plasma levels of cytokines 
A multiplex assay was used to determine the concentrations of IL-6, IL-8, and IL-10 in distal 
small intestinal samples homogenized in 1% Triton X-100 and in plasma samples, as previ-
ously described (28) with the addition of IL-1β to the assay using the conditions described 
(28). Briefly, plasma samples or intestinal homogenates were incubated with magnetic color-
coded beads coupled with specific antibodies. For the plasma analysis, standards, controls and 
samples were diluted in assay buffer, to which was added 10% filtered and heat inactivated 
(56 ºC for 30 min) normal porcine plasma. Biotinylated antibodies were added followed by 
wash and incubation with phycoerythrin-labelled streptavidin. The beads were read by the 
Luminex100 followed by analysis using the BioPlex software Manager 4.1.1 (Bio-Rad Labo-
ratories, Copenhagen, Denmark). The results were expressed relative to total protein concen-
tration in each sample determined by spectrophotometry (E280). 
  SAA plasma concentrations were determined with ELISA, according to the manufacturer's 
instructions (Tridelta Developments Ltd. Maynooth, County Kildare, Ireland). 
 
Bacterial abundance and location and organic acid concentrations 
Bacterial abundance and location were evaluated using FISH analysis. Cross-sections of 3 µm 
formalin-fixed and paraffin-embedded distal small intestinal tissue samples were mounted on 
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SuperFrost/plus slides (Menzel-Gläser, Braunschweig, Germany), deparaffinized in xylene, 
and dehydrated in 99% ethanol. Hybridization was performed using an AlexFluor555-
oligonucleotide probe targeting 16S rRNA in most bacteria (5'-GCT GCC TCC CGT AGG 
AGT-3´ ((29), Eurofins MWG Operon AG, Ebersberg, Germany) according to (30) with minor 
modifications. The slides were scanned on an ArrayWoRxe microarray scanner (Applied Pre-
cision, Issaquah, WA, USA) and evaluated using Adobe Photoshop version C4 (Adobe Sys-
tems, San Jose, CA, USA). The following two scoring systems were used to evaluate bacterial 
abundance: 1, no or very few microcolonies; 2, few microcolonies; 3, intermediate number of 
microcolonies; 4, abundant number of microcolonies; 5, extensive colonization. Bacterial lo-
cation was scored as: 1, present only in the lumen; 2, present in the lumen and in association 
with the tip of the villus; 3, present in the lumen and penetration into villus; 4, present 
throughout the section and translocation to muscularis mucosae.  
The concentrations of organic acids (OA) in gastrointestinal content were measured as de-
scribed by (31), however only one gram gastrointestinal sample were used in the extraction 
procedure. 
 
Migration of intestinal epithelial cells in vitro 
Rat intestinal epithelial cells obtained from DSMZ (IEC-6, Braunschweig, Germany; ACC 
111) were cultured in 75 cm2 flasks (Thermo Fisher Scientific, Roskilde, Denmark) in Dul-
becco’s minimal essential medium (11960-044; Invitrogen, Tåstrup, Denmark), supplemented 
with fetal calf serum (FCS, 10%; Cambrex Bio Science, Copenhagen, Denmark), sodium py-
ruvate (0.4 mM; Invitrogen), Glutamax (2 mM; Invitrogen), and penicillin/streptomycin solu-
tion (1 v/v%, P-0781; Sigma-Aldrich, Vallensbæk Strand, Denmark). A scratch wound assay 
was performed as an in vitro wound healing model. Cells were plated in 12-well plates at a 
density of 200,000 cells per well at the day before the experiments. Monolayers of cells were 
scratched with a pipette tip to create a standardized cell-free area. One scratch was established 
per well. Cells were then carefully washed with Dulbecco's Phosphate-Buffered Saline 
(14080-048, Invitrogen) to remove residual cell debris. Whey was prepared from raw colos-
trum (COLOS) diluted 1:5 in sterile water, and POW or POWPAS in solutions of 10% (v/v) 
in sterile water as previously described (7). Treatment medium containing concentrations of 
0.01, 0.1, 1, 5 and 10% (v/v) of whey but without FCS was then added to cells. As positive 
and negative controls, serum-free medium alone or medium containing 10% FCS was in-
cluded in each assay (positive control not shown). The distance migrated from the original 
wound line was determined by taking photomicrographs after wounding and 5–6 h after addi-
tion of treatment medium. An inverted microscope (Leica DMIL, Leica Microsystems, 
Wetzlar, Germany) and a Leica digital camera (DFC320) were used to obtain photomicro-
graphs. Identical regions were examined at each time point by pre-marking the base of the 
plates to facilitate alignment. Six measurements were performed in each of two replicate wells 
giving 12 replicate measurements for each treatment.  
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Characterization of proteins in colostrum products  
Whey fractions of COLOS, POW and POWPAS were prepared according to (7). Concentra-
tion of insulin-like growth factor (IGF-I), TGF-β1 and TGF-β2 in the whey fractions were 
determined in two replicate measurements by time-resolved immune-fluorescence assay 
(IGF-I) and ELISA (TGF-β1, TGF-β2) as previously described (7).  
Colostrum protein denaturation and aggregation were determined by sodium dodecyl sul-
fate polyacrylamide gel electrophoresis (SDS-page) analysis. One % (w/v) solutions of pro-
teins were prepared and used without further treatment, or centrifuged at 13,000 × g for 15 
min. Following centrifugation, the supernatant was sampled without disturbing the lipid layer. 
Samples were heated to 95°C for 3 min in non-reducing Laemmli sample buffer and then 
11.25 µg of protein from each sample was applied to 12% Tris/Glycine SDS PAGE gels and 
proteins separated using electrophoresis. Proteins were visualized by staining with Coomassie 
Brilliant Blue. The relative molecular weight of the proteins was determined by comparison to 
the migration of molecular weight marker (M).  
 
Statistical analysis 
Group differences in NEC incidences were evaluated using Fisher’s exact test. All other sta-
tistical analyses were based on parametric ANOVA in GraphPad Prism 5 (Version 5.02, La 
Jolla, CA, USA) or using the MIXED model of SAS (SAS Institute, Cary, NC, USA) with 
treatment and region as fixed variables and litter as random variable, while non-parametric 
data were analyzed using a non-parametric Kruskal-Wallis test or Mann-Whitney test in SAS 
or GraphPad Prism 5. Correlation analyses were performed in GraphPad Prism 5 using 
Spearman correlation according to (32). Statistical analyses of migration data were performed 
using the general linear models procedure (PROC GLM) of SAS. Results are presented as 
mean with standard error of the mean (SEM) and P < 0.05 was used as the critical level of 
significance. 
 
Results 
Clinical outcome and organ dimensions 
Twenty-five pigs were euthanized due clinical symptoms of NEC during the 50 h of enteral 
feeding, and afterwards evaluated as suffering from NEC based on the intestinal NEC severity 
score. This resulted in a higher mean NEC severity in FORM than POWPAS and POW pigs, 
while POWPAS had lower severity of NEC than COLOS pigs (Fig. 1A). Additionally, CO-
LOS showed a tendency towards lower NEC severity than FORM pigs (P = 0.06). The inci-
dence of NEC decreased in the order FORM (71%, 10/14), COLOS (64%, 9/14), POW (38%, 
3/8), POWPAS (33%, 3/9), with a significant difference between FORM and POWPAS pigs 
(P < 0.01). FORM pigs had reduced life span (85 ± 4 h) compared with POW and POWPAS 
pigs (both 98 ± 1 h, P < 0.01), with COLOS pigs being intermediate (90 ± 3 h). Distal small 
intestinal villus heights were lower in the FORM group relative to the three colostrum groups 
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(Fig. 1B). In addition, FORM pigs (10.3 ± 0.22 mm) had an increased small intestinal circum-
ference compared with POWPAS (9.5 ± 0.22 mm) pigs, while the small intestinal circumfer-
ence in COLOS (9.6 ± 0.13 mm) and POW (9.7 ± 0.16 mm) pigs were intermediate. No sig-
nificant group differences (pooled value) were observed in BW at birth (898 ± 28 g) or at 
euthanasia in BW (947 ± 29 g), relative length of the small intestine (322.4 ± 9.9 cm•kg-1), 
crypt depth (96 ± 3 µm), total small intestinal area (291 ± 9 cm2, pooled values), or relative 
weights (to BW, g•kg-1) of stomach (6.7 ± 0.3), small intestine (30.0 ± 0.9), large intestine 
(9.5 ± 0.4), heart (8.0 ± 0.2), lungs (21.6 ± 0.8), liver (26.0 ± 0.4), kidneys (9.9 ± 0.3) and 
spleen (2.0 ± 0.1).  
 
Intestinal digestive capacity, absorption and permeability 
Across the small intestinal regions, the activity of five of six enzymes measured was higher in 
pigs from the colostrum groups compared with FORM pigs, and some differences were ob-
served between the three colostrum groups (Fig. 1C–G). The activity of trehalase was similar 
between groups (0.32 ± 0.01 U•g-1 of wet intestine, pooled values). The three colostrum 
groups combined had a higher proportion of dry mucosa in the small intestine (0.69 ± 0.01, 
pooled values), relative to the FORM group (0.65 ± 0.02, P < 0.05). Intestinal permeability 
measured as the ratio of lactulose to mannitol did not differ between groups (0.08 ± 0.02, 
pooled values). Across groups, galactose absorption decreased during the first 6 h in which all 
pigs received formula, and with subsequent colostrum feeding in the COLOS, POW and 
POWPAS groups the values increased to become significantly higher than for the FORM 
group at 30 h (Fig. 2).  
 
Cytokine expression and concentration 
IL1B, IL8, IL6, IL10, TLR4, TNF and SAA expression in distal intestinal tissue did not differ 
between the groups, whereas DEFB4A expression was significantly higher in POWPAS pigs 
compared with COLOS pigs (Table 2). Positive correlations were observed between the mean 
NEC severity and the expression of IL1B (r = 0.55, P < 0.001), IL6 (r = 0.40, P < 0.01), and 
IL8 (r = 0.52, P < 0.001), while no correlations were observed between the mean NEC sever-
ity and the expression of IL10, PBD-2, TLR4, TNF or SAA (not shown).  
 The protein concentration of IL-1β in the distal small intestine was higher in FORM pigs 
than COLOS and POWPAS pigs with POW pigs being in-between (Fig. 1H). IL-1β correlated 
with the mean NEC severity (r = 0.50, P < 0.01) and with the expression of IL1B (r = 0.56, P 
< 0.001). The protein concentration of IL-8 (Fig. 1I) was higher in the FORM group com-
pared with the COLOS group, with intermediate values in the POW and POWPAS groups. 
No significant correlations were found for the protein concentration of IL-8 and the expres-
sion of IL8 or the total mean NEC severity (not shown). IL-10 (53.0 ± 5.5 pg•mL-1, pooled 
values) and SAA (77.7 ± 12.4 g•mL-1, pooled values) levels were similar across groups, and 
no correlation was observed between either IL-10 or SAA, and the mean NEC severity (not 
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shown). The distal small intestinal tissue concentration of IL-6 and IL-10, and plasma levels 
of IL-1β, IL-6, and IL-8 were generally below detection limit (not shown).  
Bacterial abundance and location and organic acid concentrations 
FISH analyses of the distal small intestinal mucosa-associated microbiota revealed no differ-
ences in the score for bacterial location score (2.4 ± 0.1, pooled values) or abundance score 
(1.9 ± 0.2, pooled values) between the four groups (Fig. 3A, B). A positive correlation be-
tween the mean NEC severity and the bacterial abundance score (r = 0.38, P < 0.05) was ob-
served. 
In the stomach, no differences in the total concentration of OAs were observed between 
groups (Fig. 4A), but of the major OAs in the stomach, the concentration of butyric acid was 
lower in FORM pigs than pigs from the three colostrum groups. The concentration of octa-
noic acid in the stomach was significantly higher in FORM and COLOS than POWPAS pigs, 
with POW being intermediate. The concentration OAs in the colon (Fig. 4B) was higher in 
the FORM group (51.4 ± 9.0 mmol•kg wet weight-1) compared with the three colostrum 
groups combined (30.0 ± 2.9 mmol•kg wet weight-1, P < 0.01). A higher concentration of lac-
tic acid was observed in the FORM group compared with the three colostrum groups, while 
the concentration of acetic acid in the colon was significantly lower in FORM compared with 
POW and POWPAS pigs. No differences were found for the remaining OAs in the stomach or 
colon contents. 
 
Migration of intestinal epithelial cells in vitro 
Intestinal epithelial cell migration (Fig. 5) was increased in a dose-dependent way by whey 
produced from COLOS and POWPAS (both P < 0.05). Maximum increase in migration was 
obtained at the highest whey concentration (10%) where the distance migrated was increased 
1.9 times compared with the control (no whey added). Overall, migration tended (P < 0.06) to 
be increased by whey produced from POW, and migration was significantly increased in a 
concentration of 1% relative to control (P < 0.01). In cells treated with POW whey, migration 
at a concentration of 5% was lower than at 1% of whey, and at 10%, cells were lysed indicat-
ing a too high concentration of whey added. 
 
Characterization of proteins in colostrum products  
The concentration of IGF-I was similar in whey produced from COLOS, POW and POWPAS 
(1212 ± 26 ng•g dry matter-1, pooled values). The concentration of TGF-β1 was higher in 
COLOS (35.1 ± 0.5 ng•g dry matter-1) compared with POW (18.7 ± 0.1 ng•g-1) and POWPAS 
(15.1 ± 0.4 ng•g-1), while the concentration of TGF-β2 was lower in POWPAS (166 ± 5 ng•g-
1) compared with COLOS and POW (607 ± 5 and 558 ±1 ng•g-1, respectively).  
Non-centrifuged samples had a similar protein profile on the SDS page gels (Fig. 6). Ca-
seins were observed at ~36 kDa, and centrifugation resulted in a removal of the majority of 
casein micelles (average diameter 120–180 nm (33)) in all colostrum products, while a 
smaller population of residual casein micelles (average diameter 60 nm (34)) remained. Quali-
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tatively, protein aggregation was most pronounced in the POWPAS product, observed by a 
reduction in Ig (~250 kDa) and proteins in the region 64–98 kDa, including lactoferrin and 
lactoperoxidase observed at ~80 kDa. Still, all proteins of interest were detected also in the 
POWPAS group.  
 
Discussion 
The majority of mothers giving birth to preterm infants are unable to provide enough milk for 
their infants during the first critical weeks after birth (35). Parenteral nutrients may help, but a 
gradual transition to supplementary enteral feeding is required to obtain sufficient growth and 
development. When mother´s milk or human donor milk is not available, the source of this 
enteral nutrition is artificial milk replacers. Natural milk contains not only nutrients but also a 
broad range of growth factors and bioactive components that mediate antimicrobial and im-
mune-modulatory effects in the newborns of different species. Colostrum is particularly rich 
in these factors and fresh colostrum is known to be highly important for compromised new-
borns, such as those born prematurely. Fresh BC protects against NEC in preterm pigs (14, 
36) and the potential exists that BC may be beneficial also for preterm infants. Surprisingly, 
in this study, POWPAS and POW pigs, but not COLOS pigs had a lower NEC severity than 
FORM pigs, and furthermore, of the three colostrum groups only POWPAS pigs had a lower 
NEC incidence than FORM pigs. Future studied is required to investigate what is responsible 
for this tendency towards an improved effect on NEC severity in POW and POWPAS pigs 
compared with COLOS and FORM pigs.  
However, we documented that the majority of parameters reflecting intestinal morphology 
and gut functions were improved to a similar extent in all three colostrum groups relative to 
the formula group. This is encouraging for the possible use of BC products, or fractions 
thereof, in a clinical hospital setting. A smaller intestinal circumference in the POWPAS 
group, and increased villus heights and distal small intestinal enzyme activity in all three co-
lostrum groups, relative to the formula group, indicate increased protection against loss of 
muscular tone, mucosal atrophy and brush-border enzyme dysfunction. With regard to hexose 
absorptive function, measured by plasma galactose levels, the capacity decreased dramatically 
during the 6 hours of formula feeding in all four groups. However, the mucosa regained its 
capacity to absorb hexose when pigs subsequently were fed either one of the three colostrum 
products, while the values remained low after continued formula feeding, as assessed by 
plasma galactose levels 30 hours after start of enteral feeding. Again, the results suggest that 
processed colostrum products (POW and POWPAS) have the same effects as raw colostrum 
on intestinal maturation and development.  
We observed some inflammation in all three colostrum treated groups based on the NEC 
severity score. This is in agreement with earlier observations showing that a few days of TPN 
after birth followed by formula feeding, in contrast to colostrum feeding, predispose preterm 
pigs to inflammatory lesions, impaired intestinal function and NEC (14, 15, 22, 37). These 
changes are present after just 8 hours of formula feeding after the TPN period (20). This ex-
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plains the relatively high incidence of NEC in the COLOS group compared with colostrum-
fed preterm pigs from other studies in which colostrum was the only enteral diet introduced 
after the TPN period (14, 36). The present study now shows that colostrum acts to repair 
damage induced by a short initial period of formula feeding given after a two-day TPN pe-
riod. Small amounts of colostrum given during parenteral nutrition may also prevent inflam-
matory lesions induced by later aggressive formula feeding, and full prevention of NEC is 
achieved when colostrum is given as a combination of minimal and full enteral feeding (38). 
These results are supported by the in vitro study in which COLOS, POW and POWPAS in-
creased migration of intestinal epithelial cells as a measure of wound healing properties. The 
ability of colostrum to stimulate cell migration and healing of epithelial wounds might be par-
ticularly important for the sensitive epithelium of preterm newborns. 
Colostrum feeding resulted in a decreased level of IL-1β and IL-8 production in the distal 
small intestinal tissue and thereby reverted an initial pro-inflammatory state induced by TPN- 
and formula feeding. Thus, results from this study support previous observations showing that 
feeding sow's colostrum compared with formula feeding to preterm pigs down-regulate early 
intestinal lesions and IL-1β levels (37) and here we show that colostrum from a different spe-
cies has the same effect. These differences were not observed in the expression of IL1B and 
IL8, and actually, a tendency toward higher expression of IL1B was observed in COLOS pigs 
compared with FORM pigs. The differences in mRNA and protein levels may be explained 
by differences in onset of the expression of the gene and the following secretion of the protein 
(39). The correlation between the expression of IL1B, IL6 and IL8 and the total mean NEC 
severity, suggests a close relationship between the expression of these inflammatory media-
tors and the degree of intestinal inflammation, more than a relation with the type of diet. Bac-
terial overgrowth is associated with the progression of feeding-induced inflammatory lesions 
in preterm pigs (38), which was also observed here by the positive correlation between mean 
NEC severity and bacterial abundance score. We confirmed that the density of the microbiota 
appears relatively independent of the nature and amount of enteral feeding (38). However, the 
tendency towards higher total amount of OA in the colon of FORM pigs is an indication of a 
higher microbial activity in the colon.  
The processing conditions employed to prepare the colostrum products used in this study, 
did not seem to influence the biological effect of POW and POWPAS compared with CO-
LOS, despite the observed changes in the protein fraction. Interestingly, no differences were 
observed between COLOS and POW products, indicating that the type of spray drying used in 
this commercial production of colostrum powder is gentle in contrast to pasteurization, which 
resulted in a higher degree of protein aggregation. Furthermore, the concentration of espe-
cially TGF-β2 was reduced by pasteurization, while spray drying reduced the concentration of 
TGF-β1 in POW and POWPAS compared with COLOS. The concentration of IGF-I were not 
affected by pasteurization or spray drying. This suggests that significant amounts of the inves-
tigated proteins remain unaffected and could account for the biological effects observed to be 
protective against NEC. This is in agreement with a recent review on the effect of pasteuriza-
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tion on immune component of donor milk showing that despite a reduction of bioactive fac-
tors after pasteurization, human milk still retains its beneficial effects (40). Furthermore, sev-
eral other non-protein bioactive factors are present in milk. For example polyunsaturated fatty 
acids (PUFA), which are not affected by Holder pasteurization (41) and thus also may be pre-
served during high temperature, short time pasteurization as performed in this study. Long-
chain polyunsaturated fatty acids have shown to reduce the incidence of NEC and intestinal 
inflammation in a neonatal rat model, and TLR4 and PAFR expression in IEC-6 cells have 
been blocked by PUFA supplementation (42, 43). Further studies in the preterm pig model of 
NEC could include groups receiving BC products exposed to pasteurization or spray drying at 
lower or higher temperatures to further explore the effects of bioactive factors after heat 
treatment on intestinal repair and NEC, and the mechanism behind the effects could be stud-
ied in vitro. The gamma-irradiation used in this study did not appear to lead to significant de-
naturation of colostrum proteins as indicated by a study comparing gamma-irradiated colos-
trum from this study and non-irradiated colostrum from the same pool of colostrum (unpub-
lished data). 
We conclude that the beneficial effects of colostrum feeding in preterm pigs are not altered 
notably by spray drying or pasteurization. BC products, modified to meet the nutritional re-
quirements of the preterm infant, may therefore serve as valuable alternatives to infant for-
mula during the first critical days after birth if mother’s milk is not available for the preterm 
neonate. Studies in preterm infants are required to investigate if BC could serve as a safe and 
effective alternative, when mother’s milk is unavailable. 
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FIGURE LEGENDS 
 
FIGURE 1: Mean NEC severity scores across the five gut regions based on macroscopic tis-
sue evaluation (A), distal small intestinal villus heights (B), activity of brush-border enzymes: 
maltase (C), lactase (D), dipeptidylpeptidase IV (DPPIV) (E), aminopeptidase A (ApA) (F) 
and aminopeptidase N (ApN) (G) across the three small intestinal regions, and values for IL-
1β (H) and IL-8 (I) protein levels in distal small intestinal tissue from preterm pigs. All data 
are presented as means ± SEM, and means not sharing the same superscript letters are signifi-
cantly different (P < 0.05). 
 
FIGURE 2: Arterial plasma levels of galactose after an oral bolus of galactose given before 
(0 h, pooled values, horizontal lines) as well as 6 h and 30 h after initiation of the enteral feed-
ing period (means ± SEM) in FORM pigs (white), COLOS pigs (light gray), POW pigs (dark 
gray) and POWPAS pigs (black). Means not sharing the same superscript letters within the 
same time point differ significantly (P < 0.05). 
 
FIGURE 3: FISH analysis showing representative cross sections of distal small intestine 
from preterm pigs: bacterial abundance score (red signal) = 1, no or very few microcolonies 
and distal NEC score = 1, no or minimal focal hyperaemic gastroenterocolitis (A), and bacte-
rial abundance score = 5, extensive colonization and distal NEC score = 5 (B). 
 
FIGURE 4: Total concentration and the concentration of the dominating OA in stomach (A) 
and colon contents (B) in FORM pigs (white), COLOS pigs (light gray), POW pigs (dark 
gray) and POWPAS pigs (black) (means ± SEM). Different superscript letters indicate sig-
nificant differences (P < 0.05). 
 
FIGURE 5: Effect of increasing amounts of whey prepared from COLOS (light gray), POW 
(dark gray) and POWPAS (black). Values are least-squares means ± SEM and significant 
differences within concentrations of whey are indicated by different letters, P < 0.05. 
 
FIGURE 6: Effects of spray drying and pasteurization on protein aggregation in colostrum 
determined by SDS-page. Untreated total colostrum proteins: lane 1, COLOS; lane 2, POW; 
lane 3, POWPAS; and proteins remaining in the supernatant following removal of aggregated 
proteins by centrifugation at 13,000 × g for 15 min: lane 4, COLOS; lane 5, POW; lane 6 
POWPAS. M: Molecular weight marker. 
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TABLES 
 
Table 1. Primer sequences and reaction conditions for quantitative real-time PCR analysis.  
Gene Sequence (5´- 3´) Amplicon length Ta (ºC)a MgCl2 (mM)b 
B2M F: TGAAGCACGTGACTCTCGAT R: CTCTGTGATGCCGGTTAGTG 70 62 1.5 
ACTB F: CTACGTCGCCCTGGACTTC R: GCAGCTCGTAGCTCTTCTCC 76 62 1.5 
HPRT1 F: ACACTGGCAAAACAATGCAA  R: TGCAACCTTGACCATCTTTG 71 60 
1.5 
 
IL1B F: CCAAAGAGGGACATGGAGAA R: GGGCTTTTGTTCTGCTTGAG 123 59 3.0 
IL6 F: GCAGTCACAGAACGAGTGGA  R: CAGGCTGAACTGCAGGAAAT 82 59 3.0 
IL8  F: GAAGAGAACTGAGAAGCAACAACA R: TTGTGTTGGCATCTTTACTGAGA 99 60 3.0 
IL10 F: CTGCCTCCCACTTTCTCTTG R: TCAAAGGGGCTCCCTAGTTT 95 60 1.5 
DEFB4A F: CAGGATTGAAGGGACCTGTT R: CTTCACTTGGCCTGTGTGTC 99 60 1.5 
TLR4 F: TTTCCACAAAAGTCGGAAGG R: CAACTTCTGCAGGACGATGA 145 60 3.0 
TNF F: CCCCCAGAAGGAAGAGTTTC R: CGGGCTTATCTGAGGTTTGA 92 62 1.5 
SAA F: TAAAGTGATCAGCAATGCCAAA R: TCAACCCTTGAGTCCTCCAC 96 60 3.0 
a Annealing temperature. 
b MgCl2 is the total concentration of MgCl2 in the reaction mix. 
 
 
Table 2. Relative expression of inflammatory markers in the distal small intestine1. 
Gene  FORM COLOS POW POWPAS 
IL1B 0.39 ± 0.11 1.00 ± 0.66 0.31 ± 0.25 0.05 ± 0.01 
IL6 0.24 ± 0.09 1.00 ± 0.68 0.30 ± 0.19 0.15 ± 0.03 
IL8  1.12 ± 0.38 1.00 ± 0.56 0.61 ± 0.25 0.50 ± 0.20 
IL10 1.23 ± 0.34 1.00 ± 0.33 1.50 ± 0.95 1.02 ± 0.29 
DEFB4A 1.71 ± 0.61 1.00 ± 0.27a 2.12 ± 1.03 2.30 ± 0.51b 
TLR4 1.40 ± 0.32 1.00 ± 0.18 1.23 ± 0.39 1.08 ± 0.19 
TNF 0.83 ± 0.13 1.00 ± 0.18 2.12 ± 1.12 1.39 ± 0.35 
SAA 1.44 ± 0.38 1.00 ± 0.43 2.76 ± 1.10 1.12 ± 0.50 
1Data are presented as mean ± SEM. Means within each gene not sharing the same superscript letters are signifi-
cantly different (P < 0.05). 
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Abstract 
The IPEC-J2 cell line was studied as a simplified system for investigating responses of the 
newborn intestinal epithelium to diet. Specifically the preterm intestine is sensitive to diet-
induced inflammation.  
Gene expression in IPEC-J2 cells stimulated for 2 h with milk formula (CELL-FORM), co-
lostrum (CELL-COLOS) or growth medium (CELL-CONTR), and in distal small intestinal 
samples from preterm pigs fed milk formula (PIG-FORM) or colostrum (PIG-COLOS) was 
investigated. Expression analysis of epithelial- and immune response-related genes was per-
formed using high throughput quantitative PCR.  
Nineteen genes were expressed in IPEC-J2 cells, while 28 genes were expressed in intesti-
nal samples. Principal component analysis of all expressed genes - except reference genes - 
discriminated IPEC-J2 cells from intestinal samples. Additionally, pigs, fed either colostrum 
or milk formula, were divided into 2 distinct groups, whereas no diet-dependent effects were 
seen for IPEC-J2 cells. Expression differences of DEFB1, CXCL10, IL1RN and ALPI were 
found for PIG-FORM and PIG-COLOS, while only IL8 were up regulated in CELL-FORM 
compared with CELL-CONTR.  
The lacking responses of IPEC-J2 cells to diets known to affect inflammatory markers in 
the preterm intestine, indicate that careful considerations must be made prior to analysis and 
interpretation of diet-induced effects on gene expression in this system. 
 
 
Key words: animal model, gene expression, IPEC-J2 cell line, necrotizing enterocolitis 
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Introduction 
The intestine is the site for nutrient digestion and absorption, but also a major immunological 
defense barrier that recognizes and responds to external antigens. In addition to the gut mu-
cosal immune system, intestinal epithelial cells (IECs) are involved in the initiation and coor-
dination of the intestinal immune response by production of signaling molecules including 
cytokines and chemokines [1]. The IPEC-J2 cell line originates from the jejunum of an un-
suckled neonatal pig [2] and can be used as a simple in vitro system to investigate the IECs 
immune response in newborns. It has also been used to investigate host-pathogen interactions 
and immune responses with relevance for human and swine intestinal diseases [2-7]. IPEC-J2 
cells are very similar to IECs with microvilli and tight junctions as well as expression and 
production of cytokines, defensins, TLRs, and mucins [2,5,8].  
Necrotizing enterocolitis (NEC) is a serious gastrointestinal disease in preterm infants, 
arising from a combined result of prematurity, abnormal bacterial colonization, and enteral 
feeding. In particularly, feeding with milk formula predisposes to NEC, whereas mother’s 
milk is protective [9,10]. We set out to evaluate the IPEC-J2 cell line as an in vitro system 
that could resemble the neonatal intestine and support a well-established preterm pig model of 
NEC, which has shown to be a valuable model for investigation of diet-induced effects [11-
14]. In the preterm pig model of NEC, milk formula-fed preterm pigs have more NEC lesions 
compared with preterm pigs fed porcine or bovine colostrum, rich in growth- and immuno-
modulatory factors [11,15,16].  
Compared with animal models, cell line studies are less cost intensive, associated with no 
ethical concerns and provide a highly-controlled simple system to investigate isolated factors, 
for example diet, on the IECs response. The IPEC-J2 cell line is a promising system for in 
vitro studies of innate immune functions of perinatal IECs in response to dietary stimuli. In 
this study, we evaluated the potential of IPEC-J2 as an in vitro system to study diet-induced 
effects on the perinatal intestine. We analyzed and compared expression of epithelial- and 
immune response-related genes in the IPEC-J2 cell line and in preterm pig intestinal tissue.  
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Materials and methods 
IPEC-J2 cell line study 
IPEC-J2 cells [2] were maintained in Dulbecco’s modified eagle medium-Ham’s F-12 (1:1) 
supplemented with 10% fetal calf serum, penicillin (100 U/mL), streptomycin (100 µg/mL), 
pyruvate (1 mM), and L-glutamine (2 mM) (growth medium, Sigma-Aldrich, Brøndby, Den-
mark) in a humidified atmosphere of 5% CO2 at 37 °C. Passaging was performed approxi-
mately once a week and cells between passages 82–85 were used in the experiment. Prior to 
the experiment, the cell culture was found to be free of mycoplasma. 
For the experiment, cells were transferred to Corning Transwell-COL collagen coated-
membrane (0.4 µm pore size; Sigma-Aldrich) and grown in growth medium supplemented 
with epidermal growth factor (5 mg/mL; Sigma Aldrich) and insulin-transferrin-selenium (5 
µg/mL of each; Sigma-Aldrich) until stable trans epithelial electric resistance values, meas-
ured with an EVOM - Epithelial Voltohmmeter (World Precision Instruments, Berlin, Ger-
many), were reached after approximately 12 d. The cells were stimulated for 2 h in three dif-
ferent diet-solutions: growth medium alone (CELL-CONTR, n = 4), growth medium contain-
ing 1% gamma-irradiated bovine colostrum (CELL-COLOS, n = 4), or growth medium con-
taining 1% milk formula (CELL-FORM, n = 4). These conditions were selected based on re-
sults from pre-experiments testing cell viability under different concentration of colostrum 
and milk formula, and periods of time. The colostrum and milk formula were identical to 
those in the pig study (see below). The lipid fraction and cellular debris were removed by cen-
trifugation at 3500 rpm for 20 min at 4 °C. After stimulation, the cells were gently washed 
twice with Dulbecco’s phosphate buffered saline (D8537, Sigma-Aldrich), harvested and 
stored at -80 ºC. 
 
Preterm pig study 
Nineteen preterm pigs were delivered from four sows by Caesarean section (Large White × 
Danish Landrace × Duroc, Askelygaard Farm, Roskilde, Denmark) at 105–107 d of gestation 
(90–92% gestation). Procedures for Caesarean section and nursing of the preterm pigs fol-
lowed a standard protocol [11,12]. The pigs were given total parenteral nutrition through a 
vascular catheter (4 mL/kg/h advancing to 6 mL/kg/h) for 2 d based on Nutriflex Lipid Plus 
(Braun, Melsungen, Germany) and adjusted in nutrient composition to meet the requirements 
of pigs [11]. Hereafter, pigs were stratified according to birth weight into two enteral nutrition 
groups: gamma-irradiated (1 x 10 kGy, Sterigenics, Espergærde, Denmark) bovine colostrum 
(PIG-COLOS, n = 6; kindly donated by Biofiber-Damino A/S, Gesten, Denmark) or milk 
formula (PIG-FORM, n = 13; 80 g Pepdite, 70 g Maxipro, and 75 g Liquigen per L of water, 
all products kindly donated by Nutricia, Allerød, Denmark). Bovine colostrum was collected 
from the first milking after parturition and diluted in tap water to obtain the same dry matter 
content as in the milk formula (~15 g/L). The products were stored at -20 ºC and warmed to 
body temperature in a water bath before feeding to the pigs (feeding dose interval:15 mL/kg 
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body weight/3 h). Pigs were euthanized according to earlier protocols [15] within the follow-
ing 45–50 h after initiation of enteral nutrition dependent on NEC development. Full thick-
ness tissue samples from the distal small intestinal regions were immediately snap-frozen in 
liquid nitrogen and stored at -80 ºC. All animal protocols and procedures were approved by 
the Danish National Committee on Animal Experimentation. 
 
Gene expression analysis 
Total RNA from IPEC-J2 cells was extracted using RNeasy Mini kit (Qiagen, Ballerup, 
Denmark) and on-column DNAse treated using RNase-free DNase set (Qiagen) according to 
manufacturer’s protocol. Distal intestinal tissue was homogenized and total RNA was ex-
tracted using RNeasy Lipid Tissue Midi kit (Qiagen) and on-column DNAse treated using 
RNase-free DNase set (Qiagen) according to the manufacturer’s protocol. Purity of extracted 
total RNA was assessed using UV absorption spectrums including OD 260/280 and OD 
260/230 ratios on a Nanodrop ND-1000 spectrophotometer (Saveen Biotech, Aarhus, Den-
mark), and total RNA was quantified at OD 260. Quality (integrity) of extracted total RNA 
was determined using on-chip electrophoresis on an Agilent 2100 Bioanalyzer (Agilent Tech-
nologies, Nærum, Denmark). A RNA integrity number was assigned to each sample using the 
2100 Expert software (Agilent Technologies, v.B.02.01).  
Extracted RNA was converted into cDNA by reverse transcription of 500 ng total RNA us-
ing the QuantiTECT Reverse Transcription kit (Qiagen), containing a mix of random primers 
and oligo-dT, according to the manufacturer's instructions. cDNA was diluted 1:7 in low 
EDTA TE-buffer (VWR - Bie & Berntsen, Herlev, Denmark) prior to pre amplification. Pre 
amplification was performed using TaqMan PreAmp Master Mix (Applied Biosystems, 
Nærum, Denmark). Stocks of 200 nM primer mix were prepared combining equal concentra-
tion of all primers used in the present study (Table 1), and in the following the genes will be 
denoted by their gene symbol (Table 1). TaqMan PreAmp Master Mix (5 µl) were mixed with 
2.5 µl 200 nM stock primer mix and 2.5 µl diluted cDNA, and incubated at 95 °C in 10 min 
followed by 16 cycles of 95 °C in 15 sec and 60 °C in 4 min. Pre amplified cDNA was diluted 
at least 1:4 in low EDTA TE-buffer (VWR – Bie & Berntsen) before qPCR. 
Primers were designed using Primer3 (http://frodo.wi.mit.edu/) as described in [17], and 
synthesized at TAG Copenhagen (Copenhagen, Denmark). Primer sequences and amplicon 
length are shown in Table 1. Primer amplification efficiencies and dynamic range were ac-
quired from standard curves constructed from dilution series of highly responding samples. 
Melting curves were inspected for all primer assays and agarose gel electrophoresis and se-
quencing of most amplicons was performed to ensure primer specificity.  
Quantitative PCR (qPCR) was performed in 48.48 Dynamic Array Integrated Fluidic Cir-
cuits (Fluidigm Corporation, San Francisco, CA, USA), combining 48 samples with 48 primer 
sets for 2304 simultaneous qPCR reactions. Reaction mix was prepared using the following 
components for each of the 48 sample: 3 µl ABI TaqMan Gene Expression Master Mix (Ap-
plied Biosystems), 0.3 µl 20X DNA Binding Dye Sample Loading Reagent (Fluidigm Corpo-
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ration), 0.3 µl 20X EvaGreen (Biotium, VWR - Bie & Berntsen), and 0.9 µl low EDTA TE 
Buffer (VWR - Bie & Berntsen). Reaction mix (4.5 µl) was mixed with 1.5 µl pre amplified 
cDNA. Primer mix for each of the 48 primer sets was prepared using 2.3 µl 20 µM specific 
primer (forward and reverse), 2.5 µl 2X Assay Loading Reagent (Fluidigm Corporation) and 
0.2 µl low EDTA TE-buffer (VWR - Bie & Berntsen). Reaction mix, including cDNA (5 µl) 
and primer mix (5 µl), was dispensed and loaded into the integrated Fluidic Circuit of the Dy-
namic Array using the IFC Controller (Fluidigm Corporation). After loading, the Dynamic 
Array was placed in the BioMark real-time PCR instrument (Fluidigm Corporation) and the 
following cycle parameter was used: 2 min at 50 °C, 10 min at 95 °C, followed by 35 cycles 
with denaturing for 15 s at 95 °C and annealing/elongation for 1 min at 60 °C. Melting curves 
were generated to confirm a single PCR product for each reaction (from 60 °C to 95 °C, in-
creasing 1 °C/3 s). Reactions were performed in duplicates (cDNA replicates). No-template 
controls were included to indicate potential problems with non-specific amplification or sam-
ple contaminations. Quantification cycle (Cq) was acquired using the Fluidigm Real-Time 
PCR Analysis software 3.0.2 (Fluidigm Corporation) and exported to GenEx5 (MultiD 
Analyses AB, Göteborg, Sweden).  
 
Data analysis and statistics 
Data pre-processing, normalization, relative quantification and statistics were performed us-
ing GenEx5 (MultiD Analyses AB). Data were pre-processed as follows; 1. Data were cor-
rected for PCR efficiency for each primer assay individually; 2. Inter Dynamic Array varia-
tion was compensated by using several highly stable samples as inter Dynamic Array calibra-
tors; 3. Hypoxanthine phosphoribosyl-transferase 1 (HPRT1) and beta-actin (ACTB) were 
found to be the most stably expressed reference genes in the present study using both Ge-
Norm [18] and NormFinder [19] thus, the geometric mean of these two genes were used to 
normalize all samples in GenEx5; 4. Average of cDNA technical repeats was performed after 
reference gene normalization but before Cq were transformed to linear scale (relative quanti-
ties). In rare cases of high standard deviation between the two cDNA replicates one or both of 
the samples or the primer assay were excluded from the analysis based on visually inspection 
of fluorescence- and melting curves. To visualize differential gene expression, relative ex-
pression for all samples was calculated relative to the sample with the lowest expression for 
each primer set in the group of samples tested. Data was log2 transformed prior to t-test, 
ANOVA, and Principal Component Analysis (PCA). Gene expression was considered signifi-
cantly different if the P-value < 0.05 and fold change > 2.0.  
 
Results 
An overview of genes expressed in preterm pigs intestinal tissue and IPEC-J2 cells is pre-
sented in the heat map (Figure 1), based on color coding of the expression level before pre 
processing. Within the dynamic range, 28 epithelial- and immune response related genes were 
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expressed in pig intestinal tissue, and of these, 19 genes were expressed in IPEC-J2 cells. No 
genes were expressed only in IPEC-J2 cells.  
In PIG-COLOS, DEFB1 was more highly expressed, while CXCL10, IL1RN and ALPI 
were less expressed than in PIG-FORM intestinal tissue (Figure 2A). In IPEC-J2 cells, no 
diet-induced differences were seen in the expression of DEFB1, CXCL10, and IL1RN, while 
ALPI was not expressed. However, IL8 expression was significantly higher in CELL-FORM 
compared with CELL-CONTR with intermediate expression in CELL-COLOS (Figure 2B).  
When comparing CELL-FORM and CELL-COLOS with PIG-FORM and PIG-COLOS in 
a PCA two major groups were identified (Figure 3), discriminating gene expression profiles 
of pig intestinal tissue from that of IPEC-J2 cells. Furthermore, a discrimination between 
PIG-COLOS and PIG-FORM was generally achieved by PCA, while no discrimination be-
tween CELL-COLOS and CELL-FORM was observed. As expected, major differences in 
gene expression were seen between IPEC-J2 cells and pig intestinal tissue, which accounted 
for the clear clustering in the PCA. 
Transcripts coding for CXCL10, CCL5 and SLC5A1 was found at a higher level in pig in-
testinal tissue compared with IPEC-J2 cells; in contrast, expression of CLDN3, DEFB1, 
IL1RN, IL6, MUC1 and OCLN was lower in intestinal tissue compared with IPEC-J2 cells.  
 
Discussion  
In this study, the IPEC-J2 cell line was evaluated as a possible in vitro system to investigate 
IECs gene expression in relation to dietary effects on the preterm intestine. To our knowledge, 
this is the first demonstration of CCL5, CD14, CXCL10, IL1RN, PAFAH1B1, SLC5A1 ex-
pression in IPEC-J2 cells. The expression of DEFB1, DEFB4A, IL6, IL8, IL18, MUC1, 
NFKBIA, NFKB1, OCLN, TLR4, TGFB1 and TNFAIP3 has been reported previously [2-
5,8,20]. However, a lack of TGFB1 expression has also been reported in infection studies [2]. 
Finally, we confirmed the lack of expression of CCL2 [8] and MUC2 [2] in IPEC-J2 cells. 
With the presence of microvilli and tight junctions [2], the IPEC-J2 cell line is a suitable sys-
tem to simulate immune functions of IECs. Still, it remains questionable if IPEC-J2 is an op-
timal system to investigate diet-related effects since the gene expression differences found in 
intestinal tissue could not be demonstrated in the IPEC-J2 cell line.  
It was possible to discriminate between the gene expression profiles of the intestinal tissue 
from preterm pigs in different diet groups, as evident from the PCA. Four genes were differ-
entially expressed between pigs fed milk formula or colostrum. DEFB1, encoding the antimi-
crobial protein defensin beta1 [21], was up regulated in PIG-COLOS compared with PIG-
FORM, which suggests that colostrum may stimulate the host antimicrobial response. The 
expression of ALPI, in addition to CXCL10 and IL1RN was down regulated in PIG-COLOS 
compared with PIG-FORM. CXCL10 is involved in T lymphocyte activation and induction of 
chemotaxis toward infected tissues [22], and IL1RN, coding for the IL-1 receptor antagonist 
has previously been found to show similar expression patterns as CXCL10 in viral lung infec-
tion of pigs (Personal communication, Kerstin Skovgaard). None of these four genes were 
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differentially expressed in IPEC-J2 cells. However, the expression of IL8, coding for the po-
tent neutrophil chemoattractant IL-8, was higher in CELL-FORM and CELL-COLOS relative 
to CELL-CONTR Thus, colostrum and milk formula might induce a certain level of pro-
inflammatory response in IPEC-J2 cells.  
Of the genes up regulated in IPEC-J2 cells relative to pig intestinal tissue, MUC and 
DEF1B stood out as highly expressed, with fold change differences of more than a 1000 (data 
not shown). These differences were probably due to the heterogeneous mixture of cells in the 
intestine, while the IPEC-J2 cell line is a homogenous sample consisting of IECs only.  
In vitro cell systems provide the opportunity to investigate the interaction between a lim-
ited numbers of factors in a standardized setting. We found, the IPEC-J2 cells and the intesti-
nal tissue clustered in two very distinct groups in the PCA of gene expression patterns. Future 
studies should include gene expression analysis of intestinal samples from term born pigs, to 
further determine if the differences in gene expression were due to the difference in matura-
tional state.  
 
Conclusion 
The IPEC-J2 cell line provides the possibility to investigate the interaction between a limited 
numbers of factors in a standardized setting. However, differences in the gene expression and 
in gene responsiveness to nutritional factors were seen between intestinal tissue from preterm 
pigs and the IPEC-J2 cell line, and therefore careful considerations must be made prior to 
analysis and interpretation of diet-induced effects on gene expression in the IPEC-J2 cell line. 
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FIGURE LEGENDS 
 
FIGURE 1: Heat map showing the Cq value of samples from the distal small intestine of 
preterm pigs and IPEC-J2 cells. No-template control (NTC). A high gene expression corre-
spond to a low Cq value (yellow), while a low gene expression correspond to a high Cq value 
(black).  
 
FIGURE 2: Relative fold changes (means  SEM) of genes expressed significantly different-
ly in intestinal tissue of COLOS pigs versus FORM pigs (A), and between different IPEC-J2 
cell treatment groups: CELL-CONTR, CELL-COLOS and CELL-FORM (B). Relative ex-
pression for all samples was calculated relative to the sample with the lowest expression with-
in each gene in the group of samples tested. Different superscript letter within each gene indi-
cate significant differences (P < 0.05). 
 
FIGURE 3: Principal component analysis of expression data from distal small intestinal tis-
sue from preterm pigs, PIG-FORM (white circles) and PIG-COLOS (black circles), and 
IPEC-J2 cells, CELL-FORM (white squares) and CELL-COLOS (black squares). 
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TABLES 
Table 1. Gene symbol, forward and reverse primer sequences, and amplicon length. 
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Gene symbol Sequence (5´- 3´) Amplicon length 
ACTB F: CTACGTCGCCCTGGACTTC R: GCAGCTCGTAGCTCTTCTCC 76 
ALPI F: TCCCAGACATACAACGTGGA R: GGTCTGGTAGTTGGCCTTGA 90 
AOAH F: GTAATGGCATTTGGGGTGTC R: TCTCCCAGCAAAATGATTCC 97 
APOA1 F: GTTCTGGGACAACCTGGAAA R: GCTGCACCTTCTTCTTCACC 86 
CCL2 F: GCAAGTGTCCTAAAGAAGCAGTG R: TCCAGGTGGCTTATGGAGTC 103 
CCL3 F: CCAGGTCTTCTCTGCACCAC R: GCTACGAATTTGCGAGGAAG 90 
CCL5 F: CTCCATGGCAGCAGTCGT R: AAGGCTTCCTCCATCCTAGC 121 
CD14 F: GGGTTCCTGCTCAGATTCTG R: CCCACGACACATTACGGAGT 164 
CD40 F: TGAGAGCCCTGGTGGTTATC R: GCTCCTTGGTCACCTTTCTG 90 
CD163 F: CACATGTGCCAACAAAATAAGAC R: CACCACCTGAGCATCTTCAA 130 
CD200 F: TCCCCAGGAAGTTTTGATTG R: CCATGGTTCTTGCTGAAGGT 84 
CLDN3 F: ATCGGCAGCAGCATTATCAC R: ACACTTTGCACTGCATCTGG 94 
CRP F: GGTGGGAGACATTGGAGATG R: GAAGGTCCCACCAGCATAGA 85 
CXCL10 F: CCCACATGTTGAGATCATTGC R: GCTTCTCTCTGTGTTCGAGGA 141 
C3 F: ATCAAATCAGGCTCCGATGA R: GGGCTTCTCTGCATTTGATG 76 
DEFB1 F: ACCTGTGCCAGGTCTACTAAAAA R: GGTGCCGATCTGTTTCATCT 109 
DEFB4A F: CAGGATTGAAGGGACCTGTT R: CTTCACTTGGCCTGTGTGTC 99 
FGG F: GAATTTTGGCTGGGAAATGA R: CAGTCCTCCAGCTGCACTCT 86 
HP F: ACAGATGCCACAGATGACAGC R: CGTGCGCAGTTTGTAGTAGG 105 
HPRT1 F: ACACTGGCAAAACAATGCAA R: TGCAACCTTGACCATCTTTG 71 
IL1B F: CCAAAGAGGGACATGGAGAA R: GGGCTTTTGTTCTGCTTGAG 123 
IL1RN F: TGCCTGTCCTGTGTCAAGTC R: GTCCTGCTCGCTGTTCTTTC 90 
IL6 F: TGGGTTCAATCAGGAGACCT R: CAGCCTCGACATTTCCCTTA 116 
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Table 1, Continued from previous page 
 
 
 
 
Gene symbol Sequence (5´- 3´) Amplicon length 
IL8 F: TTGCCAGAGAAATCACAGGA R: TGCATGGGACACTGGAAATA 78 
IL10 F: CTGCCTCCCACTTTCTCTTG R: TCAAAGGGGCTCCCTAGTTT 95 
IL18 F: CTGCTGAACCGGAAGACAAT R: TCCGATTCCAGGTCTTCATC 100 
IFNG F: CCATTCAAAGGAGCATGGAT R: TTCAGTTTCCCAGAGCTACCA 76 
ITIH41 F: ATGACAGCAAGCGAACAGTG R: GGGGATCCCTCTTGGTAATC 85 
ITIH42 F: AGGCCCTCACCATATCACAG R: GTTGCCATCCAGGACTGTTT 110 
LBP F: CCCAAGGTCAATGATAAGTTGG R: ATCTGGAGAACAGGGTCGTG 83 
LCT F: CACTCAAAGCTGTGCAGGAC R: GGATCCTTGGCAGAGAAGTG 144 
MUC1 F: GGATTTCTGAATTGTTTTTGCAG R: ACTGTCTTGGAAGGCCAGAA 116 
MUC2 F: GCACGTCTGCAACAAGGAC R: CAAAGCCCTCCAGGCAGT 125 
NFKBIA F: GAGGATGAGCTGCCCTATGAC R: CCATGGTCTTTTAGACACTTTCC 85 
NFKB1 F: CTCGCACAAGGAGACATGAA R: GGGTAGCCCAGTTTTTGTCA 97 
OCLN F: CGGTGAGAAGATTGGCTGAT R: TTTCAAAAGGCCTGGATGAC 100 
PAFAH1B1 F: GCAAACTGGCTACTGTGTGAAG R: GCACAGTCTGGTCATTGGAA 113 
PTGS2 F: AGGCTGATACTGATAGGAGAAACG R: GCAGCTCTGGGTCAAACTTC 100 
RPL13A F: ATTGTGGCCAAGCAGGTACT R: AATTGCCAGAAATGTTGATGC 76 
SAA F: TAAAGTGATCAGCAATGCCAAA R: TCAACCCTTGAGTCCTCCAC 96 
SFTPA1 F: CATGGGTGTCCTCAGTTTCC R: CATCAAAAGCGACTGACTGC 86 
SLC5A1 F: CTGCAAGAGAGTCAATGAGGAG R: CCGGTTCCATAGGCAAACT 99 
TF F: CTCAACCTCAAAACTCCTGGAA R: CCGTCTCCATCAGGTGGTA 82 
TGFB1 F: GCAAGGTCCTGGCTCTGTA R: TAGTACACGATGGGCAGTGG 97 
TLR2 F: GTTTTACGGAAATTGTGAAACTG R: TCCACATTACCGAGGGATTT 136 
TLR4 F: TTTCCACAAAAGTCGGAAGG R: CAACTTCTGCAGGACGATGA 145 
TNF F: CCCCCAGAAGGAAGAGTTTC R: CGGGCTTATCTGAGGTTTGA 92 
TNFAIP3 F: CCCAGCTTTCTCTCATGGAC R: TTGGTTCTTCTGCCGTCTCT 113 
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ABSTRACT 
Increased bacterial and C. perfringens subsp. abundance has been associated with necrotizing 
enterocolitis (NEC) in preterm infants and pigs determined mainly by conventional culturing 
and semi-quantitative molecular methods.  
Therefore, we aimed to determine if a quantitative association between NEC and total bac-
teria and/or C. perfringens in a preterm pig model could be observed. The abundance of total 
bacteria and C. perfringens measured as pg DNA/reaction in distal small intestinal samples of 
58 preterm pigs were determined using quantitative real-time PCR (qPCR). Furthermore, the 
effect of increased numbers of C. perfringens type A (multiplicity of infection (MOI) = 0–50) 
on host gene expression of 48 epithelial- and immune response related genes in IPEC-J2 cells 
was analyzed using high through-put reverse transcription qPCR.  
The abundance of total bacterial and C. perfringens DNA was significantly higher in pigs 
suffering from NEC than in healthy pigs. Transcripts coding for IL8, CCL5, IL1RN, NFKBIA 
and TNFAIP3 were up regulated in MOI = 10 compared with MOI = 0, and a following de-
crease in the expression of IL8, CCL5, IL1RN was observed at MOI = 20. TNFAIP3 and 
NFKBIA expressions were higher at MOI = 20 compared with MOI = 0. The expression of 
SLC5A1 was highest in MOI = 0 and decreased with increasing MOI. At MOI = 50, the RNA 
was highly degraded.  
In conclusion, this study showed a quantitative association between NEC and total bacte-
rial and C. perfringens abundance, and induction of changes in host gene expression with in-
creasing numbers of C. perfringens type A were observed in IPEC-J2 cells. 
 
Keywords: necrotizing enterocolitis, quantitative PCR, microbiota, C. perfringens, animal 
model, IPEC-J2 cell line. 
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Introduction  
The intestinal microbiota is a contributing factor to the development of the severe gastrointes-
tinal disease necrotizing enterocolitis (NEC) in preterm infants. Bacterial overgrowth and 
increased abundance of several specific bacterial members of the enteric microbiota have 
been shown to be associated with NEC in preterm infants and pigs (1-8). One of the patho-
gens associated with NEC in preterm infants and pigs is C. perfringens type A (1;6;9).  
In a healthy intestine, the mucosal layer prevents close contact between host cells and bac-
teria, but in preterm infants, the function and restoration of the mucosal layer may be im-
paired (10). This leads to intestinal frailty that may allow opportunistic pathogens of the resi-
dent microbiota to invade the intestinal epithelium. This was shown in a study in preterm 
pigs, in which C. perfringens invaded the intestinal tissue in preterm pigs with NEC, while C. 
perfringens was located at the tissue surface in healthy pigs (11).  
Bacterial production of toxins and metabolites such as a too high level of butyrate may 
contribute to tissue necrosis (12;13). Toxin production may be a contributing factor to the 
more rapid progression of NEC and the more extensive gangrene seen in Clostridium-
associated NEC compared with NEC associated with Klebsiella, E. coli, or B. fragilis (6;8). 
An in vitro study showed a rapid up regulation of several toxins from C. perfringens type C 
when the bacteria were in close contact with Caco-2 cells (12). Furthermore, tissue necrosis 
may also be caused by excessive carbohydrate fermentation, and Clostridium spp., including 
C. perfringens type A, have been implicated in the formation of cecal NEC lesions possibly 
through excessive production of butyrate as seen in an experimental model of NEC (13). Fur-
thermore, the gas forming capacity of Clostridium spp. may contribute to an increased devel-
opment of pneumatosis intestinalis than observed with the involvement of other bacteria (3;6). 
To quantitatively establish if an associated between bacterial abundance and/or C. perfrin-
gens and NEC can be observed, we aimed to quantify the amount of total bacteria and C. per-
fringens type A using quantitative real-time PCR (qPCR). Intestinal tissue samples from 58 
preterm pigs were included in this study and analyzed using quantitative real-time PCR 
(qPCR). To investigate the effects of C. perfringens type A on host gene expression patterns 
in intestinal epithelial cells, IPEC-J2 cells, originating from the jejunum of an unsuckled neo-
natal pig (14), were stimulated with increasing numbers of C. perfringens type A. 
 
Materials and methods 
Preterm pig study 
Fifty-eight preterm pigs from two studies (Study I, n = 31, (15;16)) and (Study II, n = 27 (17)) 
were included in this study. The pigs were delivered by Caesarean section from four sows 
(Large White × Danish Landrace × Duroc; Askelygaard, Roskilde or Research Station Sjæl-
land II, Denmark) at 105–107 d of gestation (~92%). Procedures for Caesarean section, rear-
ing, euthanasia and tissue collection were described in details previously (15-17). The pigs 
were given total parenteral nutrition (TPN, prepared as described in (18)) for 36 h. Hereafter, 
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pigs within each study were randomly assigned into enteral nutrition groups (n = 6, across 
studies; feeding dose 15 ml/kg body weight/3 h) according to birth weight.  
Enteral feeding groups from Study I included pigs fed milk formula with lactose (n = 11), 
milk formula with maltodextrin (n = 11), or milk formula with a ratio of casein to whey of 
60:40 (n = 9). The diets were formulated using Seravit, Liquigen-medium-chain triglyceride 
and Calogen long chain triglycerides (Nutricia, Allerød, Denmark); Variolac, Lacprodan al-
pha 15 and Miprodan (ARLA Foods Ingredient, Viby, Denmark); and Polycose (Abbott Nu-
trition, Colombus, Ohio, USA) (15;16).  
Enteral feeding groups from Study II included pig fed porcine colostrum (n = 5) plus pep-
tone-water placebo, milk formula plus peptone-water placebo (n = 9), milk formula plus a 
probiotic mixture of B. animalis (DSM 15954) and 4 Lactobacillus species: acidophilus 
(DSM 13241), casei (ATCC 55544), pentosus (DSM 14025), and plantarum (DSM 13367) (n 
= 13, kindly donated by Chr. Hansen, Hørsholm, Denmark). The milk formula was prepared 
from Pepdite, Maxipro and Liquigen-medium-chain triglyceride (all products kindly donated 
by SHS International, Liverpool, UK). Peptone-water placebo and probiotic boluses were 
administered (2 mL/kg body weight) every 6 h during the TPN period and every 3 h during 
the enteral feeding period. Detailed information regarding the composition of the formula and 
preparation of the probiotic mixture has been given previously (17).  
Pigs were euthanized upon NEC development or after 40–48 h of enteral feeding if no 
signs of NEC were observed. The procedures for euthanasia and tissue collection have been 
described previously (15;17). The presence of NEC was determined using a NEC severity 
score (ranging from 1–6) evaluating the degree of NEC lesion in the gastrointestinal tract as 
described previously (15;17). A score of minimum three indicated a case of NEC. For qPCR, 
full thickness tissue samples of approximately 3 cm of the distal small intestinal region with-
out luminal content were snap frozen in liquid nitrogen and stored at -80 oC until DNA extrac-
tion. Across the two studies, 34 pigs developed NEC (S-NEC); 19 pigs from Study I (S1-
NEC) and 15 pigs from Study II (S2-NEC). Twenty-four pigs showed no signs of NEC (S-
HEAL); 12 pigs from Study I (S1-HEAL) and 12 pigs from Study II (S2-HEAL). All animal 
studies were approved by the National Committee on Animal Experimentation, Denmark. 
 
qPCR analyses of total bacterial and C. perfringens abundance  
DNA from full thickness tissue samples was extracted using the QIAamp DNA mini kit 
(Qiagen, Wst Sussex, UK) according to the manufacturer’s instructions with minor modifica-
tions. Quantification of total bacteria was performed according to (19), and quantification of 
C. perfringens was performed according to (20), both with minor modifications. For total bac-
terial quantification 25 µl reaction mix consisted of 5 µl template (5 ng DNA/µl), 12.5 µL 2 x 
TaqMan Universal PCR Master Mix (Applied Biosystems, Nærum, Denmark), 0.50 µL of 
each primer: universal forward primer 8FM (5´-AGAGTTTGATCMTGGCTCAG-3´), and B. 
longum forward primer 8FB (5´-AGGGTTCGATTCTGGCTCAG-3), with universal reverse 
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primer Bact515R (5´-TTACCGCGGCKGCTGGCAC-3´) and 0.25 µL TaqMan probe 
Bact338K (5´-FAM/CCAKACTCCTACGGGAGGCAGCAG/TAMRA-3´).  
For C. perfringens quantification, 25 µl reaction mix consisted of 5 µl template (5 ng 
DNA/µl), 10 µl of a 2 x Taqman Universal PCR Master Mix (Applied Biosystems), 2 µl of 
bovine serum albumin (2.5 mg/ml, Applied Biosystems), 1 µl 20 µM of each primers CP165F 
(5´-CGC ATA ACG TTG AAA GAT GG-3´) and CP269R (5´-CCT TGG TAG GCC GTT 
ACC C-3´), and 1 µl TaqMan probe CP187F (5´- FAM/TC ATC ATT CAA CCA AAG GAG 
CAA TCC/TAMRA-3´, 2 µM). Primers and probes were synthesized at DNA Technology 
A/S, Aarhus, Denmark.  
All qPCR reactions were performed on a RotorGene 3000 Detection System (Corbett Life 
Science, Sydney, Australia) under the following conditions: 95 ºC for 10 min, followed by 40 
cycles of 95 ºC for 30 s, 55 ºC for 30 s, 60 ºC for 45 s, 65 ºC for 15 s, and 72 ºC for 15 s for 
quantification of total bacteria, and 95 ºC for 10 min, 45 cycles of denaturation at 94 ºC for 10 
s, 55ºC for 20 s, and 70 ºC for 10 s for C. perfringens quantification. Standard curves were 
generated from DNA extracted from C. perfringens (NCTC 10240, National Veterinary Insti-
tute) ranging over six tenfold dilutions from the limit of detection (0.1 pg DNA/µl for total 
bacteria and 0.0125 pg DNA/µl for C. perfringens).The cycle threshold was determined using 
the Rotor-Gene 3000 data analysis software (Corbett Life Science) using the Auto-Find 
Threshold function. Both Dynamic Tube Normalisation and Noise Slope Correction functions 
were activated and a “best-fit” regression line was generated. All standards and samples were 
run in triplicates, and every qPCR reaction plate included one no-template control in tripli-
cate. The results were calculated as pg DNA/reaction.  
 
Infection study in IPEC-J2 cells 
From an overnight culture of C. perfringens type A (NCTC 10240, National Veterinary Insti-
tute) a single bacterial colony was inoculated into brain heart infusion broth (SSI diagnostics) 
and incubated 16 h at 37 ºC under anaerobic conditions. The bacterial culture was centrifuged 
at 4500 rpm for 5 min, washed twice in Dulbecco’s phosphate buffered saline (PBS, Sigma-
Aldrich, Brøndby, Denmark) and resuspended in growth medium without penicillin and strep-
tomycin. 
IPEC-J2 cells (14) were maintained in growth medium containing Dulbecco’s modified 
eagle medium (DMEM)-Ham’s F-12 (1:1) supplemented with 10% fetal calf serum, penicillin 
(100 U/ml), streptomycin (100 µg/ml), pyruvate (1 mM), and L-glutamine (2 mM), all pur-
chased from Sigma-Aldrich, in a humidified atmosphere of 5% CO2 at 37 °C. Passaging was 
performed once a week and cells from passage 83 were used in the experiment. Prior to the 
experiment, the cell culture was found to be free of mycoplasma. 
For the experiment, IPEC-J2 cells were grown in 6-well plates (growth area 9.5 cm2, Corn-
ing Costar cell culture plates, Sigma-Aldrich) until confluence were achieved after 4–5 days 
(8.5×106 cells). Twenty-four hours prior to the experiment, IPEC-J2 cells were incubated in 
growth medium without penicillin and streptomycin. IPEC-J2 cells were infected with C. per-
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fringens at multiplicity of infection (MOI) = 0, 10, 20 and 50 and incubated for 2 h in a hu-
midified atmosphere of 5% CO2 at 37 °C. OD600 measurement of bacterial cultures was used 
to determine MOI.  
To collect IPEC-J2 cells, the supernatant from two wells was combined to harvest enough 
cells for RNA extraction. The remaining monolayers were washed with pre warmed PBS, and 
harvested with 1 x trypsin:EDTA followed by a gentle wash with pre warmed growth medium 
and pooled with the supernatant containing the detached cells. The collected IPEC-J2 cells 
were centrifuged for 10 min at 1000 rpm and 4 °C, the supernatant removed completely, and 
the cells were immediately stored at -80 °C. 
 
Gene expression analysis of IPEC-J2 
For quantitative reverse transcription real-time PCR (RT-qPCR) of IPEC-J2 gene expression, 
total RNA from IPEC-J2 cells was extracted using RNeasy Mini kit (Qiagen) and on-column 
DNAse treated using RNase-free DNase set (Qiagen) according to manufacturer’s protocol. 
RT-qPCR was performed as described previously (21). After assessment of the quantity and 
quality of extracted total RNA, it was converted into cDNA by reverse transcription of 500 ng 
total RNA using the QuantiTECT Reverse Transcription kit (Qiagen), containing a mix of 
random primers (Table 1, TAG Copenhagen, Copenhagen, Denmark) and oligo-dT, according 
to the manufacturer’s instructions. cDNA was diluted 1:7 in low EDTA TE-buffer (VWR - 
Bie & Berntsen, Herlev, Denmark) prior to pre amplification performed as previously de-
scribed (21). qPCR was performed in cDNA duplicates and no-template controls were in-
cluded to indicate potential problems with non-specific amplification or sample contamina-
tions. Quantification cycle (Cq) was acquired using the Fluidigm Real-Time PCR Analysis 
software 3.0.2 (Fluidigm Corporation) and exported to GenEx5 (MultiD Analyses AB, Göte-
borg, Sweden).  
 
Data analysis and statistics 
The amount of C. perfringens and total bacteria were analyzed using a non-parametric Mann 
Whitney test, and correlation analyses were performed using Spearman correlation according 
to (22) in GraphPad Prism 5 (Version 5.02, La Jolla, CA, USA). Results are presented as 
means with standard error of mean (SEM), and p < 0.05 was used as the critical level of sig-
nificance. 
For RT-qPCR of the gene expression response in IPEC-J2 cells, normalization, relative 
quantification and statistics were performed using GenEx5 (MultiD Analyses AB). Data were 
pre-processed as follows: 1. Data were corrected for PCR efficiency for each primer assay 
individually; 2. Inter Dynamic Array variation was compensated for by using several highly 
stable samples as inter Dynamic Array calibrators; 3. Hypoxanthine phosphoribosyl-
transferase 1 (HPRT1) and beta-actin (ACTB) were found to be the most stably expressed ref-
erence genes in the present study using both GeNorm (23) and NormFinder (24) thus, the 
geometric mean of these two genes was used to normalize all samples in GenEx; 4. Average 
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of cDNA replicates was calculated after reference gene normalization but before Cq was 
transformed to linear scale (relative quantities). In rare cases of high standard deviation (> 1) 
between the two cDNA replicates, one or both of the samples or the primer assay were ex-
cluded from the analysis based on visually inspection of fluorescence- and melting curves. To 
visualize differential gene expression, relative expression for all samples was calculated rela-
tive to the average expression for each gene. For graphical presentation, the normalized mean 
for the MOI = 0 group was set to one, and the normalized mean for MOI = 10 and MOI = 20 
was displayed as fold change compared to the normalized mean for the MOI = 0 group. Data 
were log2 transformed prior to t-test and ANOVA. Gene expression was considered signifi-
cantly different if p < 0.05 and fold change > 2.0.  
 
Results 
Total bacterial and C. perfringens abundance in intestinal tissue from preterm pigs 
The amount of total bacteria was significantly higher in S1-NEC compared with S1-HEAL, 
while no difference was observed between S2-NEC and S2-HEAL (Figure 1A). Across stud-
ies, the amount of total bacteria was significantly higher in S-NEC than in S-HEAL (Figure 
1A). The amount of C. perfringens was significantly higher in pigs suffering from NEC than 
healthy pigs when analyzing the studies individual or combined (Figure 1B). A positive corre-
lation between the amount of total bacteria and C. perfringens in Study I (r = 0.749, p < 
0.001), Study II (r = 0.741, p < 0.001) and across studies was observed (r = 0.708, p < 0.001). 
 
Gene expression response in IPEC-J2 cell upon C. perfringens type A infection  
The degradation of RNA measured by RIN increased with increasing MOI, from MOI = 0 to 
MOI = 20 (Figure 2A). A RIN for MOI = 50 was only obtainable for one replicate indicating 
a high degree of RNA degradation in this group (Figure 2A). This was supported by a higher 
Cq value (lower expression) for the reference genes before normalization in the MOI = 50 
group relative to the three other groups (Figure 2B). After normalization, the level of all genes 
in the MOI = 50 group was decreased compared with the other groups indicating that the ref-
erence genes could not compensate for the RNA degradation. Therefore, in the following sta-
tistical analysis the MOI = 50 group was excluded. Furthermore, one MOI = 10 replicate was 
excluded due to a very low RIN number. 6 genes were differently expressed between the dif-
ferent MOI groups (Figure 2C). The expression of IL8, CCL5, IL1RN, NFKBIA and TNFAIP3 
was up regulated in MOI = 10 compared with MOI = 0. Furthermore, TNFAIP3 and NFKBIA 
expression was higher at MOI = 20 compared with MOI = 0, while the expression of IL8, 
CCL5, IL1RN decreased at MOI = 20, to levels comparable with MOI = 0. The expression of 
SLC5A1 was highest in MOI = 0 and decreased with increasing MOI. 
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Discussion 
To our knowledge, this is the first demonstration of an association between the amount of 
total bacteria and C. perfringens and NEC in a preterm pig model of NEC based on quantita-
tive measurements. The association between the amount of total bacteria and NEC in Study I 
has been observed previously using FISH (unpublished data). The association between C. 
perfringens and NEC observed in Study II was previously found by terminal restriction frag-
ment length polymorphism, a semi-quantitative analysis (17). In contrast, the association be-
tween C. perfringens and NEC observed in Study I has not previously been observed by ter-
minal restriction fragment length polymorphism analysis or by fluorescence in situ hybridiza-
tion (FISH) (unpublished data). These results, using different methods to analyze the intesti-
nal microbiota, indicate that quantitative methods should be preferred over semi-quantitative 
methods when analyzing the complex intestinal microbiota. 
Bacterial overgrowth has also been observed in previous studies in preterm pigs (1;2) and 
thus support the observations seen in this study. Thus, the bacterial load may at some point 
reach a threshold that will stress the intestine and concomitant with immaturity of intestinal 
function and structure may lead to intestinal damage and NEC. It could therefore be specu-
lated that the association between a specific bacteria and NEC (5-8;25) is a cause of a general 
increase in total bacteria. However, the role of increasing numbers of specific pathogens like 
C. perfringens Type A in the induction of intestinal injury may still be significant, as ob-
served in this study, in which increasing numbers of C. perfringens Type A lead to increased 
RNA degradation. The involvement of C. perfringens Type A in NEC development may be 
due to production of metabolites like butyrate (13) and up regulation of toxins especially 
when in close contact with epithelial cells (12) possible through the Agr-like quorum sensing 
system as seen for C. perfringens type C (26). However, no positive correlation between C. 
perfringens α-toxins and NEC severity and mortality rate has been established in preterm in-
fants (6).  
Increasing numbers of C. perfringens type A in this study were associated with decreased 
integrity of the RNA measured by RIN and increasing Cq values of reference genes in IPEC-
J2 cells after 2 hours incubation. This supports a study by Vidal et al. (12), who found that 3 
hours of infection with C. perfringens type C at MOI = 20 was enough to induce morphologi-
cal changes in Caco-2 cells, while 3 h incubation lead to a cytotoxic effect. In this study, RNA 
was degraded at MOI = 50. This however, was not reflected in changes in cell morphology in 
a chamber study using the same experimental setup as in this study, in which IPEC-J2 cells 
appeared to have a normal cell morphology at MOI = 50 (unpublished data). The present 
study furthermore showed that changes in intestinal epithelial gene expression is observed 
already at MOI = 10, where the cells still maintained their RNA integrity.  
The expression of the pro-inflammatory factors IL8 and CCL5 in addition to the anti-
inflammatory factors IL1RN, IkBA and TNPAIP3 was up regulated at MOI = 10 compared 
with MOI = 0. The up regulation of both pro- and anti-inflammatory factors in response to 
NEC has also been observed in preterm infants (27;28) and pigs (Personal communication, A. 
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C. F. Støy). With increased MOI and RNA degradation, the gene expression level of the so-
dium-glucose cotransporter, SGLT1, decreased. The sodium-glucose transporter-1 has been 
found to be involved in cytoprotection of intestinal epithelial cells via anti-apoptotic signaling 
during intestinal stress (29;30;30;31). Thus, the decrease in SLC5A1 may be partly involved 
in a decrease in anti-apoptotic signaling leading to cell damage.  
Future studies should include experiments on the effect of probiotic bacteria on the IPEC-
J2 cell line. Probiotic bacteria given as supplement to milk formula has in Study II shown to 
reduce the incidence and severity of NEC, and the number of C. perfringens compared with 
preterm pigs fed milk formula and placebo (17). The commensal and beneficial bacteria may 
reduce bacterial overgrowth of specific opportunistic pathogens and reduce the risk of close 
contact between these bacteria and host cells, and thus decrease the risk of intestinal injury 
and NEC. However, the use of probiotics to reduce NEC in preterm infants needs to be inves-
tigated further (32).  
In conclusion, the microbiota may play a significant role in the late pathogenesis of NEC 
since a quantitative association between the amount of total bacteria and C. perfringens type 
A was observed with NEC development, and gene expression changes were induced in host 
cells in vitro by C. perfringens type A. 
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FIGURE LEGENDS 
 
FIGURE 1: Association between NEC and the abundance of total bacteria (Study I, n = 26; 
Study II, n = 23, across studies, n = 49, (B)) and the abundance of C. perfringens (Study I, n = 
31; Study II, n = 24, across studies, n = 58, (A)) determined by qPCR. Results are presented 
as means ± SEM, and means within each study not sharing the same superscript letters indi-
cate significant differences: a and b, p < 0.01 and c and d, p < 0.001. Y-axis is log 10 scale. 
 
FIGURE 2: RNA integrity number (RIN) (A), Cq values before normalization for reference 
genes in the four groups (B) and relative fold changes of gene significantly different ex-
pressed between treatment groups (C) in IPEC-J2 cells stimulated with MOI = 0,10 and 20. 
Results are presented as means ± SEM, and means not sharing the same superscript letters 
indicate significant differences, p < 0.05. 
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TABLES 
 
Table 1. Gene symbol, forward and reverse primer sequences, and amplicon length. 
Gene symbol Sequence (5´- 3´) Amplicon length 
ACTB F: CTACGTCGCCCTGGACTTC R: GCAGCTCGTAGCTCTTCTCC 76 
ALPI F: TCCCAGACATACAACGTGGA R: GGTCTGGTAGTTGGCCTTGA 90 
AOAH F: GTAATGGCATTTGGGGTGTC R: TCTCCCAGCAAAATGATTCC 97 
APOA1 F: GTTCTGGGACAACCTGGAAA R: GCTGCACCTTCTTCTTCACC 86 
CCL2 F: GCAAGTGTCCTAAAGAAGCAGTG R: TCCAGGTGGCTTATGGAGTC 103 
CCL3 F: CCAGGTCTTCTCTGCACCAC R: GCTACGAATTTGCGAGGAAG 90 
CCL5 F: CTCCATGGCAGCAGTCGT R: AAGGCTTCCTCCATCCTAGC 121 
CD14 F: GGGTTCCTGCTCAGATTCTG R: CCCACGACACATTACGGAGT 164 
CD40 F: TGAGAGCCCTGGTGGTTATC R: GCTCCTTGGTCACCTTTCTG 90 
CD163 F: CACATGTGCCAACAAAATAAGAC R: CACCACCTGAGCATCTTCAA 130 
CD200 F: TCCCCAGGAAGTTTTGATTG R: CCATGGTTCTTGCTGAAGGT 84 
CLDN3 F: ATCGGCAGCAGCATTATCAC R: ACACTTTGCACTGCATCTGG 94 
CRP F: GGTGGGAGACATTGGAGATG R: GAAGGTCCCACCAGCATAGA 85 
CXCL10 F: CCCACATGTTGAGATCATTGC R: GCTTCTCTCTGTGTTCGAGGA 141 
C3 F: ATCAAATCAGGCTCCGATGA R: GGGCTTCTCTGCATTTGATG 76 
DEFB1 F: ACCTGTGCCAGGTCTACTAAAAA R: GGTGCCGATCTGTTTCATCT 109 
DEFB4A F: CAGGATTGAAGGGACCTGTT R: CTTCACTTGGCCTGTGTGTC 99 
FGG F: GAATTTTGGCTGGGAAATGA R: CAGTCCTCCAGCTGCACTCT 86 
HP F: ACAGATGCCACAGATGACAGC R: CGTGCGCAGTTTGTAGTAGG 105 
HPRT1 F: ACACTGGCAAAACAATGCAA R: TGCAACCTTGACCATCTTTG 71 
IL1B F: CCAAAGAGGGACATGGAGAA R: GGGCTTTTGTTCTGCTTGAG 123 
IL1RN F: TGCCTGTCCTGTGTCAAGTC R: GTCCTGCTCGCTGTTCTTTC 90 
IL6 F: TGGGTTCAATCAGGAGACCT R: CAGCCTCGACATTTCCCTTA 116 
IL8 F: TTGCCAGAGAAATCACAGGA R: TGCATGGGACACTGGAAATA 78 
IL10 F: CTGCCTCCCACTTTCTCTTG R: TCAAAGGGGCTCCCTAGTTT 95 
IL18 F: CTGCTGAACCGGAAGACAAT R: TCCGATTCCAGGTCTTCATC 100 
IFNG F: CCATTCAAAGGAGCATGGAT R: TTCAGTTTCCCAGAGCTACCA 76 
Continued on next page 
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Table 1, Continued from previous page 
 
Gene symbol Sequence (5´- 3´) Amplicon length 
ITIH41 F: ATGACAGCAAGCGAACAGTG R: GGGGATCCCTCTTGGTAATC 85 
ITIH42 F: AGGCCCTCACCATATCACAG R: GTTGCCATCCAGGACTGTTT 110 
LBP F: CCCAAGGTCAATGATAAGTTGG R: ATCTGGAGAACAGGGTCGTG 83 
LCT F: CACTCAAAGCTGTGCAGGAC R: GGATCCTTGGCAGAGAAGTG 144 
MUC1 F: GGATTTCTGAATTGTTTTTGCAG R: ACTGTCTTGGAAGGCCAGAA 116 
MUC2 F: GCACGTCTGCAACAAGGAC R: CAAAGCCCTCCAGGCAGT 125 
NFKBIA F: GAGGATGAGCTGCCCTATGAC R: CCATGGTCTTTTAGACACTTTCC 85 
NFKB1 F: CTCGCACAAGGAGACATGAA R: GGGTAGCCCAGTTTTTGTCA 97 
OCLN F: CGGTGAGAAGATTGGCTGAT R: TTTCAAAAGGCCTGGATGAC 100 
PAFAH1B1 F: GCAAACTGGCTACTGTGTGAAG R: GCACAGTCTGGTCATTGGAA 113 
PTGS2 F: AGGCTGATACTGATAGGAGAAACG R: GCAGCTCTGGGTCAAACTTC 100 
RPL13A F: ATTGTGGCCAAGCAGGTACT R: AATTGCCAGAAATGTTGATGC 76 
SAA F: TAAAGTGATCAGCAATGCCAAA R: TCAACCCTTGAGTCCTCCAC 96 
SFTPA1 F: CATGGGTGTCCTCAGTTTCC R: CATCAAAAGCGACTGACTGC 86 
SLC5A1 F: CTGCAAGAGAGTCAATGAGGAG R: CCGGTTCCATAGGCAAACT 99 
TF F: CTCAACCTCAAAACTCCTGGAA R: CCGTCTCCATCAGGTGGTA 82 
TGFB1 F: GCAAGGTCCTGGCTCTGTA R: TAGTACACGATGGGCAGTGG 97 
TLR2 F: GTTTTACGGAAATTGTGAAACTG R: TCCACATTACCGAGGGATTT 136 
TLR4 F: TTTCCACAAAAGTCGGAAGG R: CAACTTCTGCAGGACGATGA 145 
TNF F: CCCCCAGAAGGAAGAGTTTC R: CGGGCTTATCTGAGGTTTGA 92 
TNFAIP3 F: CCCAGCTTTCTCTCATGGAC R: TTGGTTCTTCTGCCGTCTCT 113 
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FIGURE 2 
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 Abstract 
Bacteria from the Clostridium group are associated with gastrointestinal diseases in both in-
fants and adults. Intestinal overgrowth with C. perfringens is commonly associated with ne-
crotizing enterocolitis (NEC) in preterm infants and pigs, and C. difficile plays a key role in 
antibiotics-associated diarrhea in adult patients. Studies in preterm pigs suggest that bovine 
colostrum reduces the risk and severity of NEC.  
Here, we investigate the effect of bovine hyperimmune colostrum against C. perfringens. 
The hyperimmune colostrum was prepared by immunizing late gestation pregnant cows (n = 
5) 4 times 14 days apart beginning 60 days before expected calving with COVEXIN® 8A (C. 
perfringens Type A, C and D toxoid; C. Chauvoei; C. novyi (oedematiens type B) toxoid; C. 
septicum toxoid; and C. tetani toxoid). Colostrum from the first milking was collected (H-
COLOS). This was compared with colostrum from non-immunized control cows (COLOS, n 
= 5). All cows received a standard vaccine (Rotavec Corona Vet). Western blot was used to 
confirm the presence of immunoreactivity in colostrum from immunized cows, using antigens 
extracted from C. perfringens NCTC 10240 and control species: C. difficile O27, E. coli 
ATCC 25922 and L. sakei DMS 20017.  
We confirmed hyper-immunity of the H-COLOS towards C. perfringens compared with 
COLOS, but no clear difference in band intensity or number of bands was observed towards 
C. difficile, E. coli and L. sakei between H-COLOS and COLOS.  
The results show that we were able to produce hyperimmune bovine colostrum towards C. 
perfringens. However, the practical use of hyperimmune colostrum products for preterm in-
fants remains questionable due to the diversity in bacterial species associated with NEC. 
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Introduction 
Necrotizing enterocolitis (NEC) is a severe gastrointestinal disease in preterm infants in 
which members of the intestinal microbiota, including C. perfringens, have found to be impli-
cated (1-5). C. perfringens-associated NEC results in a higher risk of pneumatosis intestinalis, 
and leads to a more severe and rapid disease course than NEC associated with Klebsiella, E. 
coli, or B. fragilis (2;3;6).  
The pathogenicity of C. perfringens is most likely due to toxin production and a short 
chain fatty acid profile with a high level of butyrate. An in vitro study has shown that the 
toxin production is up regulated when C. perfringens type C is in close contact with Caco-2 
cells (7). Furthermore, a short chain fatty acid profile with a high level of butyrate from fer-
mentation by Clostridium species including C. perfringens type A has been implicated in the 
formation of cecal NEC lesions in an experimental model of NEC (8). Normally, the mucosal 
layer prevents contact between host cells and bacteria. However, in a damaged and stressed 
intestinal environment, opportunistic pathogens like C. perfringens may invade the intestinal 
epithelium and become virulent. Therefore, a crucial step in reducing the risk of C. perfrin-
gens-associated NEC is to prevent a close contact between the bacterium and its toxins and 
the intestinal epithelial cells.  
Colostrum, rich in bioactive factors, reduces the risk and severity of NEC compared with 
infant formula in preterm pigs (9-11), and could serve as an alternative for preterm infants 
when mother’s milk is not available. Immunoglobulin found in high concentration in bovine 
colostrum, approximately 80 g/L in the first milking after parturition (12), could provide pas-
sive immunity by neutralization of microbes and their toxins by agglutination in the intestinal 
lumen (13-15). This could prevent a close contact between C. perfringens and intestinal 
epithelial cells during intestinal frailty.  
Studies have shown that hyperimmune colostrum preparations may prove to be beneficial 
against infections caused by E. coli (16) and rotavirus (17). Therefore, we aimed to investi-
gate if bovine colostrum with increased activity toward C. perfringens could be produced by 
immunizing late-gestational cows with a commercial clostridium vaccine.  
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Materials and methods 
Immunization of cows and collection of colostrum 
Five cows were immunized with COVEXIN® 8A containing C.	  perfringens	  Type	  A,	  C	  and	  D	  
toxoid;	  C.	  Chauvoei;	  C.	  novyi	  (oedematiens	  type	  B)	  toxoid;	  C.	  septicum	  toxoid;	  and	  C.	  tetani	  
toxoid (Pfizer, Ballerup, Denmark). The cows were immunized 4 times 14 days apart begin-
ning 60 days before expected calving (H-COLOS). Five cows were not immunized and their 
colostrum was used as control colostrum (COLOS). Cows from both groups received a stan-
dard vaccine containing rotavirus, coronavirus and E. coli (Rotavec Corona Vet, Intervet, 
Danmark). After calving, colostrum from the first milking was collected and stored at -20 °C. 
Before analysis, colostrum was centrifuged at 3500 rpm for 20 min at 4 °C to remove the fat 
fraction and cellular debris.  
 
Confirmation of hyperimmunity by western blot 
Antigens were extracted from overnight cultures of C. perfringens NCTC 10240 (National 
Veterinary Institute, Frederiksberg C, Denmark), and control species C. difficile O 27 (Kindly 
donated by Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark), E. 
coli ATCC 25922 (National Veterinary Institute, Frederiksberg C, Denmark), and L. sakei 
DSM 20017 (Kindly donated by The Faculty of Life Sciences, Copenhagen University, Fred-
eriksberg, Denmark). C. perfringens, C. difficile and E. coli were grown in brain hearth infu-
sion (BHI) broth (Oxoid, Greve, Denmark), while L. sakei were grown in deMan, Rogosa and 
Sharpe (MRS) broth (Oxoid) under anaerobic conditions at 37 °C.    
The antigen extraction was done essentially as described by Crichton et al. (18). Briefly, an 
overnight culture of each bacterium was centrifuged at 3,000 × g for 20 min at 4 °C to harvest 
the bacterial cells. The cell pellet was washed three times in Dulbecco’s phosphate buffered 
saline (0.137 M NaCl, 0.003 M KCl, 0.001 M CaCl2·2H20, 0.0005 M MgCl2·6H2O, 0.006 M 
Na2HP04·2H2O and 0.0015 M KH2P04, pH = 7.3). The pellet was resuspended in 0.04 M 
disodium phosphate buffer (pH 8.9) and sonicated on ice for 15 min (U50 control IKA la-
bortechnik, Staufen, Germany). The antigen extracts were stored at -80 °C.  
The protein concentration of the antigen extracts was determined on a Nanodrop ND-1000 
UV-spectrophotometer (Saveen Biotech, Århus, Denmark) and diluted to 1 mg/mL in Nu-
PAGE LDS sample buffer (4X, Life technologies, Nærum, Denmark). The diluted antigen 
suspensions were run on NuPAGE 12% Bis-Tris Gels (Life technologies) with NuPAGE 
MES SDS Running Buffer (20X, Life technologies) for one hour at 200 V and blotted onto 
PVDF membranes (Immobilon-P, Millipore) by electrophoresis at 150 mA for one hour. The 
nitrocellulose membranes were blocked with wash buffer (0.05 M Tris, 0.25 M NaCl, with 
0.4% Tween 20, pH 8.6) for ten minutes. The membranes were incubated with colostrum 
products diluted 1:100 in sample buffer for one hour at room temperature or NuPAGE LDS 
sample buffer (4X, Life technologies) as control. The blots were washed 3 times in TBS 
buffer for five minutes. The blots were incubated with streptavidin-alkaline phosphatase 
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(S2890, Sigma-Aldrich, Brøndby, Denmark) and biotinylated sheep anti-bovine IgG-heavy 
chain antibody (A10-118, Nordic BioSite ApS, Copenhagen, Denmark) and incubated one 
hour at room temperature. The blots were washed 3 times in wash buffer with 2% Tween 20 
(1:5) for ten minutes. Bound antibodies were detected using BCIP/NBT Tablets (Roche Diag-
nostics A/S, Hvidovre, Denmark), and the reaction stopped with ion exchanged water. Magic 
Mark (Life technologies) was used as molecular weight marker. 
 
Results  
Western blot confirmed increased activity towards C. perfringens in H-COLOS indicated by 
increased intensity of bands compared with COLOS. No clear difference in band intensity or 
number of bands was observed towards C. difficile, E. coli and L. sakei (Figure 1).  
 
Discussion 
Hyperimmunity of H-COLOS towards C. perfringens type was evident due to the differences 
in intensity in bands on the western blot. The increased activity towards C. perfringens NCTC 
10240, a Clostridium type A species, may be due to a specific activity of antibodies in H-
COLOS towards toxins remaining from the culture when the antigens were extracted, since 
the vaccine only contained C. perfringens Type A, C and D toxoid,	   but	   no	  C. perfringens 
whole cells. C.	  Chauvoei	  was	  included	  in	  the	  vaccine	  as	  the	  only	  whole	  cell	  bacterium,	  and	  
the	   increased	   activity	   of	  H-­‐COLOS	   towards	  C. perfringens may also be caused by cross-
reactivity between these two Clostridium species. No clear difference in band intensity or 
number of bands was observed between H-COLOS and COLOS towards C. difficile, E. coli 
and L. sakei. The presence of bands against the bacteria on the western blot for both H-
COLOS and COLOS may be due to a general production of antibodies towards the general 
bacterial population in the cow’s immediate environment (19). Furthermore, E. coli antigens 
were part of the standard vaccination program, and thus also contributing to the activity to-
wards this bacterium in the colostrum. 
The clinical use of hyperimmune colostrum products for preterm infants is questionable. 
Several other bacteria besides C. perfringens have been associated with NEC including E. coli 
(1;3), Klebsiella (1;3), Enterobacter (1), Enterococcus species (20), S. fecalis, S. aureus and 
B. fragilis (3), and in other cases no association between NEC and a specific bacterial species 
have been observed (6;21-24). Furthermore, colostrum has proven to decrease the risk of 
NEC in preterm pigs compared with infant formula (9-11). Therefore, production of colos-
trum with hyper-immunity towards one specific bacterium of several possible bacteria in-
volved in NEC may not be cost-effective. For preterm infants not able to receive mother’s 
milk, which is the optimal nutrition for infants (25), donor milk seems to be the best alterna-
tive for these patients, since it decreases the risk of NEC compared with infant formula (26). 
However, milk formula is a lifesaving alternative when mother’s milk or human donor milk is 
not available (27). The effect and safety of bovine colostrum products for preterm infants still 
needs to be investigated. 
 147 
 
Hyperimmune colostrum may prove valuable for the prevention and treatment of diseases 
caused by specific known pathogens (16;17) including antibiotics-associated diarrhea caused 
by C. difficile that has become a more severe disease with increased incidence and severity 
(28). Different colostrum preparations with hyperimmunity towards C. difficile toxins have in 
vivo and in vitro shown an effect against C. difficile diarrhea and the cytotoxic effects of C. 
difficile toxins (29;30). Furthermore, it may also prove to be effective in the prevention of 
recurrences of C. difficile diarrhea in humans (31). However, the efficacy and safety of hy-
perimmune products for human patients needs to be investigated further.  
In this study, an increased level of antibodies against C. perfringens was observed in the 
hyperimmune colostrum; however, the practical use of hyperimmune colostrum products for 
preterm infants remains questionable due to the diversity in bacterial species associated with 
NEC and the cost-effectiveness of such a product. In contrast, hyperimmune colostrum may 
prove to be useful in the prevention and treatment of diseases caused by known pathogens. 
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FIGURE LEGENDS 
 
FIGURE 1: Western blot comparing the activity towards C. perfringens (CP), C. difficile 
(CD), E. coli (EC) and L. sakei (LS) in H-COLOS and COLOS. 
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